0001079973-21-000292.txt : 20210419 0001079973-21-000292.hdr.sgml : 20210419 20210419161756 ACCESSION NUMBER: 0001079973-21-000292 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20210228 FILED AS OF DATE: 20210419 DATE AS OF CHANGE: 20210419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CANNABIS GLOBAL, INC. CENTRAL INDEX KEY: 0001413488 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 831754057 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-56141 FILM NUMBER: 21834818 BUSINESS ADDRESS: STREET 1: 520 S. GRAND AVENUE STREET 2: SUITE 320 CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: (310) 986-4929 MAIL ADDRESS: STREET 1: 520 S. GRAND AVENUE STREET 2: SUITE 320 CITY: LOS ANGELES STATE: CA ZIP: 90071 FORMER COMPANY: FORMER CONFORMED NAME: MCTC Holdings, Inc. DATE OF NAME CHANGE: 20190220 FORMER COMPANY: FORMER CONFORMED NAME: MICROCHANNEL TECHNOLOGIES CORP DATE OF NAME CHANGE: 20070925 10-Q 1 cbgl_10q-022821.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2021

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File Number: 000-27039

CANNABIS GLOBAL, INC.

(Exact name of registrant as specified in its charter)

Nevada		83-1754057
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

520 S. Grand Avenue, Suite 320
Los Angeles, CA		90071
(Address of principal executive offices)		(Zip Code)

(310) 986-4929

(Registrant’s telephone number, including area code)

(Former Name, former address and former fiscal year, if changed since last report)

Securities registered under Section 12(b) of the Exchange Act: 31,210,445

Securities registered under Section 12(g) of the Exchange Act: Common Stock

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” "non-accelerated filer," “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No ☒

As of the end of the quarterly reporting period ending February 28, 2021 there were 66,205,688 shares of the registrant’s common stock outstanding.

As of April 19, 2021, there were 72,133,317 shares of the registrant’s common stock outstanding.

CANNABIS GLOBAL, INC.

FORM 10-Q

For the Period Ended February 28, 2021

Table of Contents

PART I FINANCIAL INFORMATION

Item 1. Financial Statements

Condensed consolidated balance sheets as of February 28, 2021 (unaudited) and August 31, 2021 (audited)	3

Condensed consolidated statements of operations for the three and six months ended February 28, 2021 and February 29, 2020 (unaudited)	4

Condensed consolidated statements of equity for the six months ended February 28, 2021 and February 29, 2020 (unaudited)	5

Condensed consolidated statements of cash flows for the six months ended February 28, 2021 and February 29, 2020 (unaudited)	7

Notes to Condensed Consolidated Financial Statements (unaudited)	8

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	29

Item 4. Controls and Procedures	43

PART II OTHER INFORMATION

Item 1. Legal Proceedings	43

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	43

Item 3. Defaults Upon Senior Securities	43

Item 4. Mine Safety Disclosures	43

Item 5. Other Information	43

Item 6. Exhibits	44

Signatures	45

CANNABIS GLOBAL, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEET

(Unaudited)


	February 28,			August 31,
	2021			2020

ASSETS
Current Assets:
Cash	$	134,187		$	2,338
Accounts Receivable		218,374			—
Notes receivable, current		121,247			—
Inventory		180,155			75,338
Total Current Assets		653,963			77,676

Machinery & Equipment- Net		1,362,177			25,406

Other Assets
Long-Term Investments		650,000			1,714,903
Intangible Assets		500,000			500,000
Right of Use Asset		607,306			—
Notes Receivable		41,000			—
Security Deposit		7,200			7,200
Goodwill		8,098,603			—

TOTAL ASSETS	$	11,920,249		$	2,325,185



LIABILITIES & STOCKHOLDER'S EQUITY (DEFICIT)
Current Liabilities:
Accounts Payable	$	463,248		$	233,568
Accounts Payable - Related Party		1,139			1,139
Accrued Interest		139,401			33,301
Right of use liability, current		62,063			—
Notes payable, current		1,703,579			—
Convertible Notes, Net of Debt Discount of $1,032,292 and $678,246, respectively		1,948,152			1,866,872
Derivative Liability		2,054,739			1,125,803
Notes Payable - Related Party		616,844			499,788
Total Current Liabilities		6,989,165			3,760,471

Right of use liability, long term		545,243			—
Notes payable		126,615			—
Total Liabilities		7,661,023			3,760,471

Stockholder's Equity (Deficit)
Preferred Stock, par value $0.0001,
10,000,000 shares Authorized, 6,000,000 shares Issued and
Outstanding at February 28, 2021 and August 31, 2020		600			600
Common Stock, par value $0.001,
290,000,000 shares Authorized, 66,205,687 and 27,082,419 shares Issued and
Outstanding at February 28, 2021 and August 31, 2020, respectively		66,203			2,708
Additional Paid-In Capital		8,862,713			4,618,168
Shares to be issued		1,360			187
Preferred stock to be issued		—
Accumulated Deficit		(8,520,943	)		(6,056,949	)

Total Stockholder's Equity (Deficit) attributable to Cannabis Global, Inc.		409,933			(1,435,286	)

Noncontrolling Interest		3,849,293			—
Total Stockholders' Equity (Deficit)		4,259,226			(1,435,286	)

TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY (DEFICIT)	$	11,920,249		$	2,325,185

The accompanying notes are an integral part of these unaudited consolidated financial statements

CANNABIS GLOBAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


	For the Three Months Ended						For the Six Months Ended
	February 28,			February 29,			February 28,			February 29,
	2021			2020			2021			2020

Revenue:
Products Sales	$	25,816		$	—		$	30,226		$	5,003
Consulting Revenue- Related Party		—			—			—			5,000
Total Revenue		25,816			—			30,226			10,003

Cost of Goods Sold		6,653			—			7,953			2,900
Gross Profit		19,163			—			22,273			7,103.00

Operating Expenses:
Advertising Expenses		(498	)		14,262			50,524			15,694
Consulting Services		20,750			67,662			252,051			103,545
Professional Fees		129,263			133,159			179,895			282,114
General and Administrative Expenses		282,056			195,832			396,492			383,355
Total Operating Expenses		431,571			410,915			878,962			784,708

Operating Loss		(412,408	)		(410,915	)		(856,689	)		(777,605	)

Other Income (Expense)
Interest Expense		(1,933,728	)		(522,203	)		(2,706,483	)		(553,453	)
Changes in FV of Derivatives		593,235			170,922			1,308,912			183,425
Other Income		1,522			—			1,642
Equity method loss		(359,391	)		—			(211,376	)		—
Total Other Income (Expense)		(1,698,362	)		(351,281	)		(1,607,305	)		(370,028	)

Net Loss		(2,110,770	)		(762,196	)		(2,463,994	)		(1,147,633	)

Net loss attributable to noncontrolling interest		—			—			—			—

Net loss attributable to Cannabis Global, Inc.	$	(2,110,770	)	$	(762,196	)	$	(2,463,994	)	$	(1,147,633	)

Basic & Diluted Loss per Common Share	$	(0.05	)	$	(0.06	)	$	(0.06	)	$	(0.09	)

Weighted Average Common Shares
Outstanding		43,196,439			12,321,639			39,744,494			12,752,506

The accompanying notes are an integral part of these unaudited consolidated financial statements

CANNABIS GLOBAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT


	Class A Preferred Stock				Common Stock				Common Stock to be issued						Additional Paid In			Accumulated			Stockholders' Equity Attributable to Cannabis			Noncontrolling		Total Stockholders'
	Shares		Amount		Shares		Amount		Shares			Amount			Capital			Deficit			Global Inc.			Interest		Equity
Balance, August 31, 2019		—	$	—		12,524,307	$	1,253		1,893,333		$	189		$	1,187,574		$	(1,127,601	)	$	61,415		$	—		61,415
Common stock issued for services rendered		—		—		1,893,333		189		(1,893,333	)		(189	)		—			—			—					—
Shares Issued for Services		—		—		23,333		2								20,881						20,883					20,883
Stock based compensation		—		—		—		—		—			—			95,670			—			95,670					95,670
Proceeds from common stock subscriptions		—		—		203,333		20		—			—			74,980						75,000					75,000
Proceeds from common stock subscriptions - To be Issued		—		—		—		—		260,000			26			64,974			—			65,000					65,000
Discount on convertible note		—		—		—		—		—			—			20,000			—			20,000					20,000
Effects of Reverse stock-split						188,822		19								(19	)					—					—
Net Loss																			(385,437	)	$	(385,437	)				(385,437	)
Balance, November 30, 2019		—		—		14,833,128	$	1,483		260,000		$	26		$	1,464,060		$	(1,513,038	)	$	(47,469	)	$	—	$	(47,469	)

Common stock to be issued for investment		—		—		—		—		400,000			40			112,360					$	112,400					112,400
Proceeds from common stock subscriptions - To be Issued						260,000		26		(260,000	)		(26	)		—						—					—
Stock based compensation		—		—		—		—		—			—			94,618						94,618					94,618
Net Loss		—		—		—		—		—			—			—			(762,196	)		(762,196	)				(762,196	)
Balance, February 29, 2020		—		—		15,093,128		1,509		400,000			40			1,671,038			(2,275,234	)		(602,647	)		—		(602,647	)

CANNABIS GLOBAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT

(continued)


	Class A Preferred Stock				Common Stock				Common Stock to be issued						Additional Paid In			Accumulated			Stockholders' Equity Attributable to Cannabis			Noncontrolling		Total Stockholders'
	Shares		Amount		Shares		Amount		Shares			Amount			Capital			Deficit			Global Inc.			Interest		Equity

Balance, August 31,2020		6,000,000		600		27,082,419		2,708		1,871,858		$	187		$	4,618,168		$	(6,056,949	)	$	(1,435,286	)	$	—	$	(1,435,286	)
Stock based compensation						3,400,000		3,400								179,600			—			183,000			—		183,000
Proceeds from common stock subscriptions						510,204		510		89,796			90			(600	)		—			0			—		0
Common stock issued for investment						7,222,222		7,222		—			—			642,778			—			650,000			—		650,000
Common stock issued in settlement of convertible notes payable and accrued interest						1,500,000		1,500								28,500			—			30,000			—		30,000
Discount on convertible notes																			—			—			—		—
Preferred stock issued																—			—			—			—		—
Effects of Par value adjustment								24,372					1,683			(26,055	)		—			—			—		—
Net Loss																		$	(353,224	)		(353,224	)		—		(353,224	)
Balance, November 30, 2020		6,000,000	$	600		39,714,845	$	39,712		1,961,654		$	1,960		$	5,442,391		$	(6,410,173	)	$	(925,510	)	$	—	$	(925,510	)

Stock based compensation		—		—		4,106,543		4,107		(600,000	)		(600	)		335,827			—			339,334			—		339,334
Proceeds from common stock subscriptions		—		—		6,516,667		6,517		—			—			384,483			—			391,000			—		391,000
Common stock issued for investment		—		—		12,820,297		12,820		—			—			2,209,355			—			2,222,175			3,849,293		6,071,468
Common stock issued in settlement of convertible notes payable and accrued interest		—		—		3,047,335		3,047		—			—			213,682			—			216,729			—		216,729
Derivative impact of conversions		—		—		—		—		—			—			276,975			—			276,975			—		276,975
Net Loss		—		—		—		—		—			—			—			(2,110,770	)		(2,110,770	)		—		(2,110,770	)
Balance, February 28, 2021		6,000,000		600		66,205,687		66,203		1,361,654			1,360			8,862,713		$	(8,520,943	)		409,933			3,849,293		4,259,226

The accompanying notes are an integral part of these unaudited consolidated financial statements

CANNABIS GLOBAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)


	For the Six Months Ended
	February 28,			February 29,
	2021			2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss		(2,463,994	)		(1,147,633	)
Adjustments to reconcile net loss to net cash
used in operating activities:
Non-Cash Interest Expense		2,342,280			547,671
Equity method loss from investments		211,376			—
Depreciation Expense		1,798			1,571
Stock Based Compensation		522,334			211,171
Changes in Fair Value of Derivative Liabilities		(1,308,912	)		(183,425	)
Changes In:
Accounts Receivable		(24,767	)		(10,003	)
Inventory		(104,817	)		(22,831	)
Accounts Payable and accrued expenses		(61,053	)		79,168
Accounts Payable - Related Party		—			(1,139	)
Accrued Interest		111,311			5,782
Net Cash Used in Operating Activities		(774,444	)		(519,668	)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of Machinery & Equipment		—			(3,500	)
Cash acquired in acquisition		2,200			—
Net Cash Provided by Investing Activities		2,200			(3,500	)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issuance of Common Stock		391,000			140,000
Proceeds from convertible notes payable		1,086,000			388,101
Repayment of convertible notes payable		(578,000	)		—
Repayment of notes payable		5,093			—
Net Cash Provided by Financing Activities		904,093			528,101

Net (Decrease) Increase in Cash		131,849			4,933
Cash at Beginning of Period		2,338			152,082

Cash at End of Period		134,187			157,015

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the year for:
Interest	$	188,292		$	—
Income Taxes	$	—		$	—

Shares issued and loan incurred for acquisition of intangible assets	$	650,000		$	612,400
Common stock issued for acquisition of NPE	$	2,222,175		$	—
Increase in noncontrolling interest from acquisition of NPE	$	3,849,293			—
Shares issued for conversion of notes payable and accrued interest	$	246,729		$	—

The accompanying notes are an integral part of these unaudited consolidated financial statements

Note 1. Organization and Description of Business

Cannabis Global, Inc. is located at 520 S. Grand Avenue, Suite 320, Los Angeles, California 90071. Our telephone number is (310) 986-4929 and our website is accessible at www.cannabisglobalinc.com. Our shares of Common Stock are quoted on the OTC Markets Pink Tier, operated by OTC Markets Group, Inc., under the ticker symbol “CBGL.”

Historical Development

We incorporated in Nevada in 2005 under the name MultiChannel Technologies Corporation, a wholly owned subsidiary of Octillion Corporation, a development stage technology company focused on the identification, acquisition and development of emerging solar energy and solar related technologies. In April, 2005, we changed our name to MicroChannel Technologies, Inc., and in June, 2008, began trading on the OTC Markets under the trading symbol “MCTC.” Our business focused on research and development of a patented intellectual properties combining physical, chemical and biological cues at the “cellular” level to facilitate peripheral nerve regeneration.

On June 27, 2018, we changed domiciles from the State of Nevada to the State of Delaware, and thereafter reorganized under the Delaware Holding Company Statute. On or about July 12, 2018, we formed two subsidiaries for the purpose of effecting the reorganization. We incorporated MCTC Holdings, Inc. and MCTC Holdings Inc. incorporated MicroChannel Corp. We then effected a merger involving the three constituent entities, and under the terms of the merger we were merged into MicroChannel Corp., with MicroChannel Corp. surviving and our separate corporate existence ceasing. Following the merger, MCTC Holdings, Inc. became the surviving publicly traded issuer, and all of our assets and liabilities were merged into MCTC Holdings, Inc.’s wholly owned subsidiary MicroChannel Corp. Our shareholders became the shareholders of MCTC Holdings, Inc. on a one for one basis.

On May 25, 2019, Lauderdale Holdings, LLC, a Florida limited liability company, and beneficial owner 70.7% of our issued and outstanding common stock, sold 130,000,000 common shares, to Mr. Robert Hymers, Mr. Edward Manolos and Mr. Dan Nguyen, all of whom were previously unaffiliated parties of the Company. Each individual purchased 43,333,333 common shares for $108,333,333 or an aggregate of $325,000. These series of transactions constituted a change in control.

On August 9, 2019, we filed a DBA in California registering the operating name Cannabis Global. On July 1, 2019, the Company entered into a 100% business acquisition with Action Nutraceuticals, Inc., a company owned by our CEO, Arman Tabatabaei in exchange for $1,000 (see “Related Party Transactions”).

Subsequent to the closing of the fiscal year ending August 31, 2019, we affected a reverse split of our common shares effective as of September 30, 2019 at the rate of 1:15.

On September 11, 2019, we formed a subsidiary Aidan & Co, Inc. (“Aidan”) a California corporation as a wholly owned subsidiary of the Company. Aidan will be engaged in various related business opportunities. At this time Aidan has no operations.

On December 4, 2019, our shareholders approved and authorized (i) re-domiciling the Company from Delaware to Nevada; (ii) changing the name of the Company from MCTC Holdings, Inc. to Cannabis Global, Inc.; and, (iii) seeking a corresponding change of name and new trading symbol for the Company with FINRA.

On March 30, 2020, we filed Articles of Conversion with the Delaware Secretary of State, electing to convert and re-domicile the Company from a Delaware corporation to a newly formed Nevada corporation named Cannabis Global, Inc. Concurrently, the Registrant filed Articles of Incorporation and Articles of Domestication with the Nevada Secretary of State incorporating the Registrant in Nevada under the name Cannabis Global, Inc. and accepting the re-domicile of Registrant’s Delaware corporation. There was no change to the Registrant’s fiscal year end. As a result of our FINRA corporate action, our name was changed to Cannabis Global, Inc. and our trading symbol changed to “CBGL.”

On April 18, 2020, we formed a subsidiary Hemp You Can Feel, Inc., a California corporation (“HYCF”), as a wholly owned subsidiary of the Company. HYCF will be engaged in various related business opportunities. At this time HYCF has no operations.

On May 6, 2020, we signed a joint venture agreement with RxLeaf, Inc. (“RxLeaf”) a Delaware corporation, creating a joint venture for the purpose of marketing the Company’s products to consumers. Under the terms of the agreement, the Company will produce products, which will be sold by RX Leaf via its digital marketing assets. The Company agreed to share the profits from the joint venture on a 50/50 basis.

On July 22, 2020, we signed a management agreement with Whisper Weed, Inc., a California corporation (“Whisper Weed”). Edward Manolos, our director, is a shareholder in Whisper Weed (see “Related Party Transactions”). Whisper Weed conducts licensed delivery of cannabis products in California. The material definitive agreement requires the parties to create a separate entity, CGI Whisper W, Inc. in California as a wholly owned subsidiary of the Company. The business of CGI Whisper W, Inc. will be to provide management services for the lawful delivery of cannabis in the State of California. The Company will manage CGI Whisper W, Inc. operations. In exchange for the Company providing management services to Whisper Weed through the auspices of CGI Whisper W, Inc., the Company will receive as consideration a quarterly fee of 51% of the net profits earned by Whisper Weed. As separate consideration for the transaction, the Company agreed to issue to Whisper Weed $150,000 in the Company’s restricted common stock, valued for purposes of issuance based on the average closing price of the Company’s common stock for the twenty days preceding the entry into the material definitive agreement. Additionally, the Company agreed to amend its articles of incorporation to designate a new class of preferred shares. The preferred class will be designated and issued to Whisper Weed in an amount equal to two times the quarterly payment made to the Company. The preferred shares will be convertible into the Company’s common stock after 6 months, and shall be senior to other debts of the Company. The conversion to common stock will be based on a value of common stock equal to at least two times the actual sales for the previous 90 day period The Company agreed to include in the designation the obligation to make a single dividend payment to Whisper Weed equal to 90% of the initial quarterly net profits payable by Whisper Weed. As of February 24, 2021, the Company has not issued the common or preferred shares, and the business is in the development stage.

On August 31, 2020, we entered into a stock purchase agreement with Robert L. Hymers III (“Hymers”). Pursuant to the Stock Purchase Agreement, the Company purchased from Hymers 266,667 shares of common stock of Natural Plant Extract of California Inc., a private California corporation (“NPE”), in exchange for $2,040,000. The purchased shares of common stock represents 18.8% of the outstanding capital stock of NPE on a fully diluted basis. NPE operates a licensed psychoactive cannabis manufacturing and distribution business operation in Lynwood, California. In connection with the stock purchase agreement, we became a party to a Shareholders Agreement, dated June 5, 2020, by and among Alan Tsai, Hymers, Betterworld Ventures, LLC, Marijuana Company of America, Inc. and NPE. The Shareholders Agreement contains customary rights and obligations, including restrictions on the transfer of the Shares.

On September 30, 2020, the Company entered into a securities exchange agreement with Marijuana Company of America, Inc., a Utah corporation (“MCOA”). By virtue of the agreement, the Company issued 7,222,222 shares of its unregistered common stock to MCOA in exchange for 650,000,000 shares of MCOA unregistered common stock. The Company and MCOA also entered into a lock up leak out agreement which prevents either party from sales of the exchanged shares for a period of 12 months. Thereafter the parties may sell not more than the quantity of shares equaling an aggregate maximum sale value of $20,000 per week, or $80,000 per month until all Shares and Exchange Shares are sold.

On November 16, 2020, we entered into a business acquisition agreement with Ethos Technology LLC, dba Comply Bag, a California limited liability company (“Ethos”). Ethos is a development stage business in the process of entering the market for cannabis trackable storage bags. By virtue of the agreement, Ethos sold, assigned, and transferred to the Company all of Ethos’ business, including all of its assets and associated liabilities, in exchange for the Company’s issuance of an aggregate of 6,000,000 common shares. 3,000,000 shares were due at signing, with 1,500,000 shares being issued to Edward Manolos, and 1,500,000 shares being issued to Thang Nguyen. Mr. Manolos is our director and a related party. Mr. Nguyen is the brother of Dan Van Nguyen, our director and a related party. After Ethos ships orders for Ethos products equaling $1,000,000 to unaffiliated parties, the Company will issue to Messrs. Manolos and Nguyen an additional 1,500,000 shares of common stock each. At the closing we sold an aggregate 3,000,000 shares of Company common stock, par value $0.001, equal in value to $177,000 based on the closing price on November 16, 2020. Of the total sold, 1,500,000 shares of common stock were sold to Edward Manolos and 1,500,000 shares of common stock were sold to Thang Nguyen. We issued the above shares of its common stock pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended, available to the Company by Section 4(a)(2) promulgated thereunder due to the fact that it was an isolated issuance and did not involve a public offering of securities.

On January 27, 2021, we closed a material definitive agreement (MDA) with Edward Manolos, our director and related party. Pursuant to the MDA, the Company purchased from Mr. Manolos 266,667 shares of common stock in Natural Plant Extract of California Inc., a California corporation (“NPE”), representing 18.8% of the outstanding capital stock of NPE on a fully diluted basis. NPE operates a licensed psychoactive cannabis manufacturing and distribution business operation in Lynwood, California. NPE is a privately held corporation. Under the terms of the MDA, we acquired all beneficial ownership over the NPE shares in exchange for a purchase price of two million forty thousand dollars ($2,040,000).. In lieu of a cash payment, we agreed to issue Mr. Manolos 11,383,929 restricted common shares, valued for purposes of the MDA at $0.1792 per share. In connection with the MDA, we became a party to a Shareholders Agreement by and among Alan Tsai, Hymers, Betterworld Ventures, LLC, Marijuana Company of America, Inc. and NPE. The Shareholders Agreement contains customary rights and obligations, including restrictions on the transfer of the Shares. Mr. Manolos is our director as well as a directly of Marijuana Company of America and is therefore a related party.

On February 16, 2021, we purchased 266,667 shares of common stock of Natural Plant Extract of California Inc., a California corporation (“NPE”), from Alan Tsai, in exchange for the issuance of 1,436,368 common shares. Other than with respect to the transaction, there was no material relationship between Mr. Tsai and the Registrant. By virtue of the transaction, the Registrant acquired 18.8% of the outstanding capital stock of NPE, bringing its total beneficial ownership in NPE to 56.5%. NPE operates a licensed psychoactive cannabis manufacturing and distribution business operation in Lynwood, California. By virtue of its 56.5% ownership over NPE, the Company will control production, manufacturing and distribution of both NPE and Company products. In connection with the MDA, the Registrant became a party to a Shareholders Agreement by and among Edward Manolos, a director of the Company, Robert L. Hymers III, Betterworld Ventures, LLC, Marijuana Company of America, Inc. and NPE. The Shareholders Agreement contains customary rights and obligations concerning operations, management, including restrictions on the transfer of the Shares.

Current Business Operations

Cannabis Global conducts research and development and operates multiple cannabis businesses in California and hemp-related business in the United States. We recently announced our acquisition of a 56.5%, controlling interest in Natural Plant Extract (NPE), which operates a licensed cannabis manufacturing and distribution business in Lynwood, California, holding a Type 7 California Manufacturing and a distribution license, allowing for cannabis product distribution anywhere in the state. We plan to use the Lynwood NPE operation, combined with our internally developed technologies, as a testbed to launch multi-state operations as soon as possible after the expected removal of cannabis as a Scheduled substance from the federal CSA is completed, and interstate commerce in cannabis is approved by the federal government. As of the date of this filing, cannabis remains a Schedule 1 controlled substance and so illegal under the CSA. However, As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug. In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated. Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws).

Our operations at the Natural Plant Extract facility emphasizes cannabis product manufacturing and distribution. In addition to business opportunities available from cannabis product manufacturing and distribution to all parts of the State of California, we also sees strong synergies between NPE operations and our developing technologies in the areas of secure cannabis transport, cannabis infusions, and all-natural polymeric nanoparticle technologies.

We also have an active research and development program primarily focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Additionally we invest, or provide managerial services, in specialized areas of the regulated hemp and cannabis industries. Thus far, the Company has filed six provisional patents, three non-provisional patents and recently announced its "Comply Bag" secure cannabis transport system with integrated track and trace capabilities via smartphones, which will be available soon.

Our R&D programs included the following:

Development of new routes and vehicles for hemp extract and cannabinoid delivery to the human body.

Production of unique polymeric nanoparticles and fibers for use in oral and dermal cannabinoid delivery.

Research and commercialization of new methodologies to isolate and/or concentrate various cannabinoids and other substances that comprise industrial hemp oil and other extracts.

Establishment of new methods to increase the bioavailability of cannabinoids to the human body utilizing nanoparticles and other proven bioenhancers, including naturally occurring and insect produced glycosides.

Development of other novel inventions for the delivery of cannabinoids to the human body, which at this time are considered trade secrets by the Company.

Note 2. Going Concern Uncertainties

During recent financial reporting periods, the Company began reporting revenue and has been active in reorganizing its business operations, these revenues being generated are nominal. The Company has an accumulated deficit of $8,520,943 as of February 28, 2021, and does not have positive cash flows from operating activities. Furthermore, as shown in the accompanying financial statements for six months ended February 28, 2021, the Company had a net loss of $2,463,994 and used cash in operations of $774,444. The Company expects to incur additional losses as it executes its business strategy in the cannabis, hemp and cannabinoid marketplaces. The Company will be subject to the risks, uncertainties, and difficulties frequently encountered by early-stage companies. The Company may not be able to successfully address any or all of these risks and uncertainties. Failure to adequately do so could cause the Company’s business, results of operations, and financial condition to suffer. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance date of these financial statements.

The Company’s ability to continue as a going concern is an issue due to its net losses and negative cash flows from operations, and its need for additional financing to fund future operations. Management plans to obtain necessary funding from outside sources and through the sales of Company shares. There can be no assurance that such funds, if available, can be obtained on terms reasonable to the Company. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that may result from the outcome of this uncertainty.

Based on the Company’s current level of expenditures, management believes that cash on hand is not adequate to fund operations for the next twelve months. Management of the Company is estimating approximately $1,000,000 will be required over the next twelve months to fully execute its business strategy. These can be no assurance the Company will be able to obtain such funds.

Note 3. Summary of Significant Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the amounts reported in those statements. We have made our best estimates of certain amounts contained in our consolidated financial statements. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. However, application of our accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties, and, as a result, actual results could differ materially from these estimates. Management believes that the estimates, assumptions, and judgments involved in the accounting policies described below have the most significant impact on our consolidated financial statements.

We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.

Derivative Instruments

The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in the fair value of derivatives liability are recorded in the consolidated statement of operations under non-operating income (expense).

We evaluate all of our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, we use a weighted average Binomial option-pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Action Nutraceuticals, Inc. and Aidan & Co, Inc. All intercompany balances and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.

Inventory

Inventory is primarily comprised of work in progress. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of February 28, 2021, and August 31, 2020, market values of all of our inventory were at cost, and accordingly, no such valuation allowance was recognized.

Deposits

Deposits is comprised of advance payments made to third parties, primarily for inventory for which we have not yet taken title. When we take title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see “Costs of Revenues” below). There were no deposits as of February 28, 2021.

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

Accounts Receivable

Accounts receivable are recorded at the net value of face amount less any allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and, based on a method of specific identification of any accounts receivable for which we deem the net realizable value to be less than the gross amount of accounts receivable recorded, we establish an allowance for doubtful accounts for those balances. In determining our need for an allowance for doubtful accounts, we consider historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, our actual experience may vary from our estimates. If the financial condition of our clients were to deteriorate, resulting in their inability or unwillingness to pay our fees, we may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that we collect retainers from our clients prior to performing significant services.

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of February 28, 2021, and February 29, 2020, we had $0 and $0 allowance for doubtful accounts, respectively.

Property and Equipment, net

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Depreciation of capitalized construction in progress costs, a component of property and equipment, net, begins once the underlying asset is placed into service and is recognized over the estimated useful life. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.”

Accounting for the Impairment of Long-Lived Assets

We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets.

Beneficial Conversion Feature

market value at issuance, this feature is characterized as a beneficial conversion feature (“BCF”). We record a BCF as a debt discount pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ACF”) Topic 470-20 Debt with Conversion and Other Options. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and we amortize the discount to interest expense over the life of the debt using the effective interest method.

Revenue Recognition

For annual reporting periods after December 15, 2017, the Financial Accounting Standards Board (“FASB”) made effective ASU 2014-09 “Revenue from Contracts with Customers” to supersede previous revenue recognition guidance under current U.S. GAAP. Revenue is now recognized in accordance with FASB ASC Topic 606, Revenue Recognition. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. We determined to implement the cumulative effect adjustment approach to our implementation of FASB ASC Topic 606, with no restatement of the comparative periods presented. We intend to apply this method to any incomplete contracts we determine are subject to FASB ASC Topic 606 prospectively. As is more fully discussed below, we are of the opinion that none of our contracts for services or products contain significant financing components that require revenue adjustment under FASB ASC Topic 606.

In accordance with FASB ASC Topic 606, Revenue Recognition, we will recognize revenue when persuasive evidence of a significant financing component exists in our consulting and product sales contracts. We examine and evaluate when our customers become liable to pay for goods and services; how much consideration is paid as compared to the cash selling price of the goods or services; and, the length of time between our performance and the receipt of payment.

Product Sales

Revenue from product sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is shipped, and collectability is reasonably assured. For any shipments with destination terms, the Company defers revenue until delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant customer financing that would materially change the amount of revenue recognized under the sales transaction, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606.

Costs of Revenues

Our policy is to recognize the costs of revenue in the same manner in conjunction with revenue recognition. Costs of revenues include the costs directly attributable to revenue recognition and include compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

Stock-Based Compensation

Restricted shares are awarded to employees and entitle the grantee to receive shares of restricted common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. Stock-based compensation during the quarterly reporting period ended February 28, 2021 was $0.

Income Taxes

We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the quarterly reporting periods ending February 28, 2021 and February 29, 2020, we incurred no income taxes and had no liabilities related to federal or state income taxes.

Loss Contingencies

From time to time the Company is subject to various legal proceedings and claims that arise in the ordinary course of business. On at least a quarterly basis, consistent with ASC 450-20-50-1C, if the Company determines that there is a reasonable possibility that a material loss may have been incurred, or is reasonably estimable, regardless of whether the Company accrued for such a loss (or any portion of that loss), the Company will confer with its legal counsel, consistent with ASC 450. If the material loss is determinable or reasonably estimable, the Company will record it in its accounts and as a liability on the balance sheet. If the Company determines that such an estimate cannot be made, the Company's policy is to disclose a demonstration of its attempt to estimate the loss or range of losses before concluding that an estimate cannot be made, and to disclose it in the notes to the financial statements under Contingent Liabilities.

Net Income (Loss) Per Common Share

We report net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

Note 4. Net Loss Per Share

During three and six months ending February 28, 2021 and February 28, the Company recorded a net loss. Basic and diluted net loss per share are the same for those periods. The dilutive weighted average shares for each period reported excludes the effect of shares issuable upon conversion of debt, as the effect would have been anti-dilutive. As of February 28, 2021, the Company’s convertible debt was convertible into 13,385,151 shares of common stock.

Note 5. – Notes Receivable – Related Party

On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Receivable, Related Party and in the footnote outlining Related Party Transactions. These notes are additionally described herein in Footnote 6- Notes to Shareholders, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos’ and Mr. Nguyen’s associations as directors, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

On July 9, 2019, the Company, through its Action Nutraceuticals subsidiary, loaned, Split Tee, LLC (“Split Tee”), a venture associated with Director Edward Manolos, $20,000 to engage in an exploratory research project. An additional $20,000 was supplied to Split Tee on August 23, 2019. The loans carry interest at the rate of 10% per annum and are due in one year for issuance. In addition, The Company, via Action Nutraceuticals subsidiary, invoiced Split Tee $5,000 as a consulting fee. Because of Mr. Manolos’ association as a director, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

Note 6. Intangible Assets

On February 20, 2020, the Company entered into a material definitive agreement with Lelantos Biotech, Inc., a Wyoming corporation (“Lelantos”), and its owners. On June 15, 2020, the Company and Lelantos entered into a modification agreement cancelling the Company's obligation to issue 400,000 shares of common stock and the convertible promissory notes. The Company and Lelantos agreed to a purchase price of five hundred thousand dollars ($500,000), payable by the issuance of a promissory note. The aggregate unpaid principal amount of the note is paid in monthly payments of seven thousand, five hundred dollars ($7,500) beginning on September 1, 2020, terminating on February 1, 2025. There is no interest on the note or on the unpaid balance.

Note 7. Acquisition of Natural Plant Extract of California, Inc.

NPE Acquisition

On August 21, 2020 the Company, issued a convertible note pursuant to a Stock Purchase Agreement (the “SPA) to acquire 266,667 shares of common stock of Natural Plant Extract of California Inc., a California corporation (“NPE”), representing 18.8% of the outstanding capital stock of NPE on a fully diluted basis. With the exception of the entry into the subject material definitive agreements, no material relationship exists between the Registrant, or any of the Registrant’s affiliates or control persons and Hymers. Under the terms of the SPA, the Registrant acquired all rights and responsibilities of the equity stake for a purchase price of Two Million Forty Thousand United States Dollars ($2,040,000) (the “Purchase Price”). Relative to the payment of the Purchase Price, the registrant agreed to: 1) pay Hymers Twenty Thousand United States Dollars ($20,000) each month for a period of twenty-seven (27) months, with the first payment commencing September 1, 2020 and the remaining payments due and payable on the first day of each subsequent month until Hymers has received Five Hundred Forty Thousand United Stated Dollars ($540,000), and 2) issue Hymers a convertible promissory note in the amount of One Million Five Hundred Thousand United States Dollars ($1,500,000) (the “Note”). The Note bears interest at ten percent (10%) per annum. The Holder shall have the right at any time six (6) months after the Issuance Date to convert all or any part of the outstanding and unpaid principal, interest, fees, or any other obligation owed pursuant to the note. Conversion Price shall be calculated as follows: 60% of the lowest Trading Price of the common shares during the ten (10) days preceding the date the Company receive a notice of conversion. Unless permitted by the applicable rules and regulations of the principal securities market on which the Common Stock is then listed or traded, in no event shall the Registrant issue upon conversion of or otherwise pursuant to the note and the other notes issued more than the maximum number of shares of Common Stock that the Company can issue pursuant to any rule of the principal United States securities market on which the Common Stock is then traded, which shall be 4.99% of the total shares outstanding at any time. A debt discount of $54,212 on the note payable at issuance was calculated based on the present value of the note using an implied interest rate of 10%. A debt discount of $270,886 was recognized. Accordingly, the Company recorded an initial value of its investment in NPE of $1,714,903.

On January 27, 20201, the Company acquired an additional 18.8% interest in NPE from Edward Manolos, a Director of the Company and a related party. The Company issued 11,383,929 shares of common stock, which had a fair value of $1,821,429.

On February 16, 2021, the Company purchased 266,667 shares of common stock of NPE from Alan Tsai, in exchange for the issuance of 1,436,368 common shares of the Company, with a fair value of $400,747. Other than with respect to the transaction, there was no material relationship between Mr. Tsai and the Company. By virtue of the transaction, the Company acquired 18.8% of the outstanding capital stock of NPE, bringing its total beneficial ownership in NPE to 56.5%. The transfer of control constituted an acquisition of NPE by the Company (the “NPE Acquisition”). For the three month period following the one year anniversary of the closing date, Mr. Tsai has the sole and irrevocable option to require the Company to repurchase the common shares issued to Mr. Tsai. If the value of the shares at the time notice is given is less than $150,000, Mr. Tsai will receive $150,000. If the value of the shares at the time notices is given is greater than $150,000, then Mr. Tsai will receive the market value of the shares.

As a result of the transaction, the Company also became party to a Shareholder Agreement with respect to its ownership over the NPE Shares, dated June 5, 2020, by and among Alan Tsai, Robert Hymers III, Betterworld Ventures, LLC (“BWV”), Marijuana Company of America, Inc. and NPE. The Joinder Agreement contains terms and conditions including, but not limited to: the ownership and management of NPE, rights of shareholders concerning the transfer of shares in NPE, pre-emptive rights, drag-along rights, confidentiality, and term and termination.

The NPE acquisition is being accounted for as a business combination under ASC 805 as a result of the transfer of control. Immediately prior to obtaining control, the total investment of the Company in NPE was adjusted to fair value of $3,684,347, resulting in a loss on investment of $359,391.

The following information summarizes the provisional purchase consideration and preliminary allocation of the fair values assigned to the assets at the purchase date:

Preliminary Purchase Price Allocation:
Cash		2,200
Accounts receivable		193,607
Notes receivable		162,247
Property and equipment		1,338,569
Right of use asset – operating lease		607,306
Goodwill		8,098,603
Total assets acquired	$	10,402,532

Accounts payable and accrued expenses		289,591
Right of use liability – operating lease		607,306
Notes payable		1,825,101
Notes payable – related party		105,539
Total Liabilities Assumed	$	2,827,537

As a result of the NPE acquisition, the Company recognized a non-controlling interest as of the date of the acquisition of $3,849,293. The Company’s consolidated revenues and net loss for the three and six months ended February 28, 2021 included the results of operations since the acquisition date of NPE of $18,864 and net loss of $17,797, respectively.

Unaudited Pro Forma Financial Information

The following table sets forth the pro-forma consolidated results of operations for the three and six months ended February 28, 2021 and February 29, 2020 as if the NPE acquisition occurred on September 1, 2019. The pro forma results of operations are presented for informational purposes only and are not indicative of the results of operations that would have been achieved if the acquisitions had taken place on the dates noted above, or of results that may occur in the future.

	For the three months ended						For the six months ended
	February 28, 2021			February 29, 2020			February 28, 2021			February 29, 2020
	Pro Forma			Pro Forma			Pro Forma			Pro Forma
Revenue	$	126,820		$	229,597		$	979,866		$	334,144
Operating loss		(1,693,708	)		(557,425	)		(1,626,929	)		(973,276	)
Net loss attributable to common shareholders		(3,392,070	)		(1,019,316	)		(4,065,390	)		1,521,976
Net loss per common share	$	(0.06	)	$	(0.04	)	$	(0.08	)	$	(0.06	)

Note 8. Note Payable to Shareholders

On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Payable, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos’ and Mr. Nguyen’s associations as directors, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

Note 9. Related Party

In October 2017 – August 31, 2018, the Company incurred a related party debt in the amount of $10,000 to an entity related to the legal custodian of the Company for professional fees. As of August 31, 2018, this balance was forgiven and was included as part of the $168,048 Cancellation of Debt Income on the Statement of Operations.

In November 30, 2017 – August 31, 2018, the Company issued a $35,554 in multiple notes payable to an entity related to the legal custodian of the Company. The notes payable bear interest at an annual rate of 10% and is convertible to common shares of the Company at $0.0001 per share. On May 8, 2018, $13,000 of the principal balance on notes payable were converted to common stock. The remaining principal balance was forgiven and included as Cancellation of Debt Income on the Income Statement for the year ended August 31, 2019.

In March 2018 and May 2018, a legal custodian of the Company funded the Company $600 in advances. On August 31, 2018, this amount was reclassified as a note payable, that bears interest at an annual rate of 10% and is payable upon demand.

In connection with the above notes, the Company recognized a beneficial conversion feature of $27,954, representing the intrinsic value of the conversion features at the time of issuance. This beneficial conversion feature was accreted to interest expense during the year ended August 31, 2018.

On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen for loans made to the Company, each in the amount of $16,666,67 for a total balance of $33,334. The notes bear interest at 5% per annum and do not have a fixed payment schedule or maturity date. These notes are additionally described herein in Footnote 6 - Notes Payable.

During the three months ended February 29, 2020, the Company issued two convertible promissory notes having an aggregate principal amount of $133,101 in exchange for accrued expenses owed to related parties, of which $79,333 is payable to the Company’s Chief Executive Officer and $53,768 is payable to the Company’s previous Chief Financial Officer, Robert L. Hymers III. The notes mature two years from the respective issuance date and bear interest at the rate of 10% per annum, payable at maturity. The noteholders shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a variable conversion price of 50% of the average of the previous twenty (20) trading day closing prices of the Company’s common stock, subject to adjustment. As a result of the variable conversion prices, upon issuance, the Company recognized total debt discount of $133,101, which is being amortized to interest expense over the term of the notes. On May 22, 2020, Mr. Tabatabaei converted the principal amount of $79,333 and interest of $2,608, for a total amount of $81,941.55 into 694,902 common shares. As of August 31, 2020, the carrying value of the remaining note with the former chief financial officer was $15,884, net of debt discount of $37,884 and accrued interest was $3,138.

On April 30, 2020, the Company entered into a settlement agreement with Robert L. Hymers III, its Chief Financial Officer (the “CFO”), whereby the CFO resigned and the Company issued a promissory note for $30,000, which represented the remaining amount owed to the CFO for services rendered. The note matures December 31, 2020 and bears interest at the rate of 10% per annum, payable at maturity. The noteholder has the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a fixed conversion price of $0.02 per share, subject to adjustment. As a result of the beneficial conversion price, upon issuance, the Company recognized debt discount of $30,000, which is being amortized to interest expense over the term of the note. As of August 31, 2020, the carrying value of the note was $15,061, net of debt discount of $14,939 and accrued interest was $1,011.

On August 31, 2020, the Company issued a convertible note payable and a note payable to Robert L. Hymers III in connection with the acquisition of an 18.8% equity interest in NPE.

On November 16, 2020, the Company entered into a business acquisition agreement with Ethos Technology LLC, dba Comply Bag, a California limited liability company (“Ethos”). Ethos is a development stage business in the process of entering the market for cannabis trackable storage bags. By virtue of the agreement, Ethos sold, assigned, and transferred to the Company all of Ethos’ business, including all of its assets and associated liabilities, in exchange for the Company’s issuance of an aggregate of 6,000,000 common shares. 3,000,000 shares were due at signing, with 1,500,000 shares being issued to Edward Manolos, and 1,500,000 shares being issued to Thang Nguyen. Mr. Manolos is a director of the Company and a related party. Mr. Nguyen is the brother of Dan Van Nguyen, a director of the Company and a related party. After Ethos ships orders for Ethos products equaling $1,000,000 to unaffiliated parties, the Company will issue to Messrs. Manolos and Nguyen an additional 1,500,000 shares of common stock each.

On November 16, 2020, the Company sold an aggregate 3,000,000 shares of Company common stock, par value $0.001, equal in value to $177,000 based on the closing price on November 16, 2020. Of the total sold, 1,500,000 shares of common stock were sold to Edward Manolos and 1,500,000 shares of common stock were sold to Thang Nguyen. The sales were made in regards to the Company’s acquisition of Ethos, and its disclosures under Item 1.01 are incorporated herein by reference. The Company issued the above shares of its common stock pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended, available to the Company by Section 4(a)(2) promulgated thereunder due to the fact that it was an isolated issuance and did not involve a public offering of securities. Messrs. Manolos and Nguyen were “accredited investors” and/or “sophisticated investors” pursuant to Section 501(a)(b) of the Securities Act, who provided the Company with representations, warranties and information concerning their qualifications as “sophisticated investors” and/or “accredited investors.” The Company provided and made available to Messrs. Manolos and Nguyen full information regarding its business and operations. There was no general solicitation in connection with the offer or sale of the restricted securities. Messrs. Manolos and Nguyen acquired the restricted common stock for their own accounts, for investment purposes and not with a view to public resale or distribution thereof within the meaning of the Securities Act. The restricted shares cannot be sold unless subject to an effective registration statement by the Company, or by an exemption from registration requirements of Section 5 of the Securities Act—the existence of any such exemption subject to legal review and approval by the Company.

On January 27, 2021 Cannabis Global, Inc. (the “Registrant”) closed a material definitive agreement (MDA) with Edward Manolos, a director and related party. Pursuant to the MDA, the Registrant purchased from Mr. Manolos 266,667 shares of common stock in Natural Plant Extract of California Inc., a California corporation (“NPE”), representing 18.8% of the outstanding capital stock of NPE on a fully diluted basis. NPE operates a licensed psychoactive cannabis manufacturing and distribution business operation in Lynwood, California. NPE is a privately held corporation. Under the terms of the MDA, the Registrant acquired all beneficial ownership over the NPE shares in exchange for a purchase price of two million forty thousand dollars ($2,040,000). In lieu of a cash payment, the Registrant agreed to issue Mr. Manolos 11,383,929 restricted common shares, valued for purposes of the MDA at $0.1792 per share. In connection with the MDA, the Registrant became a party to a Shareholders Agreement by and among Alan Tsai, Hymers, Betterworld Ventures, LLC, Marijuana Company of America, Inc. and NPE. The Shareholders Agreement contains customary rights and obligations, including restrictions on the transfer of the Shares. Additionally, the Registrant intends, upon completion of the terms and conditions of the Material Definitive Agreement, to control the production, manufacturing and distribution of both NPE and the Registrant’s products

Note 10. - Notes Payable

On February 12, 2020, the Company issued three Sellers Acquisition promissory notes having an aggregate principal amount of $500,000 pursuant to an Acquisition Agreement to acquire Lelantos Biotech. The notes mature May 31, 2020; $450,000 (two tranches of $225,000) and $50,000 of the notes bear interest at the rate of 8% and 5% per annum, respectively. In the event, the notes are not paid within the Cash Repayment Period (prior to the Maturity Date), the notes specify the holder shall have two options for repayment including: [a] an Alternative Payment Stake Option equal to a 6.75%, 6.75% and 1.5% (or a pro-rated amount if the debt has been partially paid) fully diluted ownership position in the Company after August 4, 2020, August 12, 2020 and August 30, 2020, respectively; or [b] a Buy Out Option, anytime after the note has been outstanding for at least one year, equal to the total outstanding shares of the Company on the day of election, times 6.75%, 6.75% and 1.5%, respectively, times the average closing price of the Company’s common stock over the preceding 30 trading days, times 40% (due and payable within 90 days). Anti-dilution rights are provided for five years on the Sellers Acquisition notes and for 182 days after conversion to an Alternative Payment Stake. The notes include a Leak Out provision, should the Alternative Payment Stake option be elected, whereby no more than 30% of the holdings may be sold during the first 30 days after clearance for trading and no more than 25% of the remaining shares sold during any subsequent 30-day period. The notes are secured by a Security Agreement, require common shares to be reserved, are transferrable and are Senior to other debt of the Company. At maturity, on May 31, 2020, (i) the Company received forbearance agreements for the two tranches of $225,000 each whereby the maturity date was extended to July 15, 2020 and the interest rate was increased to 9%; and (ii) the $50,000 note and all accrued interest thereon, in the amount of $747, was forgiven. Accordingly, the Company recognized a gain for debt forgiveness of $50,747. On June 15, 2020, the Company entered into a modification agreement relative to the February 12, 2020 issued notes. Pursuant to the modification agreement, the Company issued a promissory note to Lantos in the amount of five hundred thousand dollars ($500,000). The Company may prepay the note in whole or in part at any time or from time to time without penalty or premium by paying the principal amount to be prepaid. The aggregate unpaid principal amount of the note is paid in monthly payments of seven thousand, five hundred dollars ($7,500) beginning on September 1, 2020, terminating on February 1, 2025. There is no interest on the note or on the unpaid balance. As of February 28, 2021, the carrying value of the notes was $450,000 and accrued interest payable was $37,676. As of August 31, 2020, the carrying value of the notes was $450,000 and accrued interest payable was $19,824.

On February 12, 2020, the Company entered into an Independent Consulting Agreement with a consultant to provide services from February 12, 2020 through December 14, 2020 (the “Consulting Agreement”). Pursuant to the Consulting Agreement, the Company issued to the consultant a Compensation promissory note having a principal amount of $100,000 for the Deferred Compensation portion of the Consulting Agreement. The note matures August 4, 2020 and bears interest at the rate of 8% per annum. In the event, the note is not paid within the Cash Repayment Period (prior to the Maturity Date), the note specifies the holder shall have two options for repayment including: [a] an Alternative Payment Stake Option equal to a 8.5% (or a pro-rated amount if the debt has been partially paid) fully diluted ownership position in the Company after August 4, 2020; or [b] a Buy Out Option, any time after the note has been outstanding for at least one year, equal to the total outstanding shares of the Company on the day of election, times 8.5% times the average closing price of the Company’s common stock over the preceding 30 trading days, times 40% (due and payable within 90 days). Anti-dilution rights are provided for five years on the Compensation note and for 182 days after conversion to an Alternative Payment Stake. The note includes a Leak Out provision, should the Alternative Payment Stake option be elected, whereby no more than 30% of the holdings may be sold during the first 30 days after clearance for trading and no more than 25% of the remaining shares sold during any subsequent 30-day period. The note is secured by a Security Agreement, requires common shares to be reserved, is transferrable and is Senior to other debt of the Company. As of February 28, 2021, the carrying value of the note was $100,000 and accrued interest payable was $8,372. As of August 31, 2020, the carrying value of the note was $100,000 and accrued interest payable was $4,405.

Note 11. Convertible Notes Payable

On March 19, 2020, the Company issued a convertible promissory note, payable in tranches, having an aggregate principal amount of $150,000, aggregate original issue discount (OID) of $15,000, and an aggregate of 468,750 three-year warrants exercisable at $0.48/share, which contain certain exercise price reset provisions in the event of dilutive issuances. The notes mature one year from the respective issuance date of each tranche and bear interest at the rate of 10% per annum, payable at maturity. Commencing immediately following the issuances, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a variable conversion price equal to the lower of 60% of the lowest closing trade price of the Company’s common stock, subject to adjustment, during the 25 trading days prior to: (i) the issuance date; or (ii) the conversion date. On March 19, 2020, the first tranche of $50,000, less OID of $5,000, was received, resulting in net proceeds to the Company of $45,000, and the Company issued 156,250 three-year warrants exercisable at $0.48 per share. On May 4, 2020, the second tranche of $25,000, less OID of $2,500, was received, resulting in net proceeds to the Company of $22,500, and the Company issued 78,125 three-year warrants exercisable at $0.48 per share. On July 10, 2020, the third tranche of $25,000, less OID of $2,500 was received, resulting in net proceeds to the Company of $22,500, and the Company issued 78,125 three year warrants exercisable at an initial price of $0.48 per share. As a result of the OID and the variable conversion price, upon issuance, the Company recognized total debt discount of $75,000, which is being amortized to interest expense over the respective term of the tranches. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. During the six months ended February 28, 2021, the Company repaid all principal and accrued interest in full.

On July 21, 2020, the Company issued a convertible promissory note with a principal amount of $78,750, with the Company receiving proceeds of $71,250 after original issue discount of $3,750 and deferred finance costs of $3,750. The note matures on July 21, 2021 and bears interest at 6% per annum. Commencing immediately following the issuances, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a variable conversion price equal to the 60% of the lowest closing trade price of the Company’s common stock, subject to adjustment, during the 30 trading days prior to: the conversion date. As a result of the OID and the variable conversion price, upon issuance, the Company recognized total debt discount of $78,750, which is being amortized to interest expense through the maturity date. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. During the six months ended February 28, 2021, the note and accrued interest were repaid in full.

In August 2020, the Company issued two convertible promissory notes with an aggregate principal amount of $129,250, with the Company receiving proceeds of $117,500 after original issue discount of $11,750. The notes mature in May 2021 and bear interest at 10% per annum. Commencing immediately following the issuances, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a fixed price of $0.1005 per share of common stock. The conversion price may reset to a lower price if the Company issues common stock to any suppliers or vendors. As a result of the OID and the potential result for dilutive issuances, upon issuance, the Company recognized total debt discount of $129,250, which is being amortized to interest expense through the maturity date. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. During the six months ended February 28, 2021, the two notes and accrued interest were repaid in full.

The Company also entered into common stock subscription agreements with this lender, totaling share issuances of 3,409,221 (of which 510,204 are to be issued as of August 31, 2020), for cash proceeds of $329,613. In connection with these subscriptions, the Company issued a convertible promissory note of $50,000 for no consideration. The note matures on August 7, 2021 and bears interest at 10$% and is convertible at a fixed price of $0.1631 per share, subject to potential rest in the event the Company issues shares to vendors or suppliers. The Company recognized total debt discount of $50,000, which is being amortized to interest expense over the respective term of the tranches. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. During the six months ended February 28, 2021, the note and accrued interest was repaid in full.

During the six months ended February 28, 2021, the Company issued four convertible promissory notes to a lender with an aggregate principal amount of $279,500, with the Company receiving proceeds of $267,000 after deferred finance costs of $12,500. The notes matures in August, September, October and December 2021 and bear interest at 8% per annum. Commencing one hundred eighty (180) days following the issuance date of the note, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at variable conversion prices of 63% of the two lowest trading prices during previous fifteen (15) trading day of the Company’s common stock, subject to adjustment. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. As a result of the variable exercise price and deferred finance costs, the Company recognized total debt discount of $279,500, which is being amortized to interest expense through the maturity date. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. One note with principal of $113,000 and accrued interest of $4,557 was repaid during the period. As of February 28 2021, the carrying value of these notes was $60,379, net of debt discount of $106,121 and accrued interest was $4,830.

On September 2, 2020, the Company issued a convertible promissory note with an aggregate principal amount of $107,000, with the Company receiving proceeds of $100,000 after original issue discount of $5,000 and deferred finance costs of $2,000. The notes mature in September 2021 and bear interest at 12% per annum. Commencing one hundred eighty (180) days following the issuance date of the notes, the noteholders shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at variable conversion price of 60% of the lowest previous twenty (20) trading day closing trade prices of the Company’s common stock, subject to adjustment. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. As a result of the variable exercise price and deferred finance costs, upon issuance, the Company recognized total debt discount of $107,000, which is being amortized to interest expense through the maturity date. This note was repaid in full during the six months ended February 28, 2021, together with accrued interest of $5,101.

On January 5, 2021, the Company entered into a Securities Purchase Agreement in connection with the issuance of a 10% convertible note with the principal amount of $110,000, with an accredited investor. The note is convertible at a fixed conversion price of $0.005. In the event of default by the Company, or after the public announcement of a change of control transaction as defined in the agreement, the conversion price is $0.001. The Company received net proceeds of $97,500. As a result of the variable exercise price of the Company’s convertible notes and deferred finance costs, upon issuance, the Company recognized total debt discount of $110,000, which is being amortized to interest expense through the maturity date.

On January 12, 2021, the Company entered into a Securities Purchase Agreement in connection with the issuance of a 10% convertible note with the principal amount of $115,500, with an accredited investor. The note is convertible beginning 61 days from issuance at a fixed conversion price of $0.10 per share or 60% or the lowest trading price for ten days prior to conversion in the event that the Company’s stock trades at less than $0.10 per share. The Company received net proceeds of $100,000. As a result of the variable exercise price of the Company’s convertible notes and deferred finance costs, upon issuance, the Company recognized total debt discount of $115,500, which is being amortized to interest expense through the maturity date. During the three months ended February 28, 2021, the lender converted principal and accrued interest of $57,750 and $585 into 583,354 shares of common stock. As of February 28, 2021, the carrying value of the note was $14,873, net of discount of $42,877, and accrued interest was $902.

On January 26, 2021, the Company entered into a Securities Purchase Agreement in connection with the issuance of a 10% convertible note with the principal amount of $243,875, with an accredited investor. The note is convertible at 70% of the average of the three lowest trading prices for 20 days prior to conversion. The Company received net proceeds of $215,500. As a result of the variable exercise price of the Company’s convertible notes and deferred finance costs, upon issuance, the Company recognized total debt discount of $243,875, which is being amortized to interest expense through the maturity date. As of February 28, 2021, the carrying value of the note was $22,049, net of discount of $221,826, and accrued interest was $2,205.

On January 26, 2021, the Company entered into a second Securities Purchase Agreement in connection with the issuance of a 10% convertible note with the principal amount of $243,875, with an accredited investor. The note is convertible at 70% of the average of the three lowest trading prices for 20 days prior to conversion. The Company received net proceeds of $215,500. As a result of the variable exercise price of the Company’s convertible notes and deferred finance costs, upon issuance, the Company recognized total debt discount of $243,875, which is being amortized to interest expense through the maturity date. As of February 28, 2021, the carrying value of the note was $22,049, net of discount of $221,826, and accrued interest was $2,205.

Related Parties

During the three months ended February 29, 2020, the Company issued two convertible promissory notes having an aggregate principal amount of $133,101 in exchange for accrued expenses owed to related parties, of which $79,333 is payable to the Company’s Chief Executive Officer and $53,768 is payable to the Robert L. Hymers III. The notes mature two years from the respective issuance date and bear interest at the rate of 10% per annum, payable at maturity. The noteholders shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a variable conversion price of 50% of the average of the previous twenty (20) trading day closing prices of the Company’s common stock, subject to adjustment. As a result of the variable conversion prices, upon issuance, the Company recognized total debt discount of $133,101, which is being amortized to interest expense over the term of the notes. On May 22, 2020, the Chief Executive Officer converted $79,333 in principal and $2,608 of accrued interest into 694,902 shares of common stock to be issued having a fair value of $232,792. The conversion resulted in the elimination of $70,313 of remaining debt discount, the elimination of $231,632 of derivative liabilities, and a $10,468 gain on conversion that resulted from a related party and was therefore included in Additional paid-in capital. On December 9, 2020, Mr. Hymers converted all principal of $53,768 and all accrued interest of $4,626 into 878,190 shares of common stock.

On April 30, 2020, the Company entered into a settlement agreement with its former Chief Financial Officer (Robert L. Hymers III, hereinafter referred to as the “CFO”) whereby the CFO resigned and the Company issued a promissory note for $30,000, which represented the remaining amount owed to the CFO for services rendered. The note matures December 31, 2020 and bears interest at the rate of 10% per annum, payable at maturity. The noteholder has the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a fixed conversion price of $0.02 per share, subject to adjustment. As a result of the beneficial conversion price, upon issuance, the Company recognized debt discount of $30,000, which is being amortized to interest expense over the term of the note. On October 9, 2020, Mr. Hymers converted the note payable into 1,500,000 shares of common stock.

The Company is in default of the $540,000 note payable to Robert Hymers. On January 3, 2021, the Company entered into a settlement agreement with Robert Hymers concerning five delinquent payments totaling $100,000, whereby 1,585,791 shares of common stock were issued in settlement of those payments. As of February 28, 2021, the Company missed two additionally $20,000 payments, i.e., January and February 2021 payments, and remains in default of this agreement.

Note 12. Derivative Liability and Far Value Measurement

Upon the issuance of the convertible promissory notes with variable conversion prices and fixed conversion prices with reset provisions, the Company determined that the features associated with the embedded conversion option embedded in the debentures should be accounted for at fair value, as a derivative liability, as the Company cannot determine if a sufficient number of shares would be available to settle all potential future conversion transactions.

At the issuance date of the convertible notes payable during the six months ended February 28, 2021, the Company estimated the fair value of all embedded derivatives of $2,154,823 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 332% to 378%, (3) risk-free interest rate of 0.09% to 0.13%, and (4) expected life of one year.

On February 28, 2021, the Company estimated the fair value of the embedded derivatives of $2,054,739 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 328%, (3) risk-free interest rate of 0.05% to 0.08%, and (4) expected life of 0.5 to 1 year.

The Company adopted the provisions of ASC 825-10, Financial Instruments (“ASC 825-10”). ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value.

•

Level 1 — Observable inputs that reflect quoted market prices (unadjusted) for identical assets and liabilities in active markets;

•

Level 2 — Observable inputs, other than quoted market prices, that are either directly or indirectly observable in the marketplace for identical or similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities; and

•

Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to the fair value of assets or liabilities.

All items required to be recorded or measured on a recurring basis are based upon Level 3 inputs.

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

The Company recognizes its derivative liabilities as Level 3 and values its derivatives using the methods discussed below. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed are that of volatility and market price of the underlying common stock of the Company.

As of February 28, 2021, the Company did not have any derivative instruments that were designated as hedges.

Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of February 28, 2021 and August 31, 2020:

	February 28, 2021		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Derivative liability	$	2,054,739	$	—	$	—	$	2,054,739

	August 31, 2020		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Derivative liability	$	1,125,803	$	—	$	—	$	1,125,803

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities for the six months ended February 28, 2021:

Balance, August 31, 2020	$	1,125,803
Transfers in due to issuance of convertible promissory notes		2,514,823
Transfers out due to repayments of convertible promissory notes		(1,255,220	)
Transfers out due to conversions of convertible promissory notes		(276,975	)
Change in derivative liability for the six months ended February 28, 2021		(53,692	)
Balance, February 28, 2021	$	2,054,739

Fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. As the stock price increases for each of the related derivative instruments, the value to the holder of the instrument generally increases, therefore increasing the liability on the Company’s balance sheet. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company’s derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the Company’s expected volatility. Increases in expected volatility would generally result in higher fair value measurement. A 10% change in pricing inputs and changes in volatilities and correlation factors would not result in a material change in our Level 3 fair value.

Note 13. Commitments, Contingencies and Leases

The Company has entered into a lease for a production and warehouse facility located in Los Angeles, California to produce such products. The term of the lease is 12 months at a base price of $3,600 per month, beginning August 2019. At this time the lease agreement has ended and the Company rents to same facility on a month-to-month basis.

Our headquarters are located at 520 S. Grand Avenue, Suite 320, Los Angeles, California 90071 where we leased office space under a contract effective August 15, 2019, expiring on August 14, 2020. We now rent the premises on a month-to-month basis and paying $800 per month.

By way of the recent acquisition of a controlling interesting Natural Plant Extract of California, the Company is a party to a lease on a building and property in Lynwood, California. The lease term ends on May 2028. The total base rent is $11,000 a month, but the Company’s portion on the lease is $8,750 as another tenant pays the balance.

Note 14. Common Stock

Subsequent to the closing of the fiscal year ending August 31, 2019, the Company affected a reverse split as of September 30, 2019, which had the effect of reducing the number of outstanding shares from 187,864,600 to 12,524,307. All share and per share amounts in this filing have been retrospectively adjusted to reflect the impact of the reverse stock split.

As of February 28, 2021, there were 66,205,687 shares of Common Stock issued and outstanding. As of the date of this filing, April 19, 2021, there were 72,133,317 shares of Common Stock issued and outstanding.

Note 15. Preferred Stock

There are 10,000,000 shares of preferred stock, par value $0.0001 per share, of the Company Preferred Stock in one or more series, and expressly authorized the Board of Directors of the Company. On December 16, 2019, the Board of Directors authorized the issuance of 8,000,000 preferred shares as “Series A Preferred Stock.” The Series A Preferred Stock is not convertible into any other form of Securities, including common shares, of the Company. Holders of Series A Preferred Stock shall be entitled to 50 votes for every Share of Series A Preferred Stock beneficially owned as of the record date for any shareholder vote or written consent. On May 28, 2020, Mr. Robert L. Hymers III, a former director and former chief financial officer, returned 2,000,000 Series A Preferred shares to the corporate treasury. As of February 28, 2021, there were 6,000,000 Series A Preferred shares issued and outstanding.

On February 28, 2021, the Company designated 1,000,000 shares of Series B Convertible Preferred Stock (“Series B Convertible Preferred Stock”). The Series B Convertible Preferred Stock earns dividends at 8% per year, and is convertible into shares of common stock at a rate of 63% of the market price, based on the average of the two lowest trading prices during the previous 15 days. Additionally, the Series B Convertible Preferred Stock is mandatorily redeemable 16 months from the issuance date in cash. The Company entered into an agreement with an investor for 153,500 shares of Series B Convertible Preferred Stock on February 28, 2021 for a total purchase amount of $153,500, and an agreement with the same investor for 78,500 shares of Series B Convertible Preferred Stock for a purchase amount of $78,500. In March 2021, the Company received proceeds of $225,000.

Note 16. Subsequent Events

On March 8, 2021, the Company sold a convertible note with a face value of $215,000. The note carries interest at 10% annually.

On March 16, 2021, the Company sold a convertible note with a face value of $215,000. The note carries interest at 10% annually.

In March 2021, the Company received $232,000 of gross proceeds for 232,000 of its Series B Convertible Preferred Stock.

On March 25, 2021, the Company sold 1,314,188 registered common shares at a price of $0.06 for a total purchase price of $78,851.28.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Except for the historical information presented in this document, the matters discussed in this Form 10-Q for the quarter ended February 28, 2021, contain forward-looking statements which involve assumptions and our future plans, strategies, and expectations. These statements are generally identified by the use of words such as “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project,” or the negative of these words or other variations on these words or comparable terminology. These statements are expressed in good faith and based upon a reasonable basis when made, but there can be no assurance that these expectations will be achieved or accomplished.

Such forward-looking statements include statements regarding, among other things, (a) our potential profitability and cash flows, (b) our growth strategies, (c) our future financing plans, and (d) our anticipated needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in this Form 10-Q generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the matters described in this Form 10-Q generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. In addition to the information expressly required to be included in this filing, we will provide such further material information, if any, as may be necessary to make the required statements, in light of the circumstances under which they are made, not misleading.

Although forward-looking statements in this report reflect the good faith judgment of our management, forward-looking statements are inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.

Except where the context otherwise requires and for purposes of this Form 10-Q only, “we,” “us,” “our,” “Company,” “our Company,” and “MCTC” refer to Cannabis Global, Inc, formerly known as MCTC Holdings, Inc.

Overview

The following discussion and analysis of our financial condition and results of operations (“MD&A”) should be read in conjunction with our financial statements and the accompanying notes to the financial statements included in this Form 10-Q.

The MD&A is based on our financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities and expenses and related disclosure of contingent assets and liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Description of Business

Cannabis Global is a research and development company that also operates multiple cannabis businesses in California and hemp-related business in the United States. We are in the process of organizing business operations which will produce hemp products for international markets, and will supply transport technologies for shippers of hemp and cannabis.

We recently announced our acquisition a 56.5%, controlling interest in Natural Plant Extract (NPE), which operates a licensed cannabis manufacturing and distribution business in Lynwood, California, holding a Type 7 California Manufacturing and a distribution license, allowing for cannabis product distribution anywhere in the state. We plan to use the Lynwood NPE operation, combined with our internally developed technologies, as a testbed to launch multi-state operations as soon as possible after the expected removal of cannabis as a Scheduled substance from the federal CSA is completed, and interstate commerce in cannabis is approved by the federal government.

The Company recently commenced operations at the Natural Plant Extract facility effective immediately with emphasis on product manufacturing and distribution. In addition to business opportunities available from product manufacturing and distribution to all parts of the State of California.

Comply Bag™

Comply Bag™ features a multi-layer, low-density polyethylene outer shell that protects valuable shipments and allows manufacturers, buyers, and processors full view of contents to assess quality. Each Comply Bag™ contains financial institution-grade tamper-evident seams, self-sealing closures, and sequential numbering to ensure what is sent is what is received. In addition, because all U.S. states have implemented specific regulations for the tracking and tracing of cannabis shipments from seed to sale, Comply Bags™ features regulator demanded tracking features, such as those required in the California Cannabis Track-and-Trace (CCTT) system, including Unique Identifier Tags (UID) mandated by California via its contracted service provider, METRC, Inc.

Cannabis-Related Research and Development

Cannabis Global also has an active research and development program primarily focused on creating and commercialize engineered technologies delivering hemp extracts and cannabinoids to the human body. Additionally, we invest, or provide managerial services, in specialized areas of the regulated hemp and cannabis industries. Thus far, the Company has filed six provisional patents, three non-provisional patents and has recently announced its Comply Bag" secure cannabis transport system with integrated track and trace capabilities via smartphones which will be available soon.

Our R&D programs included the following;

Development of new routes and vehicles for hemp extract and cannabinoid delivery to the human body.

Production of unique polymeric nanoparticles and fibers for use in oral and dermal cannabinoid delivery.

Research and commercialization of new methodologies to isolate and/or concentrate various cannabinoids and other substances that comprise industrial hemp oil and other extracts.

Development of other novel inventions for the delivery of cannabinoids to the human body, which at this time are considered trade secrets by the Company.

The Company’s strategy is to develop a growing portfolio of intellectual property relating to the processing of hemp extracts and cannabinoids into forms that are easily and efficiently delivered to the human body and to companion animals.

The Company owns no issued patents. The Company has filed multiple provisional patents and three non-provisional patents as follows:

Cannabinoid Delivery System and Method of Making

•

September 1, 2020 Original File Date - Cannabinoid Delivery System and Method of Making

•

September 6, 2021 Second Filing Date - Cannabinoid Delivery System and Method of Making

Water Soluble Compositions With Enhanced Bioavailability

•

September 24, 2019 - Water Soluble Compositions With Enhanced Bioavailability

•

This provisional patent filing was abandoned, although the Company may refile at a later date.

Printed Shape Changing Article for the Delivery of Cannabinoids

•

October 15, 2019 Original File Date - Printed Shape Changing Article for the Delivery of Cannabinoids.

•

September 23, 2021 Second File Date - Printed Shape Changing Article for the Delivery of Cannabinoids.

Cannabinoid Enriched Composition and Method of Treating a Medical Condition Therewith

•

The invention relates to a method of treating a medical condition addressed by one or more cannabinoids, and a cannabinoid enriched treatment composition. In particular, 1) wherein the cannabinoid enriched treatment is produced by honey bees yielding a dry free-flowing solid or 2) wherein the cannabinoid enriched treatment is produced by other insects.

November 4, 2019 – Original provisional patent filing - Cannabinoid enriched composition and method for dry free-flowing powder.

•

December 15, 2020 Non-provisional Patent Filing - Cannabinoid enriched composition and method of treating a medical condition therewith. This was a non-provisional patent filing.

December 15 2020, the Company filed an application under the Patent Cooperation Treaty (PCT) seeking international protection of the Cannabinoid enriched composition and method for dry free-flowing powder.

The Company plans to utilize these unique compounds and powdered technologies to produce new cannabinoid infusion technologies for drugs, foods and beverages. The solid form of the bee honey compounds are already being utilized in the Company's Hemp You Can Feel™ branded products. Cannabis Global plans to conduct additional development on its other insect-based technologies to determine the extent of the unique properties of these new insect produced cannabinoid compounds.

There can be no assurance any patent protection will be provided, or that we will be successful in protecting our patents if issued.

Electrosprayed and Electrospun Cannabinoid Compositions

The application addresses new methods for the creation of highly bioavailable and ultra-fast acting polymeric nanoparticles and nano fibers of cannabinoids for use in beverages, food, topical, and other applications.

The non-provisional application expands on the developments and technologies outlined in the provisional applications that were filed on November 4, 2019.

November 4, 2020, the Company filed an application under the Patent Cooperation Treaty (PCT) seeking international protection of the Electrosprayed and Electrospun Cannabinoid Compositions and Process to Produce inventions.

The Company believes this technology holds significant advantages over legacy cannabis infusion technologies. For example:

1) While legacy infusion technologies generally rely on chemicals to maintain stability, the Company invented a chemical free method utilizing only two ingredients. Surfactants and stabilizers are not needed.

2) The technology allows manufacturers to use only two ingredients (the “Two Ingredient Method”). Surfactants and stabilizers are not needed. This allows for the production of products with “Clean Labels”.

3) Utilizing the "Two-Ingredient" method, food, beverage, and consumer product formulators can add cannabinoids using very small amounts of product, as each of the two ingredients make up about 50% of the product. For example, the technology allows manufacturers of cannabis-infused foods to add as little as 20 milligrams of material to dose psychoactive cannabinoids at the 10 milligram legal limit within most states. Cannabis Global expects to significantly improve this already high 50% loading rate over the next few months, with loading rates of up to 75% expected.

4) by reducing cannabinoid particle sizes to nanometer proportions, ultra-high levels of active ingredients get absorbed into the body in very short periods of time. This allows formulators to use cannabis to gain a desired effect, which can result in significant cost saving, especially relating to the rare cannabinoids, which sell at many times more than common cannabinoids, such as CBD or THC.

There can be no assurance any patent protection will be provided, or that we will be successful in protecting our patents if issued.

Animal Based Cannabosides

•

On January 18, 2021, the Company filed a non-provisional patent on a novel method to produce water-soluble cannabinoids. The invention relates to a composition comprising one or more cannabosides and a method of producing one or more cannabosides. In particular, by feeding an insect a cannabinoid and harvesting the insect, excluding honey bees, to improve aqueous solubility and stability of cannabinoids. The patent claims coverage of both the process to create the compounds, and the use of the compounds in foodstuffs and pharmaceutical preparations.

We believe this set of technologies represents a new class of nature-based cannabinoid preparations. This technology is separate from our chemical free Two Ingredient nanoparticle and nano fiber infusion technologies for which we filed a patent application during November of 2002. We believe both sets of technologies are consistent with our corporate objective to introduce novel chemical free cannabinoid infusion technologies to the cannabis and hemp marketplaces.

On January 18, 2021, the Company filed an application under the Patent Cooperation Treaty (PCT) seeking international protection of a composition comprising one or more cannabosides and a method of producing one or more cannabosides.

There can be no assurance any patent protection will be provided, or that we will be successful in protecting our patents if issued.

Trademark applications are as follows:

Trade Mark – Hemp You Can Feel™ – On August 27 2019, the Company filed a trademark application with the U.S. Patent and Trademark Office (USPTO) for its Hemp You Can Feel™ trade name. The U.S. Application Serial Number is 88595425. On June 24, 2020, the Company received a Notice of Nonfinal Office Action from the USPTO indicating the Company would have six months to respond to issues presented the Company by USPTO or be abandoned. The Company plans to re-file the application.

Trade Mark – Gummies You Can Feel™. The Company received a Notice of Allowance from the USPTO on March 24, 2020. The U.S. Serial Number for the trademark is 88590925

Trade Mark – Comply Bag™. During January of 2021, the Company filed a trademark application with the U.S. Patent and Trademark Office (USPTO) for its Comply Bag™. trade name.

There can be no assurance any trademark protection will be provided, or that we will be successful in protecting our trademarks if issued.

Hemp You Can Feel Products

The Hemp You Can Feel product line consists of hemp infused foods and beverages. The infusion technologies utilized are a combination on water soluble preparations invented by the Company’s internal partner research teams.

The product line consists of the following:

•

Hemp You Can Feel™ Alcohol Replacement Cocktail Mixers – This is a line of alcohol-free cocktail mixers marketed on line via our own website site and via our marketing partners. All products in this line test as having non-detectable levels of THC.

•

Hemp You Can Feel™ Coffee Products – This is a line of hemp infused coffee products. All products in this line test as having non-detectable levels of THC.

•

Hemp You Can Feel™ Gummies – This is a line of all natural hemp infused candy products. All products in this line test as having non-detectable levels of THC.

•

Hemp You Can Feel™ Kombucha Beverages. This is a line of hemp infused fermented tea products. All products in this line test as having non-detectable levels of THC.

•

Hemp You Can Feel™ Sweeteners – This is a line of natural and artificial sweeteners consisting of:

•

Hemp You Can Feel Organic Sugar

•

Hemp You Can Feel Sucralose Blend

•

Hemp You Can Feel Stevia Blend

•

Hemp You Can Feel Aspartame

•

Hemp You Can Feel Saccharin

Upcoming additions to the product line will include:

•

Hemp You Can Feel Monk Fruit Sweetener (monk fruit extract and erythritol)

•

Hemp You Can Feel Non-Dairy Creamer

•

Hemp You Can Feel French Vanilla Non-Dairy Creamer

•

Hemp You Can Feel Non-Dairy Creamy Chocolate Creamer

Coffee Pod and Single Serving Beverage Pod Infusion System

Based on internally developed technology and those developed by the Company’s contract research organization, the Company is marketing product lines consisting of infusion technologies designed to easily and to accurately dose single serving coffee and other beverage pods.

Management Services for Whisper Weed

On July 22, 2020, we signed a management agreement with Whisper Weed, Inc., a California corporation (“Whisper Weed”). Edward Manolos, our director, is a shareholder in Whisper Weed (see “Related Party Transactions”). Whisper Weed conducts licensed delivery of cannabis products in California. The material definitive agreement requires the parties to create a separate entity, CGI Whisper W, Inc. in California as a wholly owned subsidiary of the Company. The business of CGI Whisper W, Inc. will be to provide management services for the lawful delivery of cannabis in the State of California. The Company will manage CGI Whisper W, Inc. operations. In exchange for the Company providing management services to Whisper Weed through the auspices of CGI Whisper W, Inc., the Company will receive as consideration a quarterly fee of 51% of the net profits earned by Whisper Weed. As separate consideration for the transaction, the Company agreed to issue to Whisper Weed $150,000 in the Company’s restricted common stock, valued for purposes of issuance based on the average closing price of the Company’s common stock for the twenty days preceding the entry into the material definitive agreement. Additionally, the Company agreed to amend its articles of incorporation to designate a new class of preferred shares. The preferred class will be designated and issued to Whisper Weed in an amount equal to two times the quarterly payment made to the Company. The preferred shares will be convertible into the Company’s common stock after 6 months, and shall be senior to other debts of the Company. The conversion to common stock will be based on a value of common stock equal to at least two times the actual sales for the previous 90 day period The Company agreed to include in the designation the obligation to make a single dividend payment to Whisper Weed equal to 90% of the initial quarterly net profits payable by Whisper Weed. As of February 28, 2021, the Company has not issued the common or preferred shares, and the business is in the development stage.

Sales and Marketing

The Company recently began sales and marketing activities for its products and inventions. The Company primarily plans to market its non-psychoactive products via a “white label” strategy where the company produces products marketed and sold by other companies. The Company also plans to market its products directly to consumers. The Company

Please reference the section labeled “Risk Factors to our Business” for additional information.

Significant Customers

The company has no significant customers as of the end of the last fiscal quarterly reporting period.

Competition

We are entering markets that are highly competitive.

Relative to our prospects for commercializing polymeric nanoparticles and nanofibers, there are many competitors with various approaches to cannabinoid infusion for foods, beverages and other consumer products. While these currently available technologies are not directly competitive with us, such technologies may be viewed as being directly competitive by the marketplace in the future. Many of the current market participants are well established with considerable financial backing. We expect the quality and composition of the competitive market in the hemp processing environment to continue to evolve as the industry matures. Additionally, increased competition is possible to the extent that new states and geographies enter into the marketplace as a result of continued enactment of regulatory and legislative changes that de-criminalize and regulate cannabis and hemp products, including the 2018 Farm Bill. We believe the contemporaneous growth of the industry as a whole will result in new customers entering the marketplace, thereby further mitigating the impact of competition on our expected operations and results relating to our hemp processing businesses.

Relative to our non-psychoactive cannabis extract powdered drink business, there are relatively few market participants in this sector, but management of the Company believes the competitive situation will advance quickly over the coming months as new companies target this potentially lucrative market opportunity. Additionally, while large beverage industry participants have yet to launch products in this area, we believe such market entrances are likely as the regulatory environment is clarified by the FDA. This could significantly affect our ability to achieve market success.

We believe the contemporaneous growth of the cannabis beverage sector and the industry as a whole will result in new customers entering the marketplace, thereby further mitigating the impact of competition on our expected operations and results relating to hemp cultivation and processing business and joint venture.

The psychoactive cannabis sector is also highly competitive with many participants being better capitalized. The Company plans to distinguish its products based on both quality and brand appearance.

Employees

As of the end of the last reporting period, the Cannabis Global has one employee, CEO, Arman Tabatabaei. Additionally, the Company relies on the services of numerous consultants who perform various tasks for the Company. Natural Plant Extract of California employs two full time professional managerial staff and between four and ten part time individuals, depending on workload and order levels, engaged in production and administration activities.

Our U.S employees are not represented by a labor union.

Legal Proceedings

On November 22, 2019, the Company filed suit against Jeet Sidhru and Jatinder Bhogal in the District Court of Clark County Nevada, Case number A-19-805943-C. Mr. Sidhru and Mr. Bhogal were formerly directors and officers of the Company. The Company’s complaint alleges that Mr. Sidhru and Mr. Bhogal breached their fiduciary duties to the Company, including their fiduciary duties of due care, good faith and loyalty, by recklessly and intentionally failing to maintain the Company’s statutory corporate filings with the State of Nevada, OTC Markets and the U.S. Securities and Exchange Commission, and abandoning the Company and its shareholders. The Company’s complaint also alleges that Mr. Sidhru and Mr. Bhogal engaged in conflicted transactions involving the Company, in which each were unjustly enriched. The Company served Mr. Bhogal, and received notice of representation of both defendants. The case is currently in its early phase, as neither defendant has responded to the complaint.

Market Information

Our common stock trades on the OTC Markets Pink under the stock symbol CBGL.

Transfer Agent

Pacific Stock Transfer Company, located at 6725 Via Austin Pkwy., #300, Las Vegas NV 89119 and telephone number of (702) 361-3033 is the registrar and transfer agent for our common stock. As of April 19, 2021, there were approximately 61 holders of record of our common stock.

DESCRIPTION OF PROPERTY

Our headquarters are located at 520 S. Grand Avenue, Suite 320, Los Angeles, California 90071 where are we lease office space under a contract effective August 15, 2019, which expired on August 14, 2020. We now rent the office space on a month-to-month basis for $800 per month.

Relative to it Natural Plant Extract of California operation, the Company leases a building in Lynwood, CA where it operates a licensed cannabis operation. The Company pays $8,750 per month to occupy the building.

Our Company has also entered into a lease for a commercial food production facility, which is also located in Los Angeles, California. The one-year lease at rate of $3,300 per month was entered into as of August 2019. The lease is expired with the location now being rented on a month-to-month basis.

We believe that our existing office facilities are adequate for our needs. Should we require additional space at that time, or prior thereto, we believe that such space can be secured on commercially reasonable terms.

Results of Operations

For the Three months Ended February 28, 2021 and February 29, 2020

Product revenues for the quarterly financial period ending February 28, 2021, were $25,816 compared to $0 reported during the quarterly financial period ending February 29, 2020.

During the financial period ending February 28, 2021, cost of goods sold was $6,653 compared to $0 for the quarterly financial period ending February 29, 2020. This resulted in a gross margin of $19,163 for the period ending February 28, 2021.

Accounts receivable were $218,374 for the period ending February 28, 2021. Compared to $0 for the period ending August 31, 2020. The increase is attributable to consolidate of Natural Plant Extract of California and inclusion of its cannabis related accounts receivables relating to its orders for cannabis products for its customers.

For the period ending February 28, 2021, the Company incurred operating expenses of $431,571 compared to $410,915 for the period ending February 29, 2020. The increase was due to the Company launching new products and marketing programs.

Interest expenses for the financial period ending February 28, 2021 were $1,933, 728 compared to $522,203 for the financial period ending February 29, 2020. The increase was attributable to an increased number of notes sold during the period aimed at financing our product and marketing programs.

During the three months ending February 28, 2021, net loss was $2,110,770 compared to $762,196 for the financial period ending February 29, 2020. The increase in net loss was attributable mainly to increased spending associated with the reorganization of the business, expenses relating to hiring consultants and general costs associated with the design of new product in preparation of customer orders, and increased interest expenses. The net loss for the period ending February 28, 2021, resulted in a loss per share of $0.05, compared to a net loss per share $0.06 during the year ago period.

For the Six months Ended February 28, 2021 and February 29, 2020

Product revenues for the six months ending February 28, 2021, were $30,226 compared to $10,003 reported during the quarterly financial period ending February 29, 2020.

During the six months ending February 28, 2021, cost of goods sold was $7,953 compared to $2,900 for the quarterly financial period ending February 29, 2020. This resulted in a gross margin of $22,273 for the period ending February 28, 2021.

For the six months ending February 28, 2021, the Company incurred operating expenses of $878,962 compared to $784,708 for the six months ending February 29, 2020. The increase was due to the Company launching new products and marketing programs.

Interest expenses for the six months ending February 28, 2021 were $2,706,483 compared to $553,453 for the six months ending February 29, 2020. The increase was attributable to an increased number of notes sold during the period aimed at financing our product and marketing programs.

During the six months ending February 28, 2021, net loss was $2,463,994 compared to $1,147,633 for the six months ending February 29, 2020. The increase in net loss was attributable mainly to increased spending associated with the reorganization of the business, expenses relating to hiring consultants and general costs associated with the design of new product in preparation of customer orders, and increased interest expenses. The net loss for the period ending February 28, 2021, resulted in a loss per share of $0.06, compared to a net loss per share $0.09 during the year ago period.

Liquidity and Capital Resources

As of February 28, 2021 and August 31, 2020 our cash and cash equivalent balances were $134,187 and $2,338, respectively.

Our primary internal sources of liquidity were provided by proceeds from the sale of unregistered common shares and warrants of the Company as follows:

On July 3, 2019, we sold 2,000,000 restricted shares at $0.025 a share for the amount of $50,000 to an accredited investor. The investor also received 2,000,000 warrants to purchase 2,000,000 shares at a price of $0.15 per share. The warrants expire on July 3, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings.

On July 10, 2019, we sold 1,000,000 restricted shares at $0.025 a share for the amount of $25,000 to an accredited investor. The investor also received 1,000,000 warrants to purchase 1,000,000 shares at a price of $0.15 per share. The warrants expire on July 10, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings.

On July 16, 2019, we sold 1,400,000 restricted shares at $0.025 a share for the amount of $35,000 to an accredited investor. The investor also received 1,400,000 warrants to purchase 1,400,000 shares at a price of $0.15 per share. The warrants expire on July 16, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings.

On July 19, 2019, we sold 1,000,000 restricted shares at $0.025 a share for the amount of $25,000 to an accredited investor. The investor also received 1,000,000 warrants to purchase 1,000,000 shares at a price of $0.15 per share. The warrants expire on July 19, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings.

On August 15, 2019, we sold 2,000,000 restricted shares at $0.025 a share for the amount of $50,000 to an accredited investor. The investor also received 2,000,000 warrants to purchase 2,000,000 shares at a price of $0.15 per share. The warrants expire on August 15, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings.

On August 19, 2019, we sold 1,000,000 restricted shares at $0.025 a share for the amount of $50,000 to an accredited investor. The investor also received 1,000,000 warrants to purchase 1,000,000 shares at a price of $0.15 per share. The warrants expire on August 19, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings.

On August 27, 2019, we sold 1,000,000 restricted shares at $0.025 a share for the amount of $25,000 to an accredited investor. The investor also received 1,000,000 warrants to purchase 1,000,000 shares at a price of $0.15 per share. The warrants expire on August 27, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings. As of the date of this filing, these shares have not yet been issued to the purchaser.

On November 6, 2019, we sold a convertible not to an accredited investor for $20,000. The terms of the six month note allow 7% annual interest and for the conversion into common shares at $0.75. Additionally, the investor received a warrant providing the investor the right to purchase 26,666 common shares at a price of $3.50.

On December 30, 2019, The Company sold a convertible note to an accredited investor. The $63,000 note calls for annualized interest of 10% and is due on December 20, 2020. The note converts in common shares at 40% discount. This note is attached as an exhibit hereto.

On December 16, 2019, the Company’s board of directors by unanimous written consent caused the authorization of ten million (10,000,000) shares of preferred stock, par value $0.0001 per share, of the Company ("Preferred Stock") in one or more series, and expressly authorized the Board of Directors of the Company (the "Board"), subject to limitations prescribed by law, to provide, out of the unissued shares of Preferred Stock, for series of Preferred Stock, and, with respect to each such series, to establish and fix the number of shares to be included in any series of Preferred Stock and the designation, rights, preferences, powers, restrictions, and limitations of the shares of such series.

During the quarterly period ended February 29, 2020, the Company issued four convertible promissory notes having an aggregate principal amount of $256,500, aggregate original issue discount (OID) of $10,500, and aggregate legal fees of $11,000, resulting in aggregate net proceeds to the Company of $235,000. The notes mature in one year from the respective issuance date and bear interest at the rate of 10% per annum, payable at maturity. Commencing one hundred eighty (180) days following the issuance date of $198,750 of the notes and commencing immediately following the issuance of $57,750 of the notes, the noteholders shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at variable conversion prices ranging from 50% - 60% of the lowest previous fifteen (15) to twenty (20) trading day closing trade prices of the Company’s common stock, subject to adjustment. As a result of the variable conversion prices, upon issuance, the Company recognized total debt discount of $256,500, which is being amortized to interest expense over the term of the notes. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note.

On March 19, 2020, the Company entered into a Securities Purchases Agreement and Convertible Promissory Note in the principal amount of $150,000. The note, which is payable one year after issuance, carries interest at 10% per annum. On March 19, 2020, the Company received its first disbursement under this agreement in the amount of $50,000. Less an original discount and other certain fees, the Company netted $43,000. The note converts to common shares at a 40% discount to the lowest traded price during the 25 days prior to conversion. Additionally, the issuer was granted three-year warrant coverage at $0.48. The note shall not be able to be converted in an amount that would result in the beneficial ownership of more than 4.99% of the Company outstanding common stock.

On May 4, 2020 the Company received its Second disbursement under this agreement win the amount of $25,000. Less an original discount and other certain fees, the Company netted $21,000. This note converts to common shares at a 40% discount to the lowest traded price during the 25 days prior to conversion.

On May 28, 2020, Mr. Robert L. Hymers III, a former director and former chief financial officer, returned 2,000,000 Series A Preferred shares to the corporate treasury. As of the date of this filing, there were 6,000,000 Series A Preferred shares issued and outstanding.

On June 19, 2020, we sold 352,941 registered common shares to an investor in exchange for $60,000 by subscription from our Form S-1 registration, file number 333-238974.

On June 23, 2020, we sold 116,667 registered common shares to an investor in exchange for a settlement by subscription form our Form S-1 registration, file number 333-238974.

On June 30, 2020, we sold 289,301 registered common shares to an investor in exchange for $50,000 by subscription form our Form S-1 registration, file number 333-238974.

On July 7, 2020, we sold 305,810 registered common shares to an investor in exchange for $35,000 by subscription form our Form S-1 registration, file number 333-238974.

On July 10, 2020, the Company receives a $25,000 disbursement from a previously signed convertible note. On March 19, 2020, the Company entered into a Securities Purchases Agreement and Convertible Promissory Note in the principal amount of $150,000. The note, which is payable one year after issuance, carries interest at 10% per annum. On March 19, 2020, the Company received its first disbursement under this agreement in the amount of $50,000. Less an original discount and other certain fees, the Company netted $43,000. The note converts to common shares at a 40% discount to the lowest traded price during the 25 days prior to conversion. Additionally, the issuer was granted three-year warrant coverage at $0.48. The note shall not be able to be converted in an amount that would result in the beneficial ownership of more than 4.99% of the Company outstanding common stock.

On July 21, 2020, the Company entered into a Securities Purchases Agreement and Convertible Promissory Note in the principal amount of $78,750. The note, which is payable one year after issuance, carries interest at 6% per annum. The note converts to common shares at a 60% discount to the lowest traded price during the 30 days prior to conversion.

On August 6, 2020, we sold 2,899,017 registered common shares to an investor in exchange for $278,338, by subscription form our Form S-1 registration, file number 333-238974. Additionally, the investor was provided with 150,000 commitment shares, and was issued a convertible for $50,000. The note calls for annualized interest of 10% and is due on August 7, 2021. The note converts into common shares at a fixed price of $0.1631.

On August 12, 2020, The Company sold a convertible note to an accredited investor. The $55,000 note calls for annualized interest of 10% and is due on May 21, 2021. The note converts into common shares at a fixed price of $0.1005.

On August 14, 2020, The Company sold a convertible note to an accredited investor. The $50,000 note calls for annualized interest of 10% and is due on May 14, 2021. The note converts into common shares at a fixed price of $0.1005.

On August 17, 2020, we sold 510,204 registered common shares to an investor in exchange for $51,275.50 by subscription form our Form S-1 registration, file number 333-238974.

On August 28, 2020, the Company sold a convertible note to an accredited investor. The $113,000 note calls for annualized interest of 8% and is due on August 28, 2021. The note converts to common shares at a 37% discount to the lowest traded price during the 15 days prior to conversion.

On September 2, 2020, the Company issued two convertible promissory notes with an aggregate principal amount of $107,000, with the Company receiving proceeds of $100,000 after original issue discount of $5,000 and deferred finance costs of $2,000. The notes mature in September 2021 and bear interest at 12% per annum. Commencing one hundred eighty (180) days following the issuance date of the notes, the noteholders shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at variable conversion price of 60% of the lowest previous twenty (20) trading day closing trade prices of the Company’s common stock, subject to adjustment. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note.

On September 22, 2020, the Company issued a convertible note in the amount of $78,000. The note matures on September 22, 2021 and bears 8% interest rate per annum. The note is convertible into common shares at 37% discount for the average of the two lowest trading price of the common stock during the 15 trading day period ending on the latest complete trading day prior to the conversion date.

On September 24, 2020, the Company issued a convertible note in the amount of $78,000. The note matures on June 24, 2021 and bears 10% interest rate per annum. The note is convertible into common shares at a fixed conversion price of $0.06 or a conversion discount at rate of 30% to the lowest trading price during the previous twenty (20) trading days to the date of a conversion notice; whichever is lower.

On September 30, 2020, the Company entered into a securities exchange agreement with Marijuana Company of America, Inc., a Utah corporation (“MCOA”). By virtue of the agreement, the Company issued 7,222,222 shares of its restricted common stock to MCOA in exchange for 650,000,000 shares of MCOA restricted common stock. The Company and MCOA also entered into a lock up leak out agreement which prevents either party from sales of the exchanged shares for a period of 12 months. Thereafter the parties may sell not more than the quantity of shares equaling an aggregate maximum sale value of $20,000 per week, or $80,000 per month until all Shares and Exchange Shares are sold.

On December 1, 2020, the Company entered into a Securities Purchase Agreement in connection with the issuance of an 8% convertible note with the principal amount of $33,500, with an accredited investor. The note is convertible anytime after 180 days of issuance at a variable conversion price of 63% of the Market Price at time of conversion. Market Price is defined as the average of the two lowest trading prices during the fifteen (15) days prior to conversion. The Note and Purchase Agreement are attached to this filing. The Company received net cash proceeds of $30,000.

On December 1, 2020, the Company entered into an additional Securities Purchase Agreement in connection with the issuance of an 8% convertible note with the principal amount of $33,500, with an accredited investor. The note is convertible anytime after 180 days of issuance at a variable conversion price of 63% of the Market Price at time of conversion. Market Price is defined as the average of the two lowest trading prices during the fifteen (15) days prior to conversion. The Company received net cash proceeds of $30,000.

On January 3, 2021, we entered into a settlement agreement with Robert L. Hymers, III (“Hymers”) concerning five delinquent payments totaling $100,000 due under the stock purchase agreement whereby the Company purchased 266,667 shares of common stock of Natural Plant Extract of California Inc., a California corporation (“NPE”), The Company was required to make $20,000 monthly for a period of twenty-seven (27) months to Hymers, with the first payment commencing September 1, 2020 and the remaining payments due and payable on the first day of each subsequent month until Hymers received $540,000. On January 3, 2021, we entered into a settlement concerning the outstanding payments by agreeing to issue to Hymers a total of 1,585,791 shares of registered common stock from our S-1 registration statement made effective during February 2021.

On January 5, 2021, the Company entered into a Securities Purchase Agreement in connection with the issuance of an 10% convertible note with the principal amount of $110,000, with an accredited investor. The note is convertible at a fixed conversion price of $0.005. In the event of default by the Company, or after the public announcement of a change of control transaction as defined in the agreement, the conversion price is $0.001. The Company received net proceeds of $97,500.

On January 5, 2021, the Company entered into a Securities Purchase Agreement in connection with the issuance of an 10% convertible note with the principal amount of $110,000, with an accredited investor. The note is convertible at a fixed conversion price of $0.05. In the event of default by the Company, or after the public announcement of a change of control transaction as defined in the agreement, the conversion price is $0.01. The Company received net proceeds of $97,500.

On January 12, 2021, the Company entered into a Securities Purchase Agreement in connection with the issuance of an 10% convertible note with the principal amount of $115,500, with an accredited investor. The note is convertible beginning 61 days from issuance at a fixed conversion price of $0.10 per share or 60% or the lowest trading price for ten days prior to conversion in the event that the Company’s stock trades at less than $0.10 per share. The Company received net proceeds of $100,000.

On January 26, 2021, the Company entered into two Securities Purchase Agreements in connection with the issuance of two 10% convertible note with the principal amount of $487,750, with an accredited investor. The note is convertible at 70% of the average of the three lowest trading prices for 20 days prior to conversion. The Company received net proceeds of $431,000.

On February 3, 2021, the Registrant completed the sale of an aggregate of 4,700,000 registered shares of common stock registered on Form S-1 (File No. 333-250038) in two transactions in exchange for a total purchase price of $282,000. The parties to the transactions were the Registrant and BHP Capital NY, Inc., and Platinum Point Capital, LLC. There was no material relationship, other than in respect of the transactions, between BHP Capital NY, Inc., Platinum Point Capital, LLC and the Registrant or any of its affiliates, or any director or officer of the Registrant, or any associate of any such director or officer. BHP Capital NY, Inc. purchased 2,350,000 registered common shares in exchange for $141,000. Platinum Point Capital, LLC purchased 2,350,000 registered common shares in exchange for $141,000.

On February 16, 2021, we purchased 266,667 shares of common stock of Natural Plant Extract of California Inc., a California corporation (“NPE”), from Alan Tsai, in exchange for the issuance of 1,436,368 common shares. Other than with respect to the transaction, there was no material relationship between Mr. Tsai and the Registrant. By virtue of the transaction, the Registrant acquired 18.8% of the outstanding capital stock of NPE, bringing its total beneficial ownership in NPE to 56.5%. NPE operates a licensed psychoactive cannabis manufacturing and distribution business operation in Lynwood, California. By virtue of its 56.5% ownership over NPE, the Company will control production, manufacturing and distribution of both NPE and Company products. In connection with the MDA, the Registrant became a party to a Shareholders Agreement by and among Edward Manolos, a director of the Company, Robert L. Hymers III, Betterworld Ventures, LLC, Marijuana Company of America, Inc. and NPE. The Shareholders Agreement contains customary rights and obligations concerning operations, management,, including restrictions on the transfer of the Shares.

On February 16, 2021, the Company sold 1,133,334 registered common shares to accredited investors, realizing $68,000.

On February 18, 2021, the Company sold 683,333 registered common shares to an accredited investor, realizing proceeds of $41,000.

On February 28, 2021, the Company sold 153,000 Preferred Series B shares to an accredited investor, realizing proceeds of $153,000. The proceeds were not received until March 2021, and therefore no preferred stock shares were issued and outstanding as of February 28, 2021.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Recently Issued Accounting Pronouncements

We review new accounting standards as issued. Although some of these accounting standards issued or effective after the end of our previous fiscal year may be applicable to the Company, we have not identified any standards that we believe merit further discussion. We do not expect the adoption of any recently issued accounting pronouncements to have a significant impact on our financial position, results of operations, or cash flows.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Management is responsible for establishing and maintaining adequate disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in its Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely and reliable financial reporting and the preparation of financial statements in accordance with accounting principles generally accepted in the United States of America.

As of the quarter ended February 28, 2021, our principal executive officer and principal financial officer completed an assessment of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e), to determine the existence of any material weaknesses or significant deficiencies under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the registrant's financial reporting.

Based on that evaluation, we concluded that our disclosure controls and procedures over financial reporting were not effective as of February 28, 2021.

Changes in Internal Controls over Financial Reporting

There have been no changes in our internal control over financial reporting during the quarter ended February 28, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information.

None.

Item 6. Exhibits

	Corporate Documents Section

3	Certificate of Incorporation	Incorporated by reference to the Company’s Form S-1 filed on August 26, 2019.

3i	Amendment to Certificate of Incorporation	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

3.ii	By Laws	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

3.iii	Aidan & Co. Inc. Formation	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

3.iv	Hemp You Can Feel, Inc. Formation	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

3.v	Articles of Domestications Nevada	Incorporated by reference from the Company’s Current Report on Form 8-K filed on April 3, 2020.

3.vi	Certificate of Conversion Delaware	Incorporated by reference from the Company’s Current Report on Form 8-K filed on April 3, 2020.

3.vii	Certificates of Designation Series A Preferred Stock	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

4a.	Convertible Promissory Note	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020


	Material Contracts and Other

10.1	Executive Employment Agreement CEO Arman Tabatabaei	Incorporated by reference from the Company’s Form S-1 filed on August 26, 2019

10.2	Change of Control Stock Purchase Agreement	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.3	Director Agreement – Robert L. Hymers III	Incorporated by reference from the Company’s Form S-1 filed on August 26, 2019

10.4	Director Agreement - Dan Van Nguyen	Incorporated by reference from the Company’s Form S-1 filed on August 26, 2019.

10.5	Director Agreement – Edward Manolos	Incorporated by reference from the Company’s Form S-1 filed on August 26, 2019

10.6	Director Agreement – Mellissa Riddell	Incorporated by reference from the Company’s Form 8-K filed February 7, 2020

10.7	Director Agreement – Jim Riley	Incorporated by reference from the Company’s Form 8-K filed November 3, 2020 .


10.8	Private Placement Memorandum – July 3, 2019	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.9	Private Placement Memorandum – July 10, 2019	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.10	Private Placement Memorandum – July 16, 2019	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.11	Private Placement Memorandum – July 19, 2019	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.12	Private Placement Memorandum – August 15, 2019	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.13	Private Placement Memorandum – August 19, 2019	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.14	Property Lease 520 Grand Ave, Suite 320 Los Angeles, CA 90071	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.15	Property Lease 6130 S Avalon Ave Los Angeles, CA	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.16	Resignation of Former CEO Garry McHenry	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.17	Settlement Agreement BOD Resolution Manolos/Nguyen/Others	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.18	Riddell/Kirby Agreements BOD Resolutions	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.19	Paladin Advisors SPA	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.20	Costello SPA	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.21	K&J SPA November 2019	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.22	K&J SPA April 2020	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.23	K&J SPA May 2020	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.24	Eagle Note January 2020	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.25	Crown Bridge Note March 2020	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.26	GW Holdings Note January 2020	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.27	Power Up Note December 2019	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020


10.28	Power Up Note February 2020	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.29	BOD Action Acquisition of Action Nutraceuticals July 2019	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.30	Hymers Note January 2020	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.31	Tabatabaei Note February 2020	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.32	Tabatabaei Note Conversion	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.33	Pinnacle Consulting Agreement	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.34	Tabular Consulting Agreement	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.35	Crown Bridge Note 2^nd tranche May 2020	Incorporated by reference from the Company’s Form S-1 filed on June 5, 2020

10.36	Lelantos Convertible Notes	Incorporated by reference from the Company’s Form 8-K filed on February 20, 2020.

10.37	Modification Agreement; Lelantos Convertible Notes	Incorporated by reference from the Company’s Form 8-K filed on June 18, 2020.

10.38	Management Agreement; Whisper Weed.	Incorporated by reference from the Company’s Form 8-K filed on July 24, 2020.

10.39	Stock Purchase Agreement; GHS Investments, LLC	Incorporated by reference from the Company’s Form 8-K filed on August 13, 2020.

10.40	Stock Purchase Agreement and Form of Convertible Promissory Note; Natural Plant Extract	Incorporated by reference from the Company’s Form 8-K filed September 1, 2020.

10.41	Share Exchange Agreement; Marijuana Company of America, Inc.	Incorporated by reference from the Company’s Form 8-K filed October 2, 2020.

10.42	Securities Purchase Agreement with Redstart Holdings Corp dated September 22, 2020	Incorporated by reference from the Company’s Form 10-Q filed on January 13, 2021

10.43	Convertible Promissory Note with Redstart Holdings Corp. dated September 22, 2020	Incorporated by reference from the Company’s Form 10-Q filed on January 13, 2021

10.44	Securities Purchase Agreement with Redstart Holdings Corp. dated October 30, 2020	Incorporated by reference from the Company’s Form 10-Q filed on January 13, 2021

10.45	Convertible Promissory Note with Redstart Holdings Corp. dated October 30, 2020	Incorporated by reference from the Company’s Form 10-Q filed on January 13, 2021

10.46	Ethos Technology Acquisition Agreement dated November 16, 2020	Incorporated by reference from the Company’s Form 10-Q filed on January 13, 2021

10.47	Securities Purchase Agreement with GW Holdings Group, LLC dated January 12, 2021	Incorporated by reference from the Company’s Form 10-Q filed on January 13, 2021

10.48	Convertible Promissory Note with GW Holdings Group, LLC dated January 12, 2021	Incorporated by reference from the Company’s Form 10-Q filed on January 13, 2021

10.49	Riddell Independent Director Agreement dated February 18, 2021	Incorporated by reference from the Company’s Form S-1 filed on February 26, 2021

10.50	Securities Subscription and Purchase Agreement between Registrant and BHP Capital NY, Inc.	Incorporated by reference from the Company’s Form 8-K filed on February 4, 2021

10.51	Securities Subscription and Purchase Agreement between Registrant and Platinum Point Capital, LLC.	Incorporated by reference from the Company’s Form 8-K filed on February 4, 2021

10.52	Stock Purchase Agreement with Edward Manolos dated January 27, 2021	Incorporated by reference from the Company’s Form 8-K filed on February 2, 2021

10.53	NPE Shareholder Agreement June 5, 2020	Incorporated by reference from the Company’s Form 8-K filed on September 1, 2020

10.54	Convertible Promissory Note with GW Holdings Group, LLC dated January 12, 2021	Incorporated by reference from the Company’s Form 10-Q filed on January 13, 2021

31.1	Certification of Principal Executive Officer Pursuant to Rule 13a-14	Filed Herewith

31.2	Certification of Principal Financial Officer Pursuant to Rule 13a-14	Filed Herewith

32.1	CEO and CFO Certification Pursuant to Section 906 of the Sarbanes-Oxley Act	Filed Herewith

101.INS	XBRL Instance Document	Filed Herewith
101.PRE	XBRL Taxonomy Extension Presentation Linkbase	Filed Herewith
101.LAB	XBRL Taxonomy Extension Label Linkbase	Filed Herewith
101.DEF	XBRL Taxonomy Extension Definition Linkbase	Filed Herewith
101.CAL	XBRL Taxonomy Extension Calculation Linkbase	Filed Herewith
101.SCH	XBRL Taxonomy Extension Schema	Filed Herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

April 19, 2021

	Cannabis Global, Inc.

	By:	/s/ Arman Tabatabaei
		Arman Tabatabaei President, Chief Executive Officer, Chief Financial Officer, Director

EX-31.1 2 ex31x1.htm EXHIBIT 31.1

Exhibit 31.1

I, Arman Tabatabaei, certify that:

1. I have reviewed this quarterly report on Form 10-Q for period ended February 28, 2021 of Cannabis Global, Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 19, 2021
	By:	/s/ Arman Tabatabaei
		Arman Tabatabaei Chief Executive Officer

EX-31.2 3 ex31x2.htm EXHIBIT 31.2

Exhibit 31.2

I, Arman Tabatabaei, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended February 28, 2021 of Cannabis Global, Inc.

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 19, 2021
	By:	/s/ Arman Tabatabaei
		Arman Tabatabaei Chief Financial Officer

EX-32.1 4 ex32x1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Cannabis Global, Inc. (the “Company”) on Form 10-Q for the period ended February 28, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 19, 2021
	By:	/s/ Arman Tabatabaei
		Arman Tabatabaei Chief Executive Officer

Date: April 19, 2021
	By:	/s/ Arman Tabatabaei
		Arman Tabatabaei Chief Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

EX-101.INS 5 cbgl-20210228.xml XBRL INSTANCE FILE 0001413488 2021-02-28 0001413488 2020-09-01 2021-02-28 0001413488 2019-09-01 2020-02-29 0001413488 2020-08-31 0001413488 cbgl:SplitTeeMember 2019-07-09 0001413488 cbgl:SplitTeeMember 2019-08-23 0001413488 cbgl:SplitTeeMember 2019-07-02 2019-07-09 0001413488 cbgl:EdwardManolosMember 2019-05-25 0001413488 cbgl:CompensationPromissoryNoteMember cbgl:ConsultingAgreementMember cbgl:ConsultantMember 2020-02-01 2020-02-12 0001413488 cbgl:CompensationPromissoryNoteMember cbgl:ConsultingAgreementMember cbgl:ConsultantMember 2020-02-12 0001413488 cbgl:CompensationPromissoryNoteMember cbgl:ConsultingAgreementMember cbgl:ConsultantMember 2021-02-28 0001413488 cbgl:TwoConvertiblePromissoryNotesMember cbgl:TabatabaeiMember 2020-05-01 2020-05-22 0001413488 cbgl:TwoConvertiblePromissoryNotesMember cbgl:TabatabaeiMember cbgl:PrincipalMember 2020-05-01 2020-05-22 0001413488 cbgl:TwoConvertiblePromissoryNotesMember cbgl:TabatabaeiMember cbgl:InterestMember 2020-05-01 2020-05-22 0001413488 us-gaap:CommonStockMember 2020-08-31 0001413488 us-gaap:CommonStockMember 2021-02-28 0001413488 cbgl:CommonStockToBeIssuedMember 2020-08-31 0001413488 cbgl:CommonStockToBeIssuedMember 2021-02-28 0001413488 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0001413488 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 0001413488 us-gaap:RetainedEarningsMember 2020-08-31 0001413488 us-gaap:RetainedEarningsMember 2021-02-28 0001413488 cbgl:EdwardManolosMember 2019-05-01 2019-05-25 0001413488 srt:ChiefExecutiveOfficerMember 2019-07-01 0001413488 cbgl:WhisperMember 2020-07-02 2020-07-22 0001413488 cbgl:StockPurchaseAgreementMember 2020-09-01 2021-02-16 0001413488 cbgl:StockPurchaseAgreementMember cbgl:ShareholderMember 2020-09-01 2021-02-16 0001413488 cbgl:TwoConvertiblePromissoryNotesMember 2020-02-29 0001413488 cbgl:TwoConvertiblePromissoryNotesMember 2019-12-01 2020-02-29 0001413488 srt:ChiefFinancialOfficerMember 2020-04-01 2020-04-30 0001413488 cbgl:FormerChiefFinancialOfficerMember 2020-04-30 0001413488 cbgl:ConvertiblePromissoryNote1Member 2020-03-19 0001413488 cbgl:ConvertiblePromissoryNote1Member 2020-03-01 2020-03-19 0001413488 cbgl:ConvertiblePromissoryNote2Member 2020-07-21 0001413488 cbgl:ConvertiblePromissoryNote2Member 2020-07-01 2020-07-21 0001413488 cbgl:TwoConvertiblePromissoryNotes2Member 2020-08-31 0001413488 cbgl:TwoConvertiblePromissoryNotes2Member 2020-08-01 2020-08-31 0001413488 cbgl:CommonStockSubscriptionAgreementsMember cbgl:LenderMember 2021-02-28 0001413488 cbgl:CommonStockSubscriptionAgreementsMember cbgl:LenderMember 2020-08-01 2020-08-31 0001413488 srt:ChiefExecutiveOfficerMember 2020-02-29 0001413488 cbgl:StockPurchaseAgreementMember cbgl:NPEMember 2020-08-21 0001413488 cbgl:StockPurchaseAgreementMember cbgl:NPEMember 2020-08-01 2020-08-21 0001413488 us-gaap:FairValueInputsLevel1Member 2021-02-28 0001413488 us-gaap:FairValueInputsLevel2Member 2021-02-28 0001413488 us-gaap:FairValueInputsLevel3Member 2021-02-28 0001413488 us-gaap:FairValueInputsLevel1Member 2020-08-31 0001413488 us-gaap:FairValueInputsLevel2Member 2020-08-31 0001413488 us-gaap:FairValueInputsLevel3Member 2020-08-31 0001413488 us-gaap:ConvertibleNotesPayableMember srt:MinimumMember 2020-09-01 2021-02-28 0001413488 us-gaap:ConvertibleNotesPayableMember srt:MaximumMember 2020-09-01 2021-02-28 0001413488 srt:MinimumMember 2020-09-01 2021-02-28 0001413488 srt:MaximumMember 2020-09-01 2021-02-28 0001413488 us-gaap:SeriesAPreferredStockMember 2019-12-16 0001413488 us-gaap:SeriesAPreferredStockMember 2019-12-01 2019-12-16 0001413488 us-gaap:SeriesAPreferredStockMember 2020-05-02 2020-05-28 0001413488 us-gaap:SeriesAPreferredStockMember 2021-02-28 0001413488 2021-04-19 0001413488 us-gaap:ProductMember 2020-09-01 2021-02-28 0001413488 us-gaap:ProductMember 2019-09-01 2020-02-29 0001413488 cbgl:ConsultingRevenueRelatedPartyMember 2020-09-01 2021-02-28 0001413488 cbgl:ConsultingRevenueRelatedPartyMember 2019-09-01 2020-02-29 0001413488 cbgl:PreferredStockClassAMember 2019-08-31 0001413488 cbgl:PreferredStockClassAMember 2020-02-29 0001413488 cbgl:PreferredStockClassAMember 2020-08-31 0001413488 cbgl:PreferredStockClassAMember 2021-02-28 0001413488 us-gaap:CommonStockMember 2019-08-31 0001413488 us-gaap:CommonStockMember 2020-02-29 0001413488 cbgl:CommonStockToBeIssuedMember 2019-08-31 0001413488 cbgl:CommonStockToBeIssuedMember 2020-02-29 0001413488 us-gaap:AdditionalPaidInCapitalMember 2019-08-31 0001413488 us-gaap:AdditionalPaidInCapitalMember 2020-02-29 0001413488 us-gaap:RetainedEarningsMember 2019-08-31 0001413488 us-gaap:RetainedEarningsMember 2020-02-29 0001413488 2019-08-31 0001413488 2020-02-29 0001413488 cbgl:LauderdaleHoldingsLLCMember 2019-05-25 0001413488 cbgl:LauderdaleHoldingsLLCMember cbgl:UnaffiliatedPartiesMember 2019-05-01 2019-05-25 0001413488 cbgl:LauderdaleHoldingsLLCMember cbgl:MrRobertHymersMember 2019-05-01 2019-05-25 0001413488 cbgl:LauderdaleHoldingsLLCMember cbgl:EdwardManolosMember 2019-05-01 2019-05-25 0001413488 cbgl:LauderdaleHoldingsLLCMember cbgl:MrDanNguyenMember 2019-05-01 2019-05-25 0001413488 cbgl:StockPurchaseAgreementMember cbgl:ShareholderMember 2020-01-02 0001413488 cbgl:SettlementAgreementMember cbgl:HymersMember 2021-01-01 2021-01-03 0001413488 cbgl:MarijuanaCompanyOfAmericaIncMember 2020-09-01 2020-09-30 0001413488 cbgl:EthosTechnologyLLCMember 2020-11-01 2020-11-16 0001413488 cbgl:EthosTechnologyLLCMember cbgl:EdwardManolosMember 2020-11-01 2020-11-16 0001413488 cbgl:EthosTechnologyLLCMember cbgl:ThangNguyenMember 2020-11-01 2020-11-16 0001413488 cbgl:SplitTeeMember 2021-02-28 0001413488 2020-11-01 2020-11-16 0001413488 2020-11-16 0001413488 cbgl:EdwardManolosMember 2020-11-01 2020-11-16 0001413488 cbgl:ThangNguyenMember 2020-11-01 2020-11-16 0001413488 cbgl:LelantosMember 2020-02-01 2020-02-20 0001413488 cbgl:CompensationPromissoryNoteMember cbgl:ConsultingAgreementMember cbgl:ConsultantMember 2020-08-31 0001413488 cbgl:ThreeConvertiblePromissoryNotes2Member 2021-02-28 0001413488 cbgl:ThreeConvertiblePromissoryNotes2Member 2020-09-01 2021-02-28 0001413488 cbgl:ConvertiblePromissoryNoteThreeMember 2020-09-02 0001413488 cbgl:ConvertiblePromissoryNoteThreeMember 2020-09-01 2020-09-02 0001413488 cbgl:ConvertiblePromissoryNoteThreeMember 2021-02-28 0001413488 cbgl:RobertLHymersIIIMember 2020-02-29 0001413488 cbgl:RobertLHymersIIIMember cbgl:PrincipalMember 2020-12-01 2020-12-09 0001413488 srt:ChiefFinancialOfficerMember cbgl:PrincipalMember 2020-10-01 2020-10-09 0001413488 us-gaap:SubsequentEventMember 2021-03-01 2021-03-16 0001413488 us-gaap:ConvertibleNotesPayableMember 2020-09-01 2021-02-28 0001413488 us-gaap:SubsequentEventMember 2021-03-01 2021-03-08 0001413488 us-gaap:SubsequentEventMember 2021-03-08 0001413488 us-gaap:SubsequentEventMember us-gaap:SeriesBPreferredStockMember 2021-03-01 2021-03-31 0001413488 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2021-03-25 0001413488 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2021-03-01 2021-03-25 0001413488 us-gaap:SubsequentEventMember 2021-03-16 0001413488 us-gaap:SeriesBPreferredStockMember us-gaap:InvestorMember 2020-09-01 2021-02-28 0001413488 us-gaap:SeriesBPreferredStockMember cbgl:InvestorOneMember 2020-09-01 2021-02-28 0001413488 us-gaap:SeriesBPreferredStockMember 2021-03-01 2021-03-31 0001413488 us-gaap:SubsequentEventMember 2021-04-19 0001413488 cbgl:NaturalPlantExtractMember 2020-09-01 2021-02-28 0001413488 cbgl:ConvertiblePromissoryNoteThreeMember 2020-09-01 2021-02-28 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestorMember 2021-01-05 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestorMember 2021-01-01 2021-01-05 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestor1Member 2021-01-12 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestor1Member 2021-01-01 2021-01-12 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestor1Member cbgl:PrincipalMember 2020-09-01 2021-02-28 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestor1Member cbgl:InterestMember 2020-09-01 2021-02-28 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestor1Member 2020-09-01 2021-02-28 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestor1Member 2021-02-28 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestor2Member 2021-01-01 2021-01-26 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestor2Member 2021-02-28 0001413488 cbgl:SecuritiesPurchaseAgreementMember cbgl:AccreditedInvestor2Member 2021-01-26 0001413488 cbgl:RobertLHymersIIIMember cbgl:InterestMember 2020-12-01 2020-12-09 0001413488 cbgl:RobertLHymersIIIMember 2020-12-01 2020-12-09 0001413488 cbgl:ThreeSellersAcquisitionPromissoryNotesMember 2020-02-12 0001413488 cbgl:ThreeSellersAcquisitionPromissoryNotesMember 2020-02-01 2020-02-12 0001413488 cbgl:ThreeSellersAcquisitionPromissoryNotesMember 2021-02-28 0001413488 cbgl:ThreeSellersAcquisitionPromissoryNotesMember 2020-08-31 0001413488 cbgl:LegaCustodianMember 2017-10-01 2018-08-31 0001413488 cbgl:LegaCustodianMember 2018-08-31 0001413488 cbgl:LegaCustodian1Member 2018-08-31 0001413488 cbgl:LegaCustodian1Member 2018-05-01 2018-05-08 0001413488 cbgl:LegaCustodian2Member 2018-06-01 2018-08-31 0001413488 2017-09-01 2018-08-31 0001413488 cbgl:DanNguyenMember 2019-05-25 0001413488 srt:ChiefFinancialOfficerMember 2020-08-31 0001413488 srt:ChiefFinancialOfficerMember 2020-04-01 2020-04-30 0001413488 srt:ChiefFinancialOfficerMember 2020-04-30 0001413488 cbgl:FormerChiefFinancialOfficerMember 2020-08-31 0001413488 cbgl:MrManolosMember 2021-01-01 2021-01-27 0001413488 cbgl:MrManolosMember 2021-01-27 0001413488 cbgl:MrDanNguyenMember 2019-05-25 0001413488 cbgl:StockPurchaseAgreementMember 2020-08-01 2020-08-21 0001413488 cbgl:StockPurchaseAgreementMember cbgl:NPEMember 2021-02-01 2021-02-16 0001413488 cbgl:NPEMember 2021-02-16 0001413488 cbgl:NPEMember 2021-02-01 2021-02-16 0001413488 cbgl:NPEMember 2020-12-01 2021-02-28 0001413488 cbgl:NPEMember 2020-09-01 2021-02-28 0001413488 srt:ProFormaMember 2019-09-01 2020-02-29 0001413488 srt:ProFormaMember 2020-12-01 2021-02-28 0001413488 srt:ProFormaMember 2019-12-01 2020-02-29 0001413488 cbgl:ModificationAgreementMember cbgl:LelantosMember 2020-06-01 2020-06-15 0001413488 cbgl:StockPurchaseAgreementMember 2020-08-01 2020-08-31 0001413488 cbgl:StockPurchaseAgreementMember cbgl:ShareholderMember 2020-08-01 2020-08-31 0001413488 2020-12-01 2021-02-28 0001413488 2019-12-01 2020-02-29 0001413488 us-gaap:ProductMember 2020-12-01 2021-02-28 0001413488 us-gaap:ProductMember 2019-12-01 2020-02-29 0001413488 cbgl:ConsultingRevenueRelatedPartyMember 2020-12-01 2021-02-28 0001413488 cbgl:ConsultingRevenueRelatedPartyMember 2019-12-01 2020-02-29 0001413488 cbgl:PreferredStockClassAMember 2019-09-01 2019-11-30 0001413488 cbgl:PreferredStockClassAMember 2019-12-01 2020-02-29 0001413488 cbgl:PreferredStockClassAMember 2020-09-01 2020-11-30 0001413488 cbgl:PreferredStockClassAMember 2020-12-01 2021-02-28 0001413488 cbgl:PreferredStockClassAMember 2019-11-30 0001413488 cbgl:PreferredStockClassAMember 2020-11-30 0001413488 us-gaap:CommonStockMember 2019-09-01 2019-11-30 0001413488 us-gaap:CommonStockMember 2019-12-01 2020-02-29 0001413488 us-gaap:CommonStockMember 2020-09-01 2020-11-30 0001413488 us-gaap:CommonStockMember 2020-12-01 2021-02-28 0001413488 us-gaap:CommonStockMember 2019-11-30 0001413488 us-gaap:CommonStockMember 2020-11-30 0001413488 cbgl:CommonStockToBeIssuedMember 2019-09-01 2019-11-30 0001413488 cbgl:CommonStockToBeIssuedMember 2019-12-01 2020-02-29 0001413488 cbgl:CommonStockToBeIssuedMember 2020-09-01 2020-11-30 0001413488 cbgl:CommonStockToBeIssuedMember 2020-12-01 2021-02-28 0001413488 cbgl:CommonStockToBeIssuedMember 2019-11-30 0001413488 cbgl:CommonStockToBeIssuedMember 2020-11-30 0001413488 us-gaap:AdditionalPaidInCapitalMember 2019-09-01 2019-11-30 0001413488 us-gaap:AdditionalPaidInCapitalMember 2019-12-01 2020-02-29 0001413488 us-gaap:AdditionalPaidInCapitalMember 2020-09-01 2020-11-30 0001413488 us-gaap:AdditionalPaidInCapitalMember 2020-12-01 2021-02-28 0001413488 us-gaap:AdditionalPaidInCapitalMember 2019-11-30 0001413488 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0001413488 us-gaap:RetainedEarningsMember 2019-09-01 2019-11-30 0001413488 us-gaap:RetainedEarningsMember 2019-12-01 2020-02-29 0001413488 us-gaap:RetainedEarningsMember 2020-09-01 2020-11-30 0001413488 us-gaap:RetainedEarningsMember 2020-12-01 2021-02-28 0001413488 us-gaap:RetainedEarningsMember 2019-11-30 0001413488 us-gaap:RetainedEarningsMember 2020-11-30 0001413488 cbgl:StockholdersEquityAttributableToCannabisGlobalIncMember 2019-09-01 2019-11-30 0001413488 cbgl:StockholdersEquityAttributableToCannabisGlobalIncMember 2019-12-01 2020-02-29 0001413488 cbgl:StockholdersEquityAttributableToCannabisGlobalIncMember 2020-09-01 2020-11-30 0001413488 cbgl:StockholdersEquityAttributableToCannabisGlobalIncMember 2020-12-01 2021-02-28 0001413488 cbgl:StockholdersEquityAttributableToCannabisGlobalIncMember 2019-08-31 0001413488 cbgl:StockholdersEquityAttributableToCannabisGlobalIncMember 2019-11-30 0001413488 cbgl:StockholdersEquityAttributableToCannabisGlobalIncMember 2020-02-29 0001413488 cbgl:StockholdersEquityAttributableToCannabisGlobalIncMember 2020-08-31 0001413488 cbgl:StockholdersEquityAttributableToCannabisGlobalIncMember 2020-11-30 0001413488 cbgl:StockholdersEquityAttributableToCannabisGlobalIncMember 2021-02-28 0001413488 us-gaap:NoncontrollingInterestMember 2019-09-01 2019-11-30 0001413488 us-gaap:NoncontrollingInterestMember 2019-12-01 2020-02-29 0001413488 us-gaap:NoncontrollingInterestMember 2020-09-01 2020-11-30 0001413488 us-gaap:NoncontrollingInterestMember 2020-12-01 2021-02-28 0001413488 us-gaap:NoncontrollingInterestMember 2019-08-31 0001413488 us-gaap:NoncontrollingInterestMember 2019-11-30 0001413488 us-gaap:NoncontrollingInterestMember 2020-02-29 0001413488 us-gaap:NoncontrollingInterestMember 2020-08-31 0001413488 us-gaap:NoncontrollingInterestMember 2020-11-30 0001413488 us-gaap:NoncontrollingInterestMember 2021-02-28 0001413488 2019-09-01 2019-11-30 0001413488 2020-09-01 2020-11-30 0001413488 2019-11-30 0001413488 2020-11-30 0001413488 srt:ProFormaMember 2020-09-01 2021-02-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 72133317

0.001

290000000

0.0001

10000000

8000000

CANNABIS GLOBAL, INC. 0001413488 10-Q 2021-02-28 false --08-31 Non-accelerated Filer 2021 true true false Yes Q2 Yes 000-27039 DE

20000

30000

616844

499788

10000

35554

139401

33301

8372

4405

4830

902

2205

37676

19824

3138

1011

6000000

66205687

27082419

72133317

66205687

27082419

72133317

0.10

5000

100000

133101

150000

78750

129250

79333

279500

107000

53768

215000

110000

115500

243875

500000

0.10

0.08

0.05

0.10

0.06

0.10

0.08

0.10

0.08

100000

60379

14873

22049

450000

15884

15061

1086000

388101

71250

117500

329613

267000

100000

232000

97500

100000

215500

1032292

678246

2020-08-04

2020-12-31

2021-07-21

2021-05-31

2021-08-07

2021-09-30

2020-05-31

30226

10003

30226

5003

5000

18864

25816

266667

232000

1314188

153500

78500

266667

500000

20000

1666667

1000

150000

1436368

78851

153500

78500

2040000

0.02

0.05

0.10

0.0001

0.02

30000

27954

30000

133101

30000

75000

78750

129250

50000

279500

107000

110000

115500

243875

270886

106121

42877

221826

37884

14939

81942

79333

2608

53768

57750

585

4626

13000

13385151

694902

3409221

1500000

583354

878190

15000 3750 11750 5000

3750

12500

2000

468750

50000

P3Y 0.48

0.0499

0.565

10468

578000

113000

107000

266667

2054739

1125803

2054739

1125803

2054739 2154823

0.00

3.28

3.32

3.78

0.0009

0.0013

0.0005

0.0008

P6M

P1Y

650000000

1714903

Holders of Series A Preferred Stock shall be entitled to 50 votes for every Share of Series A Preferred Stock

2000000

2020-08-14

2028-05-31

11920249

2325185

-8520943

-6056949

1360 187

8862713

4618168

66203

2708

600

7661023

3760471

6989165

3760471

2054739

1125803

1948152

1866872

463248

233568

11920249

2325185

7200

650000

1714903

1362177

25406

653963

77676

180155

75338

218374

-0.06

-0.09

-0.05

-0.06

-1607305

-370028

-1698362

-351281

1642

1522

2706483

553453

1933728

522203

-856689

-777605

-412408

-410915

878962

784708

431571

410915

396492

383355

282056

195832

179895

282114

129263

133159

252051

103545

20750

67662

22273

7103

19163

7953

2900

6653

-2463994

-1147633

-2110770

-762196

-774444

-519668

-111311

-5782

-1139

104817

22831

-1308912

-183425

522334

211171

1798

1571

2342280

547671

2200

-3500

3500

904093

528101

391000

140000

134187

2338

152082

157015

188292

24767

10003

409933

-1435286

-2463994

-1147633

17797

-2110770

-762196

0.707

130000000

43333333

3000000

1500000

325000

108333

177000

100000

1585791 7222222

6000000

1500000

400000

266667

1500000 1500000 11383929 1436368

-53692

-276975 -1255220 2514823

Company affected a reverse split as of September 30, 2019, which had the effect of reducing the number of outstanding shares from 187,864,600 to 12,524,307.

0.001

1139

1308912

183425

593235

170922

39744494

12752506

43196439

12321639

false

0.06

0.1792

225000

11000

8750

4557

5101

50747

168048

600

0.10

1703579

1666667

0.05

0.10

0.05

1821429 400747

3684347

359391

3849293

400000

62063

8098603

41000

607306

121247

126615

545243

4259226

-1435286

2708

66203

187

1360

4618168

8862713

-6056949

-8520943

600

1253

1509

189

1187574

1671038

-1127601

-2275234

61415

-602647

600

1483

39712

1960

1464060

5442391

-1513038

-6410173

61415

-47469

-602647

-1435286

-925510

409933

3849293

-47469

-925510

3849293

0 0

-211376

-359391

-61053

79168

246729 0

2200

650000 612400 2222175 0 3849293 0

27082419

66205687

1871858

1361654

6000000

12524307

15093128

1893333

400000

6000000

14833128

39714845

260000

1961654

1893333

-1893333

189

-189

23333

20881

20883

3400000

4106543

-600000

95670

203333 510204 6516667 89796 391000 20 510 6517 90 74980 -600 384483 75000 0 391000 75000 0 260000 260000 -260000 26 26 -26 64974 65000 65000 20000 20000 20000

188822

-19

7222222 12820297 400000 6071468 112400 7222 12820 40 112360 642778 2209355 112400 650000 2222175 3849293 650000

339334

94618

3400

4107

-600

94618

179600

335827

94618

183000

339334

183000

1500000 3047335 216729 1500 3047 28500 213682 30000 216729 30000 24372 1683 -26055 276975 276975 276975

334144

126820

229597

979866

-973276 -1693708 -557425 -1626929

1521976

-3392070

-1019316

-4065390

-0.06

-0.04

-0.08

Note 1. Organization and Description of Business   Cannabis Global, Inc. is located at 520 S. Grand Avenue, Suite 320, Los Angeles, California 90071. Our telephone number is (310) 986-4929 and our website is accessible at www.cannabisglobalinc.com. Our shares of Common Stock are quoted on the OTC Markets Pink Tier, operated by OTC Markets Group, Inc., under the ticker symbol “CBGL.”   Historical Development   We incorporated in Nevada in 2005 under the name MultiChannel Technologies Corporation, a wholly owned subsidiary of Octillion Corporation, a development stage technology company focused on the identification, acquisition and development of emerging solar energy and solar related technologies. In April, 2005, we changed our name to MicroChannel Technologies, Inc., and in June, 2008, began trading on the OTC Markets under the trading symbol “MCTC.” Our business focused on research and development of a patented intellectual properties combining physical, chemical and biological cues at the “cellular” level to facilitate peripheral nerve regeneration.   On June 27, 2018, we changed domiciles from the State of Nevada to the State of Delaware, and thereafter reorganized under the Delaware Holding Company Statute. On or about July 12, 2018, we formed two subsidiaries for the purpose of effecting the reorganization. We incorporated MCTC Holdings, Inc. and MCTC Holdings Inc. incorporated MicroChannel Corp. We then effected a merger involving the three constituent entities, and under the terms of the merger we were merged into MicroChannel Corp., with MicroChannel Corp. surviving and our separate corporate existence ceasing. Following the merger, MCTC Holdings, Inc. became the surviving publicly traded issuer, and all of our assets and liabilities were merged into MCTC Holdings, Inc.’s wholly owned subsidiary MicroChannel Corp. Our shareholders became the shareholders of MCTC Holdings, Inc. on a one for one basis.   On May 25, 2019, Lauderdale Holdings, LLC, a Florida limited liability company, and beneficial owner 70.7% of our issued and outstanding common stock, sold 130,000,000 common shares, to Mr. Robert Hymers, Mr. Edward Manolos and Mr. Dan Nguyen, all of whom were previously unaffiliated parties of the Company. Each individual purchased 43,333,333 common shares for $108,333,333 or an aggregate of $325,000. These series of transactions constituted a change in control.   On August 9, 2019, we filed a DBA in California registering the operating name Cannabis Global. On July 1, 2019, the Company entered into a 100% business acquisition with Action Nutraceuticals, Inc., a company owned by our CEO, Arman Tabatabaei in exchange for $1,000 (see “Related Party Transactions”).    Subsequent to the closing of the fiscal year ending August 31, 2019, we affected a reverse split of our common shares effective as of September 30, 2019 at the rate of 1:15.   On September 11, 2019, we formed a subsidiary Aidan & Co, Inc. (“Aidan”) a California corporation as a wholly owned subsidiary of the Company. Aidan will be engaged in various related business opportunities. At this time Aidan has no operations.   On December 4, 2019, our shareholders approved and authorized (i) re-domiciling the Company from Delaware to Nevada; (ii) changing the name of the Company from MCTC Holdings, Inc. to Cannabis Global, Inc.; and, (iii) seeking a corresponding change of name and new trading symbol for the Company with FINRA.   On March 30, 2020, we filed Articles of Conversion with the Delaware Secretary of State, electing to convert and re-domicile the Company from a Delaware corporation to a newly formed Nevada corporation named Cannabis Global, Inc. Concurrently, the Registrant filed Articles of Incorporation and Articles of Domestication with the Nevada Secretary of State incorporating the Registrant in Nevada under the name Cannabis Global, Inc. and accepting the re-domicile of Registrant’s Delaware corporation. There was no change to the Registrant’s fiscal year end. As a result of our FINRA corporate action, our name was changed to Cannabis Global, Inc. and our trading symbol changed to “CBGL.”   On April 18, 2020, we formed a subsidiary Hemp You Can Feel, Inc., a California corporation (“HYCF”), as a wholly owned subsidiary of the Company. HYCF will be engaged in various related business opportunities. At this time HYCF has no operations.   On May 6, 2020, we signed a joint venture agreement with RxLeaf, Inc. (“RxLeaf”) a Delaware corporation, creating a joint venture for the purpose of marketing the Company’s products to consumers. Under the terms of the agreement, the Company will produce products, which will be sold by RX Leaf via its digital marketing assets. The Company agreed to share the profits from the joint venture on a 50/50 basis.   On July 22, 2020, we signed a management agreement with Whisper Weed, Inc., a California corporation (“Whisper Weed”). Edward Manolos, our director, is a shareholder in Whisper Weed (see “Related Party Transactions”). Whisper Weed conducts licensed delivery of cannabis products in California. The material definitive agreement requires the parties to create a separate entity, CGI Whisper W, Inc. in California as a wholly owned subsidiary of the Company. The business of CGI Whisper W, Inc. will be to provide management services for the lawful delivery of cannabis in the State of California. The Company will manage CGI Whisper W, Inc. operations. In exchange for the Company providing management services to Whisper Weed through the auspices of CGI Whisper W, Inc., the Company will receive as consideration a quarterly fee of 51% of the net profits earned by Whisper Weed. As separate consideration for the transaction, the Company agreed to issue to Whisper Weed $150,000 in the Company’s restricted common stock, valued for purposes of issuance based on the average closing price of the Company’s common stock for the twenty days preceding the entry into the material definitive agreement. Additionally, the Company agreed to amend its articles of incorporation to designate a new class of preferred shares. The preferred class will be designated and issued to Whisper Weed in an amount equal to two times the quarterly payment made to the Company. The preferred shares will be convertible into the Company’s common stock after 6 months, and shall be senior to other debts of the Company. The conversion to common stock will be based on a value of common stock equal to at least two times the actual sales for the previous 90 day period The Company agreed to include in the designation the obligation to make a single dividend payment to Whisper Weed equal to 90% of the initial quarterly net profits payable by Whisper Weed. As of February 24, 2021, the Company has not issued the common or preferred shares, and the business is in the development stage.   On August 31, 2020, we entered into a stock purchase agreement with Robert L. Hymers III (“Hymers”). Pursuant to the Stock Purchase Agreement, the Company purchased from Hymers 266,667 shares of common stock of Natural Plant Extract of California Inc., a private California corporation (“NPE”), in exchange for $2,040,000. The purchased shares of common stock represents 18.8% of the outstanding capital stock of NPE on a fully diluted basis. NPE operates a licensed psychoactive cannabis manufacturing and distribution business operation in Lynwood, California. In connection with the stock purchase agreement, we became a party to a Shareholders Agreement, dated June 5, 2020, by and among Alan Tsai, Hymers, Betterworld Ventures, LLC, Marijuana Company of America, Inc. and NPE. The Shareholders Agreement contains customary rights and obligations, including restrictions on the transfer of the Shares.   On September 30, 2020, the Company entered into a securities exchange agreement with Marijuana Company of America, Inc., a Utah corporation (“MCOA”). By virtue of the agreement, the Company issued 7,222,222 shares of its unregistered common stock to MCOA in exchange for 650,000,000 shares of MCOA unregistered common stock. The Company and MCOA also entered into a lock up leak out agreement which prevents either party from sales of the exchanged shares for a period of 12 months. Thereafter the parties may sell not more than the quantity of shares equaling an aggregate maximum sale value of $20,000 per week, or $80,000 per month until all Shares and Exchange Shares are sold.   On November 16, 2020, we entered into a business acquisition agreement with Ethos Technology LLC, dba Comply Bag, a California limited liability company (“Ethos”). Ethos is a development stage business in the process of entering the market for cannabis trackable storage bags. By virtue of the agreement, Ethos sold, assigned, and transferred to the Company all of Ethos’ business, including all of its assets and associated liabilities, in exchange for the Company’s issuance of an aggregate of 6,000,000 common shares. 3,000,000 shares were due at signing, with 1,500,000 shares being issued to Edward Manolos, and 1,500,000 shares being issued to Thang Nguyen. Mr. Manolos is our director and a related party. Mr. Nguyen is the brother of Dan Van Nguyen, our director and a related party. After Ethos ships orders for Ethos products equaling $1,000,000 to unaffiliated parties, the Company will issue to Messrs. Manolos and Nguyen an additional 1,500,000 shares of common stock each. At the closing we sold an aggregate 3,000,000 shares of Company common stock, par value $0.001, equal in value to $177,000 based on the closing price on November 16, 2020. Of the total sold, 1,500,000 shares of common stock were sold to Edward Manolos and 1,500,000 shares of common stock were sold to Thang Nguyen. We issued the above shares of its common stock pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended, available to the Company by Section 4(a)(2) promulgated thereunder due to the fact that it was an isolated issuance and did not involve a public offering of securities.    On January 27, 2021, we closed a material definitive agreement (MDA) with Edward Manolos, our director and related party. Pursuant to the MDA, the Company purchased from Mr. Manolos 266,667 shares of common stock in Natural Plant Extract of California Inc., a California corporation (“NPE”), representing 18.8% of the outstanding capital stock of NPE on a fully diluted basis. NPE operates a licensed psychoactive cannabis manufacturing and distribution business operation in Lynwood, California. NPE is a privately held corporation. Under the terms of the MDA, we acquired all beneficial ownership over the NPE shares in exchange for a purchase price of two million forty thousand dollars ($2,040,000).. In lieu of a cash payment, we agreed to issue Mr. Manolos 11,383,929 restricted common shares, valued for purposes of the MDA at $0.1792 per share. In connection with the MDA, we became a party to a Shareholders Agreement by and among Alan Tsai, Hymers, Betterworld Ventures, LLC, Marijuana Company of America, Inc. and NPE. The Shareholders Agreement contains customary rights and obligations, including restrictions on the transfer of the Shares. Mr. Manolos is our director as well as a directly of Marijuana Company of America and is therefore a related party. On February 16, 2021, we purchased 266,667 shares of common stock of Natural Plant Extract of California Inc., a California corporation (“NPE”), from Alan Tsai, in exchange for the issuance of 1,436,368 common shares. Other than with respect to the transaction, there was no material relationship between Mr. Tsai and the Registrant. By virtue of the transaction, the Registrant acquired 18.8% of the outstanding capital stock of NPE, bringing its total beneficial ownership in NPE to 56.5%. NPE operates a licensed psychoactive cannabis manufacturing and distribution business operation in Lynwood, California. By virtue of its 56.5% ownership over NPE, the Company will control production, manufacturing and distribution of both NPE and Company products. In connection with the MDA, the Registrant became a party to a Shareholders Agreement by and among Edward Manolos, a director of the Company, Robert L. Hymers III, Betterworld Ventures, LLC, Marijuana Company of America, Inc. and NPE. The Shareholders Agreement contains customary rights and obligations concerning operations, management, including restrictions on the transfer of the Shares. Current Business Operations   Cannabis Global conducts research and development and operates multiple cannabis businesses in California and hemp-related business in the United States. We recently announced our acquisition of a 56.5%, controlling interest in Natural Plant Extract (NPE), which operates a licensed cannabis manufacturing and distribution business in Lynwood, California, holding a Type 7 California Manufacturing and a distribution license, allowing for cannabis product distribution anywhere in the state. We plan to use the Lynwood NPE operation, combined with our internally developed technologies, as a testbed to launch multi-state operations as soon as possible after the expected removal of cannabis as a Scheduled substance from the federal CSA is completed, and interstate commerce in cannabis is approved by the federal government. As of the date of this filing, cannabis remains a Schedule 1 controlled substance and so illegal under the CSA. However, As a result of the November, 2020 federal elections, and the election of Joseph R. Biden as president, it is expected that the federal government will move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug. In late January, 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, that would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated. Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally-insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws). Our operations at the Natural Plant Extract facility emphasizes cannabis product manufacturing and distribution. In addition to business opportunities available from cannabis product manufacturing and distribution to all parts of the State of California, we also sees strong synergies between NPE operations and our developing technologies in the areas of secure cannabis transport, cannabis infusions, and all-natural polymeric nanoparticle technologies.   We also have an active research and development program primarily focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Additionally we invest, or provide managerial services, in specialized areas of the regulated hemp and cannabis industries. Thus far, the Company has filed six provisional patents, three non-provisional patents and recently announced its "Comply Bag" secure cannabis transport system with integrated track and trace capabilities via smartphones, which will be available soon.   Our R&D programs included the following: <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 12pt/12.65pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 8pt">1.</td> <td style="font: 12pt/12.65pt Times New Roman, Times, Serif; padding-bottom: 8pt; text-align: justify">Development of new routes and vehicles for hemp extract and cannabinoid delivery to the human body.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 12pt/12.65pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 8pt">2.</td> <td style="font: 12pt/12.65pt Times New Roman, Times, Serif; padding-bottom: 8pt; text-align: justify">Production of unique polymeric nanoparticles and fibers for use in oral and dermal cannabinoid delivery.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 12pt/12.65pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 8pt">3.</td> <td style="font: 12pt/12.65pt Times New Roman, Times, Serif; padding-bottom: 8pt; text-align: justify">Research and commercialization of new methodologies to isolate and/or concentrate various cannabinoids and other substances that comprise industrial hemp oil and other extracts.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 12pt/12.65pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 8pt">4.</td> <td style="font: 12pt/12.65pt Times New Roman, Times, Serif; padding-bottom: 8pt; text-align: justify">Establishment of new methods to increase the bioavailability of cannabinoids to the human body utilizing nanoparticles and other proven bioenhancers, including naturally occurring and insect produced glycosides.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 12pt/12.65pt Times New Roman, Times, Serif; width: 24px; padding-bottom: 8pt">5.</td> <td style="font: 12pt/12.65pt Times New Roman, Times, Serif; padding-bottom: 8pt; text-align: justify">Development of other novel inventions for the delivery of cannabinoids to the human body, which at this time are considered trade secrets by the Company.</td></tr> </table>

Note 2. Going Concern Uncertainties   During recent financial reporting periods, the Company began reporting revenue and has been active in reorganizing its business operations, these revenues being generated are nominal. The Company has an accumulated deficit of $8,520,943 as of February 28, 2021, and does not have positive cash flows from operating activities. Furthermore, as shown in the accompanying financial statements for six months ended February 28, 2021, the Company had a net loss of $2,463,994 and used cash in operations of $774,444. The Company expects to incur additional losses as it executes its business strategy in the cannabis, hemp and cannabinoid marketplaces. The Company will be subject to the risks, uncertainties, and difficulties frequently encountered by early-stage companies. The Company may not be able to successfully address any or all of these risks and uncertainties. Failure to adequately do so could cause the Company’s business, results of operations, and financial condition to suffer. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance date of these financial statements.   The Company’s ability to continue as a going concern is an issue due to its net losses and negative cash flows from operations, and its need for additional financing to fund future operations. Management plans to obtain necessary funding from outside sources and through the sales of Company shares. There can be no assurance that such funds, if available, can be obtained on terms reasonable to the Company. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that may result from the outcome of this uncertainty. Based on the Company’s current level of expenditures, management believes that cash on hand is not adequate to fund operations for the next twelve months. Management of the Company is estimating approximately $1,000,000 will be required over the next twelve months to fully execute its business strategy. These can be no assurance the Company will be able to obtain such funds.

Note 3.  Summary of Significant Accounting Policies   Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the amounts reported in those statements. We have made our best estimates of certain amounts contained in our consolidated financial statements. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. However, application of our accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties, and, as a result, actual results could differ materially from these estimates. Management believes that the estimates, assumptions, and judgments involved in the accounting policies described below have the most significant impact on our consolidated financial statements. We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.   Derivative Instruments   The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in the fair value of derivatives liability are recorded in the consolidated statement of operations under non-operating income (expense). We evaluate all of our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, we use a weighted average Binomial option-pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Consolidation   The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Action Nutraceuticals, Inc. and Aidan & Co, Inc. All intercompany balances and transactions have been eliminated in consolidation.   Cash and Cash Equivalents   We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.   Inventory   Inventory is primarily comprised of work in progress. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of February 28, 2021, and August 31, 2020, market values of all of our inventory were at cost, and accordingly, no such valuation allowance was recognized.   Deposits   Deposits is comprised of advance payments made to third parties, primarily for inventory for which we have not yet taken title. When we take title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see “Costs of Revenues” below). There were no deposits as of February 28, 2021.   Prepaid Expenses and Other Current Assets   Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.   Accounts Receivable   Accounts receivable are recorded at the net value of face amount less any allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and, based on a method of specific identification of any accounts receivable for which we deem the net realizable value to be less than the gross amount of accounts receivable recorded, we establish an allowance for doubtful accounts for those balances. In determining our need for an allowance for doubtful accounts, we consider historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, our actual experience may vary from our estimates. If the financial condition of our clients were to deteriorate, resulting in their inability or unwillingness to pay our fees, we may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that we collect retainers from our clients prior to performing significant services.   The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of February 28, 2021, and February 29, 2020, we had $0 and $0 allowance for doubtful accounts, respectively.   Property and Equipment, net   Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Depreciation of capitalized construction in progress costs, a component of property and equipment, net, begins once the underlying asset is placed into service and is recognized over the estimated useful life. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.”   Accounting for the Impairment of Long-Lived Assets   We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets.   Beneficial Conversion Feature   market value at issuance, this feature is characterized as a beneficial conversion feature (“BCF”). We record a BCF as a debt discount pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ACF”) Topic 470-20 Debt with Conversion and Other Options. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and we amortize the discount to interest expense over the life of the debt using the effective interest method.   Revenue Recognition   For annual reporting periods after December 15, 2017, the Financial Accounting Standards Board (“FASB”) made effective ASU 2014-09 “Revenue from Contracts with Customers” to supersede previous revenue recognition guidance under current U.S. GAAP. Revenue is now recognized in accordance with FASB ASC Topic 606, Revenue Recognition. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. We determined to implement the cumulative effect adjustment approach to our implementation of FASB ASC Topic 606, with no restatement of the comparative periods presented. We intend to apply this method to any incomplete contracts we determine are subject to FASB ASC Topic 606 prospectively. As is more fully discussed below, we are of the opinion that none of our contracts for services or products contain significant financing components that require revenue adjustment under FASB ASC Topic 606.   In accordance with FASB ASC Topic 606, Revenue Recognition, we will recognize revenue when persuasive evidence of a significant financing component exists in our consulting and product sales contracts. We examine and evaluate when our customers become liable to pay for goods and services; how much consideration is paid as compared to the cash selling price of the goods or services; and, the length of time between our performance and the receipt of payment.   Product Sales   Revenue from product sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is shipped, and collectability is reasonably assured. For any shipments with destination terms, the Company defers revenue until delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant customer financing that would materially change the amount of revenue recognized under the sales transaction, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606.   Costs of Revenues   Our policy is to recognize the costs of revenue in the same manner in conjunction with revenue recognition. Costs of revenues include the costs directly attributable to revenue recognition and include compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred. Stock-Based Compensation Restricted shares are awarded to employees and entitle the grantee to receive shares of restricted common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. Stock-based compensation during the quarterly reporting period ended February 28, 2021 was $0.   Income Taxes   We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the quarterly reporting periods ending February 28, 2021 and February 29, 2020, we incurred no income taxes and had no liabilities related to federal or state income taxes.   Loss Contingencies   From time to time the Company is subject to various legal proceedings and claims that arise in the ordinary course of business. On at least a quarterly basis, consistent with ASC 450-20-50-1C, if the Company determines that there is a reasonable possibility that a material loss may have been incurred, or is reasonably estimable, regardless of whether the Company accrued for such a loss (or any portion of that loss), the Company will confer with its legal counsel, consistent with ASC 450. If the material loss is determinable or reasonably estimable, the Company will record it in its accounts and as a liability on the balance sheet. If the Company determines that such an estimate cannot be made, the Company's policy is to disclose a demonstration of its attempt to estimate the loss or range of losses before concluding that an estimate cannot be made, and to disclose it in the notes to the financial statements under Contingent Liabilities.   Net Income (Loss) Per Common Share   We report net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

Note 4. Net Loss Per Share   During three and six months ending February 28, 2021 and February 28, the Company recorded a net loss. Basic and diluted net loss per share are the same for those periods. The dilutive weighted average shares for each period reported excludes the effect of shares issuable upon conversion of debt, as the effect would have been anti-dilutive. As of February 28, 2021, the Company’s convertible debt was convertible into 13,385,151 shares of common stock.

Note 5. – Notes Receivable – Related Party   On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Receivable, Related Party and in the footnote outlining Related Party Transactions. These notes are additionally described herein in Footnote 6- Notes to Shareholders, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos’ and Mr. Nguyen’s associations as directors, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.   On July 9, 2019, the Company, through its Action Nutraceuticals subsidiary, loaned, Split Tee, LLC (“Split Tee”), a venture associated with Director Edward Manolos, $20,000 to engage in an exploratory research project. An additional $20,000 was supplied to Split Tee on August 23, 2019. The loans carry interest at the rate of 10% per annum and are due in one year for issuance. In addition, The Company, via Action Nutraceuticals subsidiary, invoiced Split Tee $5,000 as a consulting fee. Because of Mr. Manolos’ association as a director, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

Note 6. Intangible Assets   On February 20, 2020, the Company entered into a material definitive agreement with Lelantos Biotech, Inc., a Wyoming corporation (“Lelantos”), and its owners. On June 15, 2020, the Company and Lelantos entered into a modification agreement cancelling the Company's obligation to issue 400,000 shares of common stock and the convertible promissory notes. The Company and Lelantos agreed to a purchase price of five hundred thousand dollars ($500,000), payable by the issuance of a promissory note. The aggregate unpaid principal amount of the note is paid in monthly payments of seven thousand, five hundred dollars ($7,500) beginning on September 1, 2020, terminating on February 1, 2025. There is no interest on the note or on the unpaid balance.

Note 7. Acquisition of Natural Plant Extract of California, Inc.   NPE Acquisition   On August 21, 2020 the Company, issued a convertible note pursuant to a Stock Purchase Agreement (the “SPA) to acquire 266,667 shares of common stock of Natural Plant Extract of California Inc., a California corporation (“NPE”), representing 18.8% of the outstanding capital stock of NPE on a fully diluted basis. With the exception of the entry into the subject material definitive agreements, no material relationship exists between the Registrant, or any of the Registrant’s affiliates or control persons and Hymers. Under the terms of the SPA, the Registrant acquired all rights and responsibilities of the equity stake for a purchase price of Two Million Forty Thousand United States Dollars ($2,040,000) (the “Purchase Price”). Relative to the payment of the Purchase Price, the registrant agreed to: 1) pay Hymers Twenty Thousand United States Dollars ($20,000) each month for a period of twenty-seven (27) months, with the first payment commencing September 1, 2020 and the remaining payments due and payable on the first day of each subsequent month until Hymers has received Five Hundred Forty Thousand United Stated Dollars ($540,000), and 2) issue Hymers a convertible promissory note in the amount of One Million Five Hundred Thousand United States Dollars ($1,500,000) (the “Note”). The Note bears interest at ten percent (10%) per annum. The Holder shall have the right at any time six (6) months after the Issuance Date to convert all or any part of the outstanding and unpaid principal, interest, fees, or any other obligation owed pursuant to the note. Conversion Price shall be calculated as follows: 60% of the lowest Trading Price of the common shares during the ten (10) days preceding the date the Company receive a notice of conversion. Unless permitted by the applicable rules and regulations of the principal securities market on which the Common Stock is then listed or traded, in no event shall the Registrant issue upon conversion of or otherwise pursuant to the note and the other notes issued more than the maximum number of shares of Common Stock that the Company can issue pursuant to any rule of the principal United States securities market on which the Common Stock is then traded, which shall be 4.99% of the total shares outstanding at any time. A debt discount of $54,212 on the note payable at issuance was calculated based on the present value of the note using an implied interest rate of 10%. A debt discount of $270,886 was recognized. Accordingly, the Company recorded an initial value of its investment in NPE of $1,714,903.   On January 27, 20201, the Company acquired an additional 18.8% interest in NPE from Edward Manolos, a Director of the Company and a related party. The Company issued 11,383,929 shares of common stock, which had a fair value of $1,821,429.   On February 16, 2021, the Company purchased 266,667 shares of common stock of NPE from Alan Tsai, in exchange for the issuance of 1,436,368 common shares of the Company, with a fair value of $400,747. Other than with respect to the transaction, there was no material relationship between Mr. Tsai and the Company. By virtue of the transaction, the Company acquired 18.8% of the outstanding capital stock of NPE, bringing its total beneficial ownership in NPE to 56.5%. The transfer of control constituted an acquisition of NPE by the Company (the “NPE Acquisition”). For the three month period following the one year anniversary of the closing date, Mr. Tsai has the sole and irrevocable option to require the Company to repurchase the common shares issued to Mr. Tsai. If the value of the shares at the time notice is given is less than $150,000, Mr. Tsai will receive $150,000. If the value of the shares at the time notices is given is greater than $150,000, then Mr. Tsai will receive the market value of the shares.   As a result of the transaction, the Company also became party to a Shareholder Agreement with respect to its ownership over the NPE Shares, dated June 5, 2020, by and among Alan Tsai, Robert Hymers III, Betterworld Ventures, LLC (“BWV”), Marijuana Company of America, Inc. and NPE. The Joinder Agreement contains terms and conditions including, but not limited to: the ownership and management of NPE, rights of shareholders concerning the transfer of shares in NPE, pre-emptive rights, drag-along rights, confidentiality, and term and termination.    The NPE acquisition is being accounted for as a business combination under ASC 805 as a result of the transfer of control. Immediately prior to obtaining control, the total investment of the Company in NPE was adjusted to fair value of $3,684,347, resulting in a loss on investment of $359,391.   The following information summarizes the provisional purchase consideration and preliminary allocation of the fair values assigned to the assets at the purchase date:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>Preliminary Purchase Price Allocation:</td> <td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; padding-left: 9pt">Cash</td> <td style="width: 10%"> </td> <td style="width: 1%"> </td> <td style="width: 17%; text-align: right">2,200</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt">Accounts receivable</td> <td> </td> <td> </td> <td style="text-align: right">193,607</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt">Notes receivable</td> <td> </td> <td> </td> <td style="text-align: right">162,247</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt">Property and equipment</td> <td> </td> <td> </td> <td style="text-align: right">1,338,569</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt">Right of use asset – operating lease</td> <td> </td> <td> </td> <td style="text-align: right">607,306</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 9pt">Goodwill</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">8,098,603</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Total assets acquired</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">10,402,532</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt">Accounts payable and accrued expenses</td> <td> </td> <td> </td> <td style="text-align: right">289,591</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt">Right of use liability – operating lease</td> <td> </td> <td> </td> <td style="text-align: right">607,306</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt">Notes payable</td> <td> </td> <td> </td> <td style="text-align: right">1,825,101</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 9pt">Notes payable – related party</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">105,539</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total Liabilities Assumed</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,827,537</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>    As a result of the NPE acquisition, the Company recognized a non-controlling interest as of the date of the acquisition of $3,849,293. The Company’s consolidated revenues and net loss for the three and six months ended February 28, 2021 included the results of operations since the acquisition date of NPE of $18,864 and net loss of $17,797, respectively.   Unaudited Pro Forma Financial Information   The following table sets forth the pro-forma consolidated results of operations for the three and six months ended February 28, 2021 and February 29, 2020 as if the NPE acquisition occurred on September 1, 2019. The pro forma results of operations are presented for informational purposes only and are not indicative of the results of operations that would have been achieved if the acquisitions had taken place on the dates noted above, or of results that may occur in the future.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center">For the three months ended</td> <td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center">For the six months ended</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center">February 28, 2021</td> <td> </td> <td colspan="3" style="text-align: center">February 29, 2020</td> <td> </td> <td colspan="3" style="text-align: center">February 28, 2021</td> <td> </td> <td colspan="3" style="text-align: center">February 29, 2020</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Pro Forma</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Pro Forma</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Pro Forma</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Pro Forma</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%">Revenue</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">126,820</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">229,597</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">979,866</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">334,144</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Operating loss</td> <td> </td> <td> </td> <td style="text-align: right">(1,693,708</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(557,425</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(1,626,929</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(973,276</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Net loss attributable to common shareholders</td> <td> </td> <td> </td> <td style="text-align: right">(3,392,070</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(1,019,316</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(4,065,390</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">1,521,976</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net loss per common share</td> <td> </td> <td>$</td> <td style="text-align: right">(0.06</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.04</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.08</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.06</td> <td>)</td></tr> </table> Note 8. Note Payable to Shareholders   On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Payable, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos’ and Mr. Nguyen’s associations as directors, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

Note 9. Related Party   In October 2017 – August 31, 2018, the Company incurred a related party debt in the amount of $10,000 to an entity related to the legal custodian of the Company for professional fees. As of August 31, 2018, this balance was forgiven and was included as part of the $168,048 Cancellation of Debt Income on the Statement of Operations.   In November 30, 2017 – August 31, 2018, the Company issued a $35,554 in multiple notes payable to an entity related to the legal custodian of the Company. The notes payable bear interest at an annual rate of 10% and is convertible to common shares of the Company at $0.0001 per share. On May 8, 2018, $13,000 of the principal balance on notes payable were converted to common stock. The remaining principal balance was forgiven and included as Cancellation of Debt Income on the Income Statement for the year ended August 31, 2019.   In March 2018 and May 2018, a legal custodian of the Company funded the Company $600 in advances. On August 31, 2018, this amount was reclassified as a note payable, that bears interest at an annual rate of 10% and is payable upon demand.   In connection with the above notes, the Company recognized a beneficial conversion feature of $27,954, representing the intrinsic value of the conversion features at the time of issuance. This beneficial conversion feature was accreted to interest expense during the year ended August 31, 2018.   On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen for loans made to the Company, each in the amount of $16,666,67 for a total balance of $33,334. The notes bear interest at 5% per annum and do not have a fixed payment schedule or maturity date. These notes are additionally described herein in Footnote 6 - Notes Payable.   On July 9, 2019, the Company, through its Action Nutraceuticals subsidiary, loaned, Split Tee, LLC (“Split Tee”), a venture associated with Director Edward Manolos, $20,000 to engage in an exploratory research project. An additional $20,000 was supplied to Split Tee on August 23, 2019. The loans carry interest at the rate of 10% per annum and are due in one year for issuance. In addition, The Company, via Action Nutraceuticals subsidiary, invoiced Split Tee $5,000 as a consulting fee. Because of Mr. Manolos’ association as a director, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.   During the three months ended February 29, 2020, the Company issued two convertible promissory notes having an aggregate principal amount of $133,101 in exchange for accrued expenses owed to related parties, of which $79,333 is payable to the Company’s Chief Executive Officer and $53,768 is payable to the Company’s previous Chief Financial Officer, Robert L. Hymers III. The notes mature two years from the respective issuance date and bear interest at the rate of 10% per annum, payable at maturity. The noteholders shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a variable conversion price of 50% of the average of the previous twenty (20) trading day closing prices of the Company’s common stock, subject to adjustment. As a result of the variable conversion prices, upon issuance, the Company recognized total debt discount of $133,101, which is being amortized to interest expense over the term of the notes. On May 22, 2020, Mr. Tabatabaei converted the principal amount of $79,333 and interest of $2,608, for a total amount of $81,941.55 into 694,902 common shares. As of August 31, 2020, the carrying value of the remaining note with the former chief financial officer was $15,884, net of debt discount of $37,884 and accrued interest was $3,138. On April 30, 2020, the Company entered into a settlement agreement with Robert L. Hymers III, its Chief Financial Officer (the “CFO”), whereby the CFO resigned and the Company issued a promissory note for $30,000, which represented the remaining amount owed to the CFO for services rendered. The note matures December 31, 2020 and bears interest at the rate of 10% per annum, payable at maturity. The noteholder has the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a fixed conversion price of $0.02 per share, subject to adjustment. As a result of the beneficial conversion price, upon issuance, the Company recognized debt discount of $30,000, which is being amortized to interest expense over the term of the note. As of August 31, 2020, the carrying value of the note was $15,061, net of debt discount of $14,939 and accrued interest was $1,011. On August 31, 2020, the Company issued a convertible note payable and a note payable to Robert L. Hymers III in connection with the acquisition of an 18.8% equity interest in NPE. On November 16, 2020, the Company entered into a business acquisition agreement with Ethos Technology LLC, dba Comply Bag, a California limited liability company (“Ethos”). Ethos is a development stage business in the process of entering the market for cannabis trackable storage bags. By virtue of the agreement, Ethos sold, assigned, and transferred to the Company all of Ethos’ business, including all of its assets and associated liabilities, in exchange for the Company’s issuance of an aggregate of 6,000,000 common shares. 3,000,000 shares were due at signing, with 1,500,000 shares being issued to Edward Manolos, and 1,500,000 shares being issued to Thang Nguyen. Mr. Manolos is a director of the Company and a related party. Mr. Nguyen is the brother of Dan Van Nguyen, a director of the Company and a related party. After Ethos ships orders for Ethos products equaling $1,000,000 to unaffiliated parties, the Company will issue to Messrs. Manolos and Nguyen an additional 1,500,000 shares of common stock each.  On November 16, 2020, the Company sold an aggregate 3,000,000 shares of Company common stock, par value $0.001, equal in value to $177,000 based on the closing price on November 16, 2020. Of the total sold, 1,500,000 shares of common stock were sold to Edward Manolos and 1,500,000 shares of common stock were sold to Thang Nguyen. The sales were made in regards to the Company’s acquisition of Ethos, and its disclosures under Item 1.01 are incorporated herein by reference. The Company issued the above shares of its common stock pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended, available to the Company by Section 4(a)(2) promulgated thereunder due to the fact that it was an isolated issuance and did not involve a public offering of securities. Messrs. Manolos and Nguyen were “accredited investors” and/or “sophisticated investors” pursuant to Section 501(a)(b) of the Securities Act, who provided the Company with representations, warranties and information concerning their qualifications as “sophisticated investors” and/or “accredited investors.” The Company provided and made available to Messrs. Manolos and Nguyen full information regarding its business and operations. There was no general solicitation in connection with the offer or sale of the restricted securities. Messrs. Manolos and Nguyen acquired the restricted common stock for their own accounts, for investment purposes and not with a view to public resale or distribution thereof within the meaning of the Securities Act. The restricted shares cannot be sold unless subject to an effective registration statement by the Company, or by an exemption from registration requirements of Section 5 of the Securities Act—the existence of any such exemption subject to legal review and approval by the Company.   On January 27, 2021 Cannabis Global, Inc. (the “Registrant”) closed a material definitive agreement (MDA) with Edward Manolos, a director and related party. Pursuant to the MDA, the Registrant purchased from Mr. Manolos 266,667 shares of common stock in Natural Plant Extract of California Inc., a California corporation (“NPE”), representing 18.8% of the outstanding capital stock of NPE on a fully diluted basis. NPE operates a licensed psychoactive cannabis manufacturing and distribution business operation in Lynwood, California. NPE is a privately held corporation. Under the terms of the MDA, the Registrant acquired all beneficial ownership over the NPE shares in exchange for a purchase price of two million forty thousand dollars ($2,040,000). In lieu of a cash payment, the Registrant agreed to issue Mr. Manolos 11,383,929 restricted common shares, valued for purposes of the MDA at $0.1792 per share. In connection with the MDA, the Registrant became a party to a Shareholders Agreement by and among Alan Tsai, Hymers, Betterworld Ventures, LLC, Marijuana Company of America, Inc. and NPE. The Shareholders Agreement contains customary rights and obligations, including restrictions on the transfer of the Shares. Additionally, the Registrant intends, upon completion of the terms and conditions of the Material Definitive Agreement, to control the production, manufacturing and distribution of both NPE and the Registrant’s products

Note 10. - Notes Payable   On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 7- Notes Payable, Related Party and in Footnote 11 – Related Party Transactions.   On July 9, 2019, the Company, through its Action Nutraceuticals subsidiary, loaned, Split Tee, LLC (“Split Tee”), a venture associated with Director Edward Manolos, $20,000 to engage in an exploratory research project (see “Related Party Transactions”). An additional $20,000 was supplied to Split Tee on August 23, 2019. The loans carry interest at the rate of 10% per annum and are due in one year for issuance. In addition, The Company, via Action Nutraceuticals subsidiary, invoiced Split Tee $5,000 as a consulting fee.   On February 12, 2020, the Company issued three Sellers Acquisition promissory notes having an aggregate principal amount of $500,000 pursuant to an Acquisition Agreement to acquire Lelantos Biotech. The notes mature May 31, 2020; $450,000 (two tranches of $225,000) and $50,000 of the notes bear interest at the rate of 8% and 5% per annum, respectively. In the event, the notes are not paid within the Cash Repayment Period (prior to the Maturity Date), the notes specify the holder shall have two options for repayment including: [a] an Alternative Payment Stake Option equal to a 6.75%, 6.75% and 1.5% (or a pro-rated amount if the debt has been partially paid) fully diluted ownership position in the Company after August 4, 2020, August 12, 2020 and August 30, 2020, respectively; or [b] a Buy Out Option, anytime after the note has been outstanding for at least one year, equal to the total outstanding shares of the Company on the day of election, times 6.75%, 6.75% and 1.5%, respectively, times the average closing price of the Company’s common stock over the preceding 30 trading days, times 40% (due and payable within 90 days). Anti-dilution rights are provided for five years on the Sellers Acquisition notes and for 182 days after conversion to an Alternative Payment Stake. The notes include a Leak Out provision, should the Alternative Payment Stake option be elected, whereby no more than 30% of the holdings may be sold during the first 30 days after clearance for trading and no more than 25% of the remaining shares sold during any subsequent 30-day period. The notes are secured by a Security Agreement, require common shares to be reserved, are transferrable and are Senior to other debt of the Company. At maturity, on May 31, 2020, (i) the Company received forbearance agreements for the two tranches of $225,000 each whereby the maturity date was extended to July 15, 2020 and the interest rate was increased to 9%; and (ii) the $50,000 note and all accrued interest thereon, in the amount of $747, was forgiven. Accordingly, the Company recognized a gain for debt forgiveness of $50,747. On June 15, 2020, the Company entered into a modification agreement relative to the February 12, 2020 issued notes. Pursuant to the modification agreement, the Company issued a promissory note to Lantos in the amount of five hundred thousand dollars ($500,000). The Company may prepay the note in whole or in part at any time or from time to time without penalty or premium by paying the principal amount to be prepaid. The aggregate unpaid principal amount of the note is paid in monthly payments of seven thousand, five hundred dollars ($7,500) beginning on September 1, 2020, terminating on February 1, 2025. There is no interest on the note or on the unpaid balance. As of February 28, 2021, the carrying value of the notes was $450,000 and accrued interest payable was $37,676. As of August 31, 2020, the carrying value of the notes was $450,000 and accrued interest payable was $19,824.    On February 12, 2020, the Company entered into an Independent Consulting Agreement with a consultant to provide services from February 12, 2020 through December 14, 2020 (the “Consulting Agreement”). Pursuant to the Consulting Agreement, the Company issued to the consultant a Compensation promissory note having a principal amount of $100,000 for the Deferred Compensation portion of the Consulting Agreement. The note matures August 4, 2020 and bears interest at the rate of 8% per annum. In the event, the note is not paid within the Cash Repayment Period (prior to the Maturity Date), the note specifies the holder shall have two options for repayment including: [a] an Alternative Payment Stake Option equal to a 8.5% (or a pro-rated amount if the debt has been partially paid) fully diluted ownership position in the Company after August 4, 2020; or [b] a Buy Out Option, any time after the note has been outstanding for at least one year, equal to the total outstanding shares of the Company on the day of election, times 8.5% times the average closing price of the Company’s common stock over the preceding 30 trading days, times 40% (due and payable within 90 days). Anti-dilution rights are provided for five years on the Compensation note and for 182 days after conversion to an Alternative Payment Stake. The note includes a Leak Out provision, should the Alternative Payment Stake option be elected, whereby no more than 30% of the holdings may be sold during the first 30 days after clearance for trading and no more than 25% of the remaining shares sold during any subsequent 30-day period. The note is secured by a Security Agreement, requires common shares to be reserved, is transferrable and is Senior to other debt of the Company. As of February 28, 2021, the carrying value of the note was $100,000 and accrued interest payable was $8,372. As of August 31, 2020, the carrying value of the note was $100,000 and accrued interest payable was $4,405. Note 11. Convertible Notes Payable   On March 19, 2020, the Company issued a convertible promissory note, payable in tranches, having an aggregate principal amount of $150,000, aggregate original issue discount (OID) of $15,000, and an aggregate of 468,750 three-year warrants exercisable at $0.48/share, which contain certain exercise price reset provisions in the event of dilutive issuances. The notes mature one year from the respective issuance date of each tranche and bear interest at the rate of 10% per annum, payable at maturity. Commencing immediately following the issuances, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a variable conversion price equal to the lower of 60% of the lowest closing trade price of the Company’s common stock, subject to adjustment, during the 25 trading days prior to: (i) the issuance date; or (ii) the conversion date. On March 19, 2020, the first tranche of $50,000, less OID of $5,000, was received, resulting in net proceeds to the Company of $45,000, and the Company issued 156,250 three-year warrants exercisable at $0.48 per share. On May 4, 2020, the second tranche of $25,000, less OID of $2,500, was received, resulting in net proceeds to the Company of $22,500, and the Company issued 78,125 three-year warrants exercisable at $0.48 per share. On July 10, 2020, the third tranche of $25,000, less OID of $2,500 was received, resulting in net proceeds to the Company of $22,500, and the Company issued 78,125 three year warrants exercisable at an initial price of $0.48 per share. As a result of the OID and the variable conversion price, upon issuance, the Company recognized total debt discount of $75,000, which is being amortized to interest expense over the respective term of the tranches. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. During the six months ended February 28, 2021, the Company repaid all principal and accrued interest in full. On July 21, 2020, the Company issued a convertible promissory note with a principal amount of $78,750, with the Company receiving proceeds of $71,250 after original issue discount of $3,750 and deferred finance costs of $3,750. The note matures on July 21, 2021 and bears interest at 6% per annum. Commencing immediately following the issuances, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a variable conversion price equal to the 60% of the lowest closing trade price of the Company’s common stock, subject to adjustment, during the 30 trading days prior to: the conversion date. As a result of the OID and the variable conversion price, upon issuance, the Company recognized total debt discount of $78,750, which is being amortized to interest expense through the maturity date. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. During the six months ended February 28, 2021, the note and accrued interest were repaid in full. In August 2020, the Company issued two convertible promissory notes with an aggregate principal amount of $129,250, with the Company receiving proceeds of $117,500 after original issue discount of $11,750. The notes mature in May 2021 and bear interest at 10% per annum. Commencing immediately following the issuances, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a fixed price of $0.1005 per share of common stock. The conversion price may reset to a lower price if the Company issues common stock to any suppliers or vendors. As a result of the OID and the potential result for dilutive issuances, upon issuance, the Company recognized total debt discount of $129,250, which is being amortized to interest expense through the maturity date. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. During the six months ended February 28, 2021, the two notes and accrued interest were repaid in full. The Company also entered into common stock subscription agreements with this lender, totaling share issuances of 3,409,221 (of which 510,204 are to be issued as of August 31, 2020), for cash proceeds of $329,613. In connection with these subscriptions, the Company issued a convertible promissory note of $50,000 for no consideration. The note matures on August 7, 2021 and bears interest at 10$% and is convertible at a fixed price of $0.1631 per share, subject to potential rest in the event the Company issues shares to vendors or suppliers. The Company recognized total debt discount of $50,000, which is being amortized to interest expense over the respective term of the tranches. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. During the six months ended February 28, 2021, the note and accrued interest was repaid in full. During the six months ended February 28, 2021, the Company issued four convertible promissory notes to a lender with an aggregate principal amount of $279,500, with the Company receiving proceeds of $267,000 after deferred finance costs of $12,500. The notes matures in August, September, October and December 2021 and bear interest at 8% per annum. Commencing one hundred eighty (180) days following the issuance date of the note, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at variable conversion prices of 63% of the two lowest trading prices during previous fifteen (15) trading day of the Company’s common stock, subject to adjustment. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. As a result of the variable exercise price and deferred finance costs, the Company recognized total debt discount of $279,500, which is being amortized to interest expense through the maturity date. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. One note with principal of $113,000 and accrued interest of $4,557 was repaid during the period. As of February 28 2021, the carrying value of these notes was $60,379, net of debt discount of $106,121 and accrued interest was $4,830.   On September 2, 2020, the Company issued a convertible promissory note with an aggregate principal amount of $107,000, with the Company receiving proceeds of $100,000 after original issue discount of $5,000 and deferred finance costs of $2,000. The notes mature in September 2021 and bear interest at 12% per annum. Commencing one hundred eighty (180) days following the issuance date of the notes, the noteholders shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at variable conversion price of 60% of the lowest previous twenty (20) trading day closing trade prices of the Company’s common stock, subject to adjustment. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. As a result of the variable exercise price and deferred finance costs, upon issuance, the Company recognized total debt discount of $107,000, which is being amortized to interest expense through the maturity date. This note was repaid in full during the six months ended February 28, 2021, together with accrued interest of $5,101.   On January 5, 2021, the Company entered into a Securities Purchase Agreement in connection with the issuance of a 10% convertible note with the principal amount of $110,000, with an accredited investor. The note is convertible at a fixed conversion price of $0.005. In the event of default by the Company, or after the public announcement of a change of control transaction as defined in the agreement, the conversion price is $0.001. The Company received net proceeds of $97,500. As a result of the variable exercise price of the Company’s convertible notes and deferred finance costs, upon issuance, the Company recognized total debt discount of $110,000, which is being amortized to interest expense through the maturity date.   On January 12, 2021, the Company entered into a Securities Purchase Agreement in connection with the issuance of a 10% convertible note with the principal amount of $115,500, with an accredited investor. The note is convertible beginning 61 days from issuance at a fixed conversion price of $0.10 per share or 60% or the lowest trading price for ten days prior to conversion in the event that the Company’s stock trades at less than $0.10 per share. The Company received net proceeds of $100,000. As a result of the variable exercise price of the Company’s convertible notes and deferred finance costs, upon issuance, the Company recognized total debt discount of $115,500, which is being amortized to interest expense through the maturity date. During the three months ended February 28, 2021, the lender converted principal and accrued interest of $57,750 and $585 into 583,354 shares of common stock. As of February 28, 2021, the carrying value of the note was $14,873, net of discount of $42,877, and accrued interest was $902.   On January 26, 2021, the Company entered into a Securities Purchase Agreement in connection with the issuance of a 10% convertible note with the principal amount of $243,875, with an accredited investor. The note is convertible at 70% of the average of the three lowest trading prices for 20 days prior to conversion. The Company received net proceeds of $215,500. As a result of the variable exercise price of the Company’s convertible notes and deferred finance costs, upon issuance, the Company recognized total debt discount of $243,875, which is being amortized to interest expense through the maturity date. As of February 28, 2021, the carrying value of the note was $22,049, net of discount of $221,826, and accrued interest was $2,205.   On January 26, 2021, the Company entered into a second Securities Purchase Agreement in connection with the issuance of a 10% convertible note with the principal amount of $243,875, with an accredited investor. The note is convertible at 70% of the average of the three lowest trading prices for 20 days prior to conversion. The Company received net proceeds of $215,500. As a result of the variable exercise price of the Company’s convertible notes and deferred finance costs, upon issuance, the Company recognized total debt discount of $243,875, which is being amortized to interest expense through the maturity date. As of February 28, 2021, the carrying value of the note was $22,049, net of discount of $221,826, and accrued interest was $2,205.   Related Parties During the three months ended February 29, 2020, the Company issued two convertible promissory notes having an aggregate principal amount of $133,101 in exchange for accrued expenses owed to related parties, of which $79,333 is payable to the Company’s Chief Executive Officer and $53,768 is payable to the Robert L. Hymers III. The notes mature two years from the respective issuance date and bear interest at the rate of 10% per annum, payable at maturity. The noteholders shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a variable conversion price of 50% of the average of the previous twenty (20) trading day closing prices of the Company’s common stock, subject to adjustment. As a result of the variable conversion prices, upon issuance, the Company recognized total debt discount of $133,101, which is being amortized to interest expense over the term of the notes. On May 22, 2020, the Chief Executive Officer converted $79,333 in principal and $2,608 of accrued interest into 694,902 shares of common stock to be issued having a fair value of $232,792. The conversion resulted in the elimination of $70,313 of remaining debt discount, the elimination of $231,632 of derivative liabilities, and a $10,468 gain on conversion that resulted from a related party and was therefore included in Additional paid-in capital. On December 9, 2020, Mr. Hymers converted all principal of $53,768 and all accrued interest of $4,626 into 878,190 shares of common stock. On April 30, 2020, the Company entered into a settlement agreement with its former Chief Financial Officer (Robert L. Hymers III, hereinafter referred to as the “CFO”) whereby the CFO resigned and the Company issued a promissory note for $30,000, which represented the remaining amount owed to the CFO for services rendered. The note matures December 31, 2020 and bears interest at the rate of 10% per annum, payable at maturity. The noteholder has the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a fixed conversion price of $0.02 per share, subject to adjustment. As a result of the beneficial conversion price, upon issuance, the Company recognized debt discount of $30,000, which is being amortized to interest expense over the term of the note. On October 9, 2020, Mr. Hymers converted the note payable into 1,500,000 shares of common stock. On August 21, 2020 the Company, issued a convertible note pursuant to a Stock Purchase Agreement (the “SPA) to acquire 266,667 shares of common stock of Natural Plant Extract of California Inc., a California corporation (“NPE”), representing 18.8% of the outstanding capital stock of NPE on a fully diluted basis. With the exception of the entry into the subject material definitive agreements, no material relationship exists between the Registrant, or any of the Registrant’s affiliates or control persons and Hymers. Under the terms of the SPA, the Registrant acquired all rights and responsibilities of the equity stake for a purchase price of Two Million Forty Thousand United States Dollars ($2,040,000) (the “Purchase Price”). Relative to the payment of the Purchase Price, the registrant agreed to: 1) pay Hymers Twenty Thousand United States Dollars ($20,000) each month for a period of twenty-seven (27) months, with the first payment commencing September 1, 2020 and the remaining payments due and payable on the first day of each subsequent month until Hymers has received Five Hundred Forty Thousand United Stated Dollars ($540,000), and 2) issue Hymers a convertible promissory note in the amount of One Million Five Hundred Thousand United States Dollars ($1,500,000) (the “Note”). The Note bears interest at ten percent (10%) per annum. The Holder shall have the right at any time six (6) months after the Issuance Date to convert all or any part of the outstanding and unpaid principal, interest, fees, or any other obligation owed pursuant to the note. Conversion Price shall be calculated as follows: 60% of the lowest Trading Price of the common shares during the ten (10) days preceding the date the Company receive a notice of conversion. Unless permitted by the applicable rules and regulations of the principal securities market on which the Common Stock is then listed or traded, in no event shall the Registrant issue upon conversion of or otherwise pursuant to the note and the other notes issued more than the maximum number of shares of Common Stock that the Company can issue pursuant to any rule of the principal United States securities market on which the Common Stock is then traded, which shall be 4.99% of the total shares outstanding at any time. A debt discount of $54,212 on the note payable at issuance was calculated based on the present value of the note using an implied interest rate of 10%. A debt discount of $270,886 was recognized. Accordingly, the Company recorded an initial value of its investment in NPE of $1,714,903. At the time the note becomes convertible, the Company will recognize a derivative liability at fair value related to the embedded conversion option at that time. Prior to these transactions, Robert Hymers III and Alan Tsai each sold equity interest representing a total of 18.8% of the outstanding equity interest of NPE to Edward Manolos, a Director and preferred stockholder of the Company in a private transaction. As a result of these transactions, the Company beneficially controls approximately 56.5% of the equity of NPE. After this transaction, a Better World Ventures LLC controls 40% of the equity interests in NPE and one other entity controls 3.5%. The Company is in default of the $540,000 note payable to Robert Hymers. On January 3, 2021, the Company entered into a settlement agreement with Robert Hymers concerning five delinquent payments totaling $100,000, whereby 1,585,791 shares of common stock were issued in settlement of those payments. As of February 28, 2021, the Company missed two additionally $20,000 payments, i.e., January and February 2021 payments, and remains in default of this agreement.

Note 13. Commitments, Contingencies and Leases   The Company has entered into a lease for a production and warehouse facility located in Los Angeles, California to produce such products. The term of the lease is 12 months at a base price of $3,600 per month, beginning August 2019. At this time the lease agreement has ended and the Company rents to same facility on a month-to-month basis.   Our headquarters are located at 520 S. Grand Avenue, Suite 320, Los Angeles, California 90071 where we leased office space under a contract effective August 15, 2019, expiring on August 14, 2020. We now rent the premises on a month-to-month basis and paying $800 per month.   By way of the recent acquisition of a controlling interesting Natural Plant Extract of California, the Company is a party to a lease on a building and property in Lynwood, California. The lease term ends on May 2028. The total base rent is $11,000 a month, but the Company’s portion on the lease is $8,750 as another tenant pays the balance.

Note 15. Preferred Stock   There are 10,000,000 shares of preferred stock, par value $0.0001 per share, of the Company Preferred Stock in one or more series, and expressly authorized the Board of Directors of the Company. On December 16, 2019, the Board of Directors authorized the issuance of 8,000,000 preferred shares as “Series A Preferred Stock.” The Series A Preferred Stock is not convertible into any other form of Securities, including common shares, of the Company. Holders of Series A Preferred Stock shall be entitled to 50 votes for every Share of Series A Preferred Stock beneficially owned as of the record date for any shareholder vote or written consent. On May 28, 2020, Mr. Robert L. Hymers III, a former director and former chief financial officer, returned 2,000,000 Series A Preferred shares to the corporate treasury. As of February 28, 2021, there were 6,000,000 Series A Preferred shares issued and outstanding.    On February 28, 2021, the Company designated 1,000,000 shares of Series B Convertible Preferred Stock (“Series B Convertible Preferred Stock”). The Series B Convertible Preferred Stock earns dividends at 8% per year, and is convertible into shares of common stock at a rate of 63% of the market price, based on the average of the two lowest trading prices during the previous 15 days. Additionally, the Series B Convertible Preferred Stock is mandatorily redeemable 16 months from the issuance date in cash. The Company entered into an agreement with an investor for 153,500 shares of Series B Convertible Preferred Stock on February 28, 2021 for a total purchase amount of $153,500, and an agreement with the same investor for 78,500 shares of Series B Convertible Preferred Stock for a purchase amount of $78,500. In March 2021, the Company received proceeds of $225,000.

Note 16. Subsequent Events                   On March 8, 2021, the Company sold a convertible note with a face value of $215,000. The note carries interest at 10% annually.                   On March 16, 2021, the Company sold a convertible note with a face value of $215,000. The note carries interest at 10% annually.                   In March 2021, the Company received $232,000 of gross proceeds for 232,000 of its Series B Convertible Preferred Stock.                   On March 25, 2021, the Company sold 1,314,188 registered common shares at a price of $0.06 for a total purchase price of $78,851.28.

Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of February 28, 2021 and August 31, 2020: <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">February 28, 2021</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Quoted Prices in Active Markets for Identical Assets (Level 1)</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Significant Unobservable Inputs (Level 3)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; text-align: justify">Derivative liability</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">2,054,739</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">—  </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">—  </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">2,054,739</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">August 31, 2020</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Quoted Prices in Active Markets for Identical Assets (Level 1)</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Significant Unobservable Inputs (Level 3)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; text-align: justify">Derivative liability</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">1,125,803</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">—  </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">—  </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">1,125,803</td> <td style="width: 1%"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center">For the three months ended</td> <td style="padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center">For the six months ended</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center">February 28, 2021</td> <td> </td> <td colspan="3" style="text-align: center">February 29, 2020</td> <td> </td> <td colspan="3" style="text-align: center">February 28, 2021</td> <td> </td> <td colspan="3" style="text-align: center">February 29, 2020</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Pro Forma</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Pro Forma</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Pro Forma</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Pro Forma</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%">Revenue</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">126,820</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">229,597</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">979,866</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">334,144</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Operating loss</td> <td> </td> <td> </td> <td style="text-align: right">(1,693,708</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(557,425</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(1,626,929</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(973,276</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Net loss attributable to common shareholders</td> <td> </td> <td> </td> <td style="text-align: right">(3,392,070</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(1,019,316</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(4,065,390</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">1,521,976</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Net loss per common share</td> <td> </td> <td>$</td> <td style="text-align: right">(0.06</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.04</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.08</td> <td>)</td> <td> </td> <td>$</td> <td style="text-align: right">(0.06</td> <td>)</td></tr> </table> The following information summarizes the provisional purchase consideration and preliminary allocation of the fair values assigned to the assets at the purchase date:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>Preliminary Purchase Price Allocation:</td> <td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; padding-left: 9pt">Cash</td> <td style="width: 10%"> </td> <td style="width: 1%"> </td> <td style="width: 17%; text-align: right">2,200</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt">Accounts receivable</td> <td> </td> <td> </td> <td style="text-align: right">193,607</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt">Notes receivable</td> <td> </td> <td> </td> <td style="text-align: right">162,247</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt">Property and equipment</td> <td> </td> <td> </td> <td style="text-align: right">1,338,569</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt">Right of use asset – operating lease</td> <td> </td> <td> </td> <td style="text-align: right">607,306</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 9pt">Goodwill</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">8,098,603</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Total assets acquired</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">10,402,532</td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt">Accounts payable and accrued expenses</td> <td> </td> <td> </td> <td style="text-align: right">289,591</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 9pt">Right of use liability – operating lease</td> <td> </td> <td> </td> <td style="text-align: right">607,306</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9pt">Notes payable</td> <td> </td> <td> </td> <td style="text-align: right">1,825,101</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 9pt">Notes payable – related party</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">105,539</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Total Liabilities Assumed</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,827,537</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Derivative Instruments   The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in the fair value of derivatives liability are recorded in the consolidated statement of operations under non-operating income (expense). We evaluate all of our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, we use a weighted average Binomial option-pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Cash and Cash Equivalents   We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.

Deposits   Deposits is comprised of advance payments made to third parties, primarily for inventory for which we have not yet taken title. When we take title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see “Costs of Revenues” below). There were no deposits as of February 28, 2021.

Prepaid Expenses and Other Current Assets   Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

Accounts Receivable   Accounts receivable are recorded at the net value of face amount less any allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and, based on a method of specific identification of any accounts receivable for which we deem the net realizable value to be less than the gross amount of accounts receivable recorded, we establish an allowance for doubtful accounts for those balances. In determining our need for an allowance for doubtful accounts, we consider historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, our actual experience may vary from our estimates. If the financial condition of our clients were to deteriorate, resulting in their inability or unwillingness to pay our fees, we may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that we collect retainers from our clients prior to performing significant services.   The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of February 28, 2021, and February 29, 2020, we had $0 and $0 allowance for doubtful accounts, respectively.

Property and Equipment, net   Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Depreciation of capitalized construction in progress costs, a component of property and equipment, net, begins once the underlying asset is placed into service and is recognized over the estimated useful life. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.”

Accounting for the Impairment of Long-Lived Assets   We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets.

Beneficial Conversion Feature   market value at issuance, this feature is characterized as a beneficial conversion feature (“BCF”). We record a BCF as a debt discount pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ACF”) Topic 470-20 Debt with Conversion and Other Options. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and we amortize the discount to interest expense over the life of the debt using the effective interest method.

Revenue Recognition   For annual reporting periods after December 15, 2017, the Financial Accounting Standards Board (“FASB”) made effective ASU 2014-09 “Revenue from Contracts with Customers” to supersede previous revenue recognition guidance under current U.S. GAAP. Revenue is now recognized in accordance with FASB ASC Topic 606, Revenue Recognition. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. We determined to implement the cumulative effect adjustment approach to our implementation of FASB ASC Topic 606, with no restatement of the comparative periods presented. We intend to apply this method to any incomplete contracts we determine are subject to FASB ASC Topic 606 prospectively. As is more fully discussed below, we are of the opinion that none of our contracts for services or products contain significant financing components that require revenue adjustment under FASB ASC Topic 606.   In accordance with FASB ASC Topic 606, Revenue Recognition, we will recognize revenue when persuasive evidence of a significant financing component exists in our consulting and product sales contracts. We examine and evaluate when our customers become liable to pay for goods and services; how much consideration is paid as compared to the cash selling price of the goods or services; and, the length of time between our performance and the receipt of payment.

Product Sales   Revenue from product sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is shipped, and collectability is reasonably assured. For any shipments with destination terms, the Company defers revenue until delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant customer financing that would materially change the amount of revenue recognized under the sales transaction, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606.

Costs of Revenues   Our policy is to recognize the costs of revenue in the same manner in conjunction with revenue recognition. Costs of revenues include the costs directly attributable to revenue recognition and include compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

Stock-Based Compensation Restricted shares are awarded to employees and entitle the grantee to receive shares of restricted common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. Stock-based compensation during the quarterly reporting period ended February 28, 2021 was $0.

Income Taxes   We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the quarterly reporting periods ending February 28, 2021 and February 29, 2020, we incurred no income taxes and had no liabilities related to federal or state income taxes.

Loss Contingencies   From time to time the Company is subject to various legal proceedings and claims that arise in the ordinary course of business. On at least a quarterly basis, consistent with ASC 450-20-50-1C, if the Company determines that there is a reasonable possibility that a material loss may have been incurred, or is reasonably estimable, regardless of whether the Company accrued for such a loss (or any portion of that loss), the Company will confer with its legal counsel, consistent with ASC 450. If the material loss is determinable or reasonably estimable, the Company will record it in its accounts and as a liability on the balance sheet. If the Company determines that such an estimate cannot be made, the Company's policy is to disclose a demonstration of its attempt to estimate the loss or range of losses before concluding that an estimate cannot be made, and to disclose it in the notes to the financial statements under Contingent Liabilities.

Net Income (Loss) Per Common Share   We report net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

50524 15694 -498 14262

5093

-2110770

-762196

-385437

-762196

-353224

-2110770

-385437

-762196

-353224

-2110770

-385437

-353224

Consolidation   The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Action Nutraceuticals, Inc. and Aidan & Co, Inc. All intercompany balances and transactions have been eliminated in consolidation.

2200

193607

162247

1338569

607306

10402532

289591

607306 1825101 105539

2827537

131849

4933

500000

Note 12. Derivative Liability and Far Value Measurement Upon the issuance of the convertible promissory notes with variable conversion prices and fixed conversion prices with reset provisions, the Company determined that the features associated with the embedded conversion option embedded in the debentures should be accounted for at fair value, as a derivative liability, as the Company cannot determine if a sufficient number of shares would be available to settle all potential future conversion transactions. At the issuance date of the convertible notes payable during the six months ended February 28, 2021, the Company estimated the fair value of all embedded derivatives of $2,154,823 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 332% to 378%, (3) risk-free interest rate of 0.09% to 0.13%, and (4) expected life of one year. On February 28, 2021, the Company estimated the fair value of the embedded derivatives of $2,054,739 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 328%, (3) risk-free interest rate of 0.05% to 0.08%, and (4) expected life of 0.5 to 1 year.  The Company adopted the provisions of ASC 825-10, Financial Instruments (“ASC 825-10”). ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value.  <table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 7%"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 7%; padding-bottom: 10pt; text-align: center">•</td> <td style="font: 12pt Times New Roman, Times, Serif; width: 86%; padding-bottom: 10pt; text-align: justify">Level 1 — Observable inputs that reflect quoted market prices (unadjusted) for identical assets and liabilities in active markets;</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 7%"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 7%; padding-bottom: 10pt; text-align: center">•</td> <td style="font: 12pt Times New Roman, Times, Serif; width: 86%; padding-bottom: 10pt; text-align: justify">Level 2 — Observable inputs, other than quoted market prices, that are either directly or indirectly observable in the marketplace for identical or similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities; and</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 7%"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 7%; padding-bottom: 10pt; text-align: center">•</td> <td style="font: 12pt Times New Roman, Times, Serif; width: 86%; padding-bottom: 10pt; text-align: justify">Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to the fair value of assets or liabilities.</td></tr> </table> All items required to be recorded or measured on a recurring basis are based upon Level 3 inputs. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement. The Company recognizes its derivative liabilities as Level 3 and values its derivatives using the methods discussed below. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed are that of volatility and market price of the underlying common stock of the Company. As of February 28, 2021, the Company did not have any derivative instruments that were designated as hedges. Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of February 28, 2021 and August 31, 2020: <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">February 28, 2021</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Quoted Prices in Active Markets for Identical Assets (Level 1)</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Significant Unobservable Inputs (Level 3)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; text-align: justify">Derivative liability</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">2,054,739</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">—  </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">—  </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">2,054,739</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">August 31, 2020</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Quoted Prices in Active Markets for Identical Assets (Level 1)</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Significant Other Observable Inputs (Level 2)</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Significant Unobservable Inputs (Level 3)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; text-align: justify">Derivative liability</td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">1,125,803</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">—  </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">—  </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">1,125,803</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> </table>  The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities for the six months ended February 28, 2021: <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; text-align: justify">Balance, August 31, 2020</td> <td style="width: 10%"> </td> <td style="width: 1%">$</td> <td style="width: 17%; text-align: right">1,125,803</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Transfers in due to issuance of convertible promissory notes</td> <td> </td> <td> </td> <td style="text-align: right">2,514,823</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Transfers out due to repayments of convertible promissory notes</td> <td> </td> <td> </td> <td style="text-align: right">(1,255,220</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Transfers out due to conversions of convertible promissory notes</td> <td> </td> <td> </td> <td style="text-align: right">(276,975</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt; text-align: justify">Change in derivative liability for the six months ended February 28, 2021</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(53,692</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify">Balance, February 28, 2021</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">2,054,739</td> <td style="padding-bottom: 1pt"> </td></tr> </table>   Fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. As the stock price increases for each of the related derivative instruments, the value to the holder of the instrument generally increases, therefore increasing the liability on the Company’s balance sheet. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company’s derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the Company’s expected volatility. Increases in expected volatility would generally result in higher fair value measurement. A 10% change in pricing inputs and changes in volatilities and correlation factors would not result in a material change in our Level 3 fair value.

Note 14. Common Stock   Subsequent to the closing of the fiscal year ending August 31, 2019, the Company affected a reverse split as of September 30, 2019, which had the effect of reducing the number of outstanding shares from 187,864,600 to 12,524,307. All share and per share amounts in this filing have been retrospectively adjusted to reflect the impact of the reverse stock split.   As of February 28, 2021, there were 66,205,687 shares of Common Stock issued and outstanding. As of the date of this filing, April 19, 2021, there were 72,133,317 shares of Common Stock issued and outstanding.

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities for the six months ended February 28, 2021: <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%; text-align: justify">Balance, August 31, 2020</td> <td style="width: 10%"> </td> <td style="width: 1%">$</td> <td style="width: 17%; text-align: right">1,125,803</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Transfers in due to issuance of convertible promissory notes</td> <td> </td> <td> </td> <td style="text-align: right">2,514,823</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Transfers out due to repayments of convertible promissory notes</td> <td> </td> <td> </td> <td style="text-align: right">(1,255,220</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Transfers out due to conversions of convertible promissory notes</td> <td> </td> <td> </td> <td style="text-align: right">(276,975</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt; text-align: justify">Change in derivative liability for the six months ended February 28, 2021</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(53,692</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; text-align: justify">Balance, February 28, 2021</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid">$</td> <td style="border-bottom: black 1pt solid; text-align: right">2,054,739</td> <td style="padding-bottom: 1pt"> </td></tr> </table>

EX-101.SCH 6 cbgl-20210228.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern Uncertainties link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Notes Receivable – Related Party link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Acquisition of Natural Plant Extract of California, Inc. link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Note Payable to Shareholders link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Related Party link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Note Payable link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Convertible Note Payable link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Derivative Liability and Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Preferred Stock link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Acquisition of Natural Plant Extract of California, Inc. (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Derivative Liability and Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Organization and Description of Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Going Concern Uncertainties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Net Loss Per Share (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Notes Receivable-Related Party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Acquisition of Natural Plant Extract of California, Inc. (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Acquisition of Natural Plant Extract of California, Inc. (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Acquisition of Natural Plant Extract of California, Inc. (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Note Payable to Shareholders (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Related Party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Note Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Convertible Note Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Derivative Liability and Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Derivative Liability and Fair Value Measurements (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Derivative Liability and Fair Value Measurements (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Common Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Preferred Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cbgl-20210228_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cbgl-20210228_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cbgl-20210228_lab.xml XBRL LABEL FILE Legal Entity [Axis] Split Tee Related Party [Axis] Edward Manolos Long-term Debt, Type [Axis] Compensation Promissory Note Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Consulting Agreement Consultant Two Convertible Promissory Notes Tabatabaei Financial Instrument [Axis] Principal Interest Equity Components [Axis] Common Stock Common Stock To Be Issued Additional Paid-In Capital Accumulated Deficit Chief Executive Officer [Member] Whisper [member] Stock Purchase Agreement Shareholder Title of Individual [Axis] Chief Financial Officer [Member] Former Chief Financial Officer [Member] Convertible Promissory Note Convertible Promissory Note Two Convertible Promissory Notes Common stock subscription agreements Lender Business Acquisition [Axis] NPE Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Convertible Notes Payable [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Product and Service [Axis] Product Sales [Member] Consulting Revenue Related Party Member Class A Preferred Stock Lauderdale Holdings, LLC [Member] Counterparty Name [Axis] Unaffiliated Parties [Member] Mr. Robert Hymers [Member] Edward Manolos [Member] Dan Nguyen [Member] Settlement Agreement [Member] Hymers [Member] Marijuana Company of America, Inc [Member] Ethos Technology LLC [Member] Thang Nguyen [Member] Lelantos Three Convertible Promissory Notes Convertible Promissory Note Robert L. Hymers III [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Series B Preferred Stock [Member] Investor [Member] Investor One [Member] Natural Plant Extract Securities Purchase Agreement [Member] Accredited Investor Accredited Investor 1 Accredited Investor 2 Three Sellers Acquisition Promissory Notes Legal custodian Legal custodian 1 Legal custodian 2 Dan Nguyen Mr. Manolos Scenario [Axis] Pro Forma [Member] Modification agreement Common Stock to be issued Stockholders' Equity Attributable to Cannabis Global Inc Noncontrolling Interest Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Amendment description Current Fiscal Year End Date Document Fiscal Period Focus Is Entity a Shell Company? Is Entity's Reporting Status Current? Entity Filer Category Entity File Number Entity Common Stock, Shares Outstanding Entity Interactive Data Current Entity Incorporation, State or Country Code Document Fiscal Year Focus Entity Emerging Growth Company Entity Small Business Entity Ex Transition Period Statement of Financial Position [Abstract] ASSETS Current Assets: Cash Accounts Receivable Notes receivable, current Inventory Total Current Assets Machinery & Equipment- Net Other Assets Long-Term Investments Intangible Assets Right of Use Asset Notes Receivable Security Deposit Goodwill TOTAL ASSETS LIABILITIES & STOCKHOLDER'S EQUITY (DEFICIT) Current Liabilities: Accounts Payable Accounts Payable - Related Party Accrued Interest Right of use liability, current Notes payable, current Convertible Notes, Net of Debt Discount of $1,032,292 and $678,246, respectively Derivative Liability Note Payable - Related Party Total Current Liabilities Right of use liability, long term Notes payable Total Liabilities Stockholder's Equity (Deficit) Preferred Stock, par value $0.0001, 10,000,000 shares Authorized, 6,000,000 shares Issued and Outstanding at February 28, 2021 and August 31, 2020 Common Stock, par value $0.001, 290,000,000 shares Authorized, 66,205,687 and 27,082,419 shares Issued and Outstanding at February 28, 2021 and August 31, 2020, respectively Additional Paid-In Capital Shares to be issued Preferred stock to be issued Accumulated Deficit Total Stockholder's Equity (Deficit) attributable to Cannabis Global, Inc. Noncontrolling Interest Total Stockholders' Equity (Deficit) TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY (DEFICIT) Convertible Notes, Debt Discount Current Preferred stock, par or stated value per share (in dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par or stated value per share (in dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Statement [Table] Statement [Line Items] Revenues: Total Revenue Cost of Goods Sold Gross Profit Operating Expenses: Advertising fees Consulting services Professional fees General and administrative expense Total Operating Expenses Operating Loss Other Income (Expense) Interest expense Changes in FV of Derivative Liabilities Other Income Equity method loss Total Other Income (Expense) Net Loss Net loss attributable to noncontrolling interest Net loss attributable to Cannabis Global, Inc. Basic & Diluted Loss per Common Share Weighted Average Common Shares Outstanding Beginning Balance, Shares Beginning Balance, Value Stock based compensation, Share Stock based compensation, Value Proceeds from common stock subscriptions, Shares Proceeds from common stock subscriptions, Value Common stock issued for investment, Shares Common stock issued for investment, Value Common stock issued in settlement of convertible notes payable and accrued interest, Shares Common stock issued in settlement of convertible notes payable and accrued interest, Value Derivative impact of conversions Discount on convertible notes Preferred stock issued, Shares EX-101.PRE 10 cbgl-20210228_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Feb. 28, 2021	Apr. 19, 2021
Document And Entity Information
Entity Registrant Name	CANNABIS GLOBAL, INC.
Entity Central Index Key	0001413488
Document Type	10-Q
Document Period End Date	Feb. 28, 2021
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Document Fiscal Period Focus	Q2
Is Entity a Shell Company?	false
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Non-accelerated Filer
Entity File Number	000-27039
Entity Common Stock, Shares Outstanding		72,133,317
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	DE
Document Fiscal Year Focus	2021
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Feb. 28, 2021	Aug. 31, 2020
Current Assets:
Cash	$ 134,187	$ 2,338
Accounts Receivable	218,374	0
Notes receivable, current	121,247	0
Inventory	180,155	75,338
Total Current Assets	653,963	77,676
Machinery & Equipment- Net	1,362,177	25,406
Other Assets
Long-Term Investments	650,000	1,714,903
Intangible Assets	500,000	500,000
Right of Use Asset	607,306	0
Notes Receivable	41,000	0
Security Deposit	7,200	7,200
Goodwill	8,098,603	0
TOTAL ASSETS	11,920,249	2,325,185
Current Liabilities:
Accounts Payable	463,248	233,568
Accounts Payable - Related Party	1,139	1,139
Accrued Interest	139,401	33,301
Right of use liability, current	62,063	0
Notes payable, current	1,703,579	0
Convertible Notes, Net of Debt Discount of $1,032,292 and $678,246, respectively	1,948,152	1,866,872
Derivative Liability	2,054,739	1,125,803
Note Payable - Related Party	616,844	499,788
Total Current Liabilities	6,989,165	3,760,471
Right of use liability, long term	545,243	0
Notes payable	126,615	0
Total Liabilities	7,661,023	3,760,471
Stockholder's Equity (Deficit)
Preferred Stock, par value $0.0001, 10,000,000 shares Authorized, 6,000,000 shares Issued and Outstanding at February 28, 2021 and August 31, 2020	600	600
Common Stock, par value $0.001, 290,000,000 shares Authorized, 66,205,687 and 27,082,419 shares Issued and Outstanding at February 28, 2021 and August 31, 2020, respectively	66,203	2,708
Additional Paid-In Capital	8,862,713	4,618,168
Shares to be issued	1,360	187
Preferred stock to be issued	0	0
Accumulated Deficit	(8,520,943)	(6,056,949)
Total Stockholder's Equity (Deficit) attributable to Cannabis Global, Inc.	409,933	(1,435,286)
Noncontrolling Interest	3,849,293	0
Total Stockholders' Equity (Deficit)	4,259,226	(1,435,286)
TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY (DEFICIT)	$ 11,920,249	$ 2,325,185

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)	Feb. 28, 2021	Aug. 31, 2020
Statement of Financial Position [Abstract]
Convertible Notes, Debt Discount Current	$ 1,032,292	$ 678,246
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	6,000,000	6,000,000
Preferred stock, shares outstanding	6,000,000	6,000,000
Common stock, par or stated value per share (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	290,000,000	290,000,000
Common stock, shares issued	66,205,687	27,082,419
Common stock, shares outstanding	66,205,687	27,082,419

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2021	Feb. 29, 2020	Feb. 28, 2021	Feb. 29, 2020
Revenues:
Total Revenue	$ 25,816	$ 0	$ 30,226	$ 10,003
Cost of Goods Sold	6,653	0	7,953	2,900
Gross Profit	19,163	0	22,273	7,103
Operating Expenses:
Advertising fees	(498)	14,262	50,524	15,694
Consulting services	20,750	67,662	252,051	103,545
Professional fees	129,263	133,159	179,895	282,114
General and administrative expense	282,056	195,832	396,492	383,355
Total Operating Expenses	431,571	410,915	878,962	784,708
Operating Loss	(412,408)	(410,915)	(856,689)	(777,605)
Other Income (Expense)
Interest expense	(1,933,728)	(522,203)	(2,706,483)	(553,453)
Changes in FV of Derivative Liabilities	593,235	170,922	1,308,912	183,425
Other Income	1,522	0	1,642	0
Equity method loss	(359,391)	0	(211,376)	0
Total Other Income (Expense)	(1,698,362)	(351,281)	(1,607,305)	(370,028)
Net Loss	(2,110,770)	(762,196)	(2,463,994)	(1,147,633)
Net loss attributable to noncontrolling interest	0	0	0	0
Net loss attributable to Cannabis Global, Inc.	$ (2,110,770)	$ (762,196)	$ (2,463,994)	$ (1,147,633)
Basic & Diluted Loss per Common Share	$ (0.05)	$ (0.06)	$ (0.06)	$ (0.09)
Weighted Average Common Shares Outstanding	43,196,439	12,321,639	39,744,494	12,752,506
Product Sales [Member]
Revenues:
Total Revenue	$ 25,816	$ 0	$ 30,226	$ 5,003
Consulting Revenue Related Party Member
Revenues:
Total Revenue	$ 0	$ 0	$ 0	$ 5,000

XML 15 R5.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Class A Preferred Stock	Common Stock	Common Stock to be issued	Additional Paid-In Capital	Accumulated Deficit	Stockholders' Equity Attributable to Cannabis Global Inc	Noncontrolling Interest	Total
Beginning Balance, Shares at Aug. 31, 2019		12,524,307	1,893,333
Beginning Balance, Value at Aug. 31, 2019		$ 1,253	$ 189	$ 1,187,574	$ (1,127,601)	$ 61,415		$ 61,415
Stock based compensation, Share				95,670		95,670		95,670
Proceeds from common stock subscriptions, Shares		203,333
Proceeds from common stock subscriptions, Value		$ 20		$ 74,980		$ 75,000		$ 75,000
Discount on convertible notes				20,000		20,000		20,000
Proceeds from common stock subscriptions - To be Issued, Shares			260,000
Proceeds from common stock subscriptions - To be Issued, Value			$ 26	64,974		65,000		65,000
Common stock issued for services rendered, Shares		1,893,333	(1,893,333)
Common stock issued for services rendered, Value		$ 189	$ (189)
Shares Issued for Services, Shares		23,333
Shares Issued for Services, value		$ 2		20,881		20,883		20,883
Effects of Reverse stock-split, shares		188,822
Effects of Reverse stock-split, Value		$ 19		(19)
Net Loss					(385,437)	(385,437)		(385,437)
Ending Balance, Shares at Nov. 30, 2019		14,833,128	260,000
Ending Balance, Value at Nov. 30, 2019		$ 1,483	$ 26	1,464,060	(1,513,038)	(47,469)		(47,469)
Stock based compensation, Value				94,618		94,618		94,618
Common stock issued for investment, Shares			400,000
Common stock issued for investment, Value			$ 40	112,360		112,400		112,400
Proceeds from common stock subscriptions - To be Issued, Shares		260,000	(260,000)
Proceeds from common stock subscriptions - To be Issued, Value		$ 26	$ (26)
Net Loss					(762,196)	(762,196)		(762,196)
Ending Balance, Shares at Feb. 29, 2020		15,093,128	400,000
Ending Balance, Value at Feb. 29, 2020		$ 1,509	$ 40	1,671,038	(2,275,234)	(602,647)		(602,647)
Beginning Balance, Shares at Aug. 31, 2020	6,000,000	27,082,419	1,871,858
Beginning Balance, Value at Aug. 31, 2020	$ 600	$ 2,708	$ 187	4,618,168	(6,056,949)	(1,435,286)		(1,435,286)
Stock based compensation, Share		3,400,000
Stock based compensation, Value		$ 3,400		179,600		183,000		183,000
Proceeds from common stock subscriptions, Shares		510,204	89,796
Proceeds from common stock subscriptions, Value		$ 510	$ 90	(600)		0		0
Common stock issued for investment, Shares		7,222,222
Common stock issued for investment, Value		$ 7,222		642,778		650,000		650,000
Common stock issued in settlement of convertible notes payable and accrued interest, Shares		1,500,000
Common stock issued in settlement of convertible notes payable and accrued interest, Value		$ 1,500		28,500		30,000		30,000
Discount on convertible notes
Preferred stock issued, Value
Effects of Par value adjustment		24,372	1,683	(26,055)
Net Loss					(353,224)	(353,224)		(353,224)
Ending Balance, Shares at Nov. 30, 2020	6,000,000	39,714,845	1,961,654
Ending Balance, Value at Nov. 30, 2020	$ 600	$ 39,712	$ 1,960	5,442,391	(6,410,173)	(925,510)		(925,510)
Stock based compensation, Share		4,106,543	(600,000)
Stock based compensation, Value		$ 4,107	$ (600)	335,827		339,334		339,334
Proceeds from common stock subscriptions, Shares		6,516,667
Proceeds from common stock subscriptions, Value		$ 6,517		384,483		391,000		391,000
Common stock issued for investment, Shares		12,820,297
Common stock issued for investment, Value		$ 12,820		2,209,355		2,222,175	3,849,293	6,071,468
Common stock issued in settlement of convertible notes payable and accrued interest, Shares		3,047,335
Common stock issued in settlement of convertible notes payable and accrued interest, Value		$ 3,047		213,682		216,729		216,729
Derivative impact of conversions				276,975		276,975		276,975
Net Loss					(2,110,770)	(2,110,770)		(2,110,770)
Ending Balance, Shares at Feb. 28, 2021	6,000,000	66,205,687	1,361,654
Ending Balance, Value at Feb. 28, 2021	$ 600	$ 66,203	$ 1,360	$ 8,862,713	$ (8,520,943)	$ 409,933	$ 3,849,293	$ 4,259,226

XML 16 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Feb. 28, 2021	Feb. 29, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$ (2,463,994)	$ (1,147,633)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-Cash Interest Expense	2,342,280	547,671
Equity method loss from investments	211,376	0
Depreciation Expense	1,798	1,571
Stock Based Compensation	522,334	211,171
Changes in Fair Value of Derivative Liabilities	(1,308,912)	(183,425)
Changes In:
Accounts Receivable	(24,767)	(10,003)
Inventory	(104,817)	(22,831)
Accounts Payable and accrued expenses	(61,053)	79,168
Accounts Payable - Related Party	0	(1,139)
Accrued Interest	111,311	5,782
Net Cash Used in Operating Activities	(774,444)	(519,668)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of Machinery & Equipment	0	(3,500)
Cash acquired in acquisition	2,200	0
Net Cash Provided by Investing Activities	2,200	(3,500)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issuance of Common Stock	391,000	140,000
Proceeds from convertible notes payable	1,086,000	388,101
Repayment of convertible notes payable	(578,000)	0
Repayment of notes payable	5,093	0
Net Cash Provided by Financing Activities	904,093	528,101
Net (Decrease) Increase in Cash	131,849	4,933
Cash at Beginning of Period	2,338	152,082
Cash at End of Period	134,187	157,015
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest	188,292	0
Income Taxes	0	0
Shares issued and loan incurred for acquisition of intangible assets	650,000	612,400
Common stock issued for acquisition of NPE	2,222,175	0
Increase in noncontrolling interest from acquisition of NPE	3,849,293	0
Shares issued for conversion of notes payable and accrued interest	$ 246,729	$ 0

XML 17 R7.htm IDEA: XBRL DOCUMENT

Organization and Description of Business

6 Months Ended

Feb. 28, 2021

Accounting Policies [Abstract]

Organization and Description of Business

Note 1. Organization and Description of Business

Historical Development

Subsequent to the closing of the fiscal year ending August 31, 2019, we affected a reverse split of our common shares effective as of September 30, 2019 at the rate of 1:15.

Current Business Operations

Our R&D programs included the following:

Development of new routes and vehicles for hemp extract and cannabinoid delivery to the human body.

Production of unique polymeric nanoparticles and fibers for use in oral and dermal cannabinoid delivery.

Research and commercialization of new methodologies to isolate and/or concentrate various cannabinoids and other substances that comprise industrial hemp oil and other extracts.

Development of other novel inventions for the delivery of cannabinoids to the human body, which at this time are considered trade secrets by the Company.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Going Concern Uncertainties

6 Months Ended

Feb. 28, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Going Concern Uncertainties

Note 2. Going Concern Uncertainties

XML 19 R9.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Feb. 28, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 3. Summary of Significant Accounting Policies

Derivative Instruments

Consolidation

Cash and Cash Equivalents

Inventory

Deposits

Prepaid Expenses and Other Current Assets

Accounts Receivable

Property and Equipment, net

Accounting for the Impairment of Long-Lived Assets

Beneficial Conversion Feature

Revenue Recognition

Product Sales

Costs of Revenues

Stock-Based Compensation

Income Taxes

Loss Contingencies

Net Income (Loss) Per Common Share

XML 20 R10.htm IDEA: XBRL DOCUMENT

Net Loss Per Share

6 Months Ended

Feb. 28, 2021

Earnings Per Share [Abstract]

Net Loss Per Share

Note 4. Net Loss Per Share

XML 21 R11.htm IDEA: XBRL DOCUMENT

Notes Receivable – Related Party

6 Months Ended

Feb. 28, 2021

Notes to Financial Statements

Notes Receivable – Related Party

Note 5. – Notes Receivable – Related Party

XML 22 R12.htm IDEA: XBRL DOCUMENT

Intangible Assets

6 Months Ended

Feb. 28, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 6. Intangible Assets

XML 23 R13.htm IDEA: XBRL DOCUMENT

Acquisition of Natural Plant Extract of California, Inc.

6 Months Ended

Feb. 28, 2021

Notes to Financial Statements

Acquisition of Natural Plant Extract of California, Inc.

Note 7. Acquisition of Natural Plant Extract of California, Inc.

NPE Acquisition

The following information summarizes the provisional purchase consideration and preliminary allocation of the fair values assigned to the assets at the purchase date:

Preliminary Purchase Price Allocation:
Cash		2,200
Accounts receivable		193,607
Notes receivable		162,247
Property and equipment		1,338,569
Right of use asset – operating lease		607,306
Goodwill		8,098,603
Total assets acquired	$	10,402,532

Accounts payable and accrued expenses		289,591
Right of use liability – operating lease		607,306
Notes payable		1,825,101
Notes payable – related party		105,539
Total Liabilities Assumed	$	2,827,537

Unaudited Pro Forma Financial Information

	For the three months ended						For the six months ended
	February 28, 2021			February 29, 2020			February 28, 2021			February 29, 2020
	Pro Forma			Pro Forma			Pro Forma			Pro Forma
Revenue	$	126,820		$	229,597		$	979,866		$	334,144
Operating loss		(1,693,708	)		(557,425	)		(1,626,929	)		(973,276	)
Net loss attributable to common shareholders		(3,392,070	)		(1,019,316	)		(4,065,390	)		1,521,976
Net loss per common share	$	(0.06	)	$	(0.04	)	$	(0.08	)	$	(0.06	)

XML 24 R14.htm IDEA: XBRL DOCUMENT

Note Payable to Shareholders

6 Months Ended

Feb. 28, 2021

Notes to Financial Statements

Note Payable to Shareholders

Note 8. Note Payable to Shareholders

On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Payable, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos’ and Mr. Nguyen’s associations as directors, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

XML 25 R15.htm IDEA: XBRL DOCUMENT

Related Party

6 Months Ended

Feb. 28, 2021

Related Party

Related Party

Note 9. Related Party

On August 31, 2020, the Company issued a convertible note payable and a note payable to Robert L. Hymers III in connection with the acquisition of an 18.8% equity interest in NPE.

XML 26 R16.htm IDEA: XBRL DOCUMENT

Note Payable

6 Months Ended

Feb. 28, 2021

Note Payable

Note Payable

Note 10. - Notes Payable

XML 27 R17.htm IDEA: XBRL DOCUMENT

Convertible Note Payable

6 Months Ended

Feb. 28, 2021

Notes to Financial Statements

Convertible Note Payable

Note 11. Convertible Notes Payable

Related Parties

During the three months ended February 29, 2020, the Company issued two convertible promissory notes having an aggregate principal amount of $133,101 in exchange for accrued expenses owed to related parties, of which $79,333 is payable to the Company’s Chief Executive Officer and $53,768 is payable to the Robert L. Hymers III. The notes mature two years from the respective issuance date and bear interest at the rate of 10% per annum, payable at maturity. The noteholders shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a variable conversion price of 50% of the average of the previous twenty (20) trading day closing prices of the Company’s common stock, subject to adjustment. As a result of the variable conversion prices, upon issuance, the Company recognized total debt discount of $133,101, which is being amortized to interest expense over the term of the notes. On May 22, 2020, the Chief Executive Officer converted $79,333 in principal and $2,608 of accrued interest into 694,902 shares of common stock to be issued having a fair value of $232,792. The conversion resulted in the elimination of $70,313 of remaining debt discount, the elimination of $231,632 of derivative liabilities, and a $10,468 gain on conversion that resulted from a related party and was therefore included in Additional paid-in capital. On December 9, 2020, Mr. Hymers converted all principal of $53,768 and all accrued interest of $4,626 into 878,190 shares of common stock.

XML 28 R18.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements

6 Months Ended

Feb. 28, 2021

Notes to Financial Statements

Derivative Liability and Fair Value Measurements

Note 12. Derivative Liability and Far Value Measurement

•

Level 1 — Observable inputs that reflect quoted market prices (unadjusted) for identical assets and liabilities in active markets;

•

Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to the fair value of assets or liabilities.

All items required to be recorded or measured on a recurring basis are based upon Level 3 inputs.

As of February 28, 2021, the Company did not have any derivative instruments that were designated as hedges.

Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of February 28, 2021 and August 31, 2020:

	February 28, 2021		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Derivative liability	$	2,054,739	$	—	$	—	$	2,054,739

	August 31, 2020		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Derivative liability	$	1,125,803	$	—	$	—	$	1,125,803

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities for the six months ended February 28, 2021:

Balance, August 31, 2020	$	1,125,803
Transfers in due to issuance of convertible promissory notes		2,514,823
Transfers out due to repayments of convertible promissory notes		(1,255,220	)
Transfers out due to conversions of convertible promissory notes		(276,975	)
Change in derivative liability for the six months ended February 28, 2021		(53,692	)
Balance, February 28, 2021	$	2,054,739

XML 29 R19.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

6 Months Ended

Feb. 28, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 13. Commitments, Contingencies and Leases

XML 30 R20.htm IDEA: XBRL DOCUMENT

Common Stock

6 Months Ended

Feb. 28, 2021

Equity [Abstract]

Common Stock

Note 14. Common Stock

XML 31 R21.htm IDEA: XBRL DOCUMENT

Preferred Stock

6 Months Ended

Feb. 28, 2021

Equity [Abstract]

Preferred Stock

Note 15. Preferred Stock

XML 32 R22.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Feb. 28, 2021

Subsequent Events [Abstract]

Subsequent Events

Note 16. Subsequent Events

On March 8, 2021, the Company sold a convertible note with a face value of $215,000. The note carries interest at 10% annually.

On March 16, 2021, the Company sold a convertible note with a face value of $215,000. The note carries interest at 10% annually.

In March 2021, the Company received $232,000 of gross proceeds for 232,000 of its Series B Convertible Preferred Stock.

On March 25, 2021, the Company sold 1,314,188 registered common shares at a price of $0.06 for a total purchase price of $78,851.28.

XML 33 R23.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)	6 Months Ended
Summary of Significant Accounting Policies (Policies)	Feb. 28, 2021
Accounting Policies [Abstract]
Derivative Instruments	Derivative Instruments The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in the fair value of derivatives liability are recorded in the consolidated statement of operations under non-operating income (expense). We evaluate all of our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, we use a weighted average Binomial option-pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Consolidation	Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Action Nutraceuticals, Inc. and Aidan & Co, Inc. All intercompany balances and transactions have been eliminated in consolidation.
Cash and Cash Equivalents	*Cash and Cash Equivalents* We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.
Inventory	*Inventory* Inventory is primarily comprised of work in progress. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of February 28, 2021, and August 31, 2020, market values of all of our inventory were at cost, and accordingly, no such valuation allowance was recognized.
Deposits	*Deposits* Deposits is comprised of advance payments made to third parties, primarily for inventory for which we have not yet taken title. When we take title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see “Costs of Revenues” below). There were no deposits as of February 28, 2021.
Prepaid Expenses and Other Current Assets	*Prepaid Expenses and Other Current Assets* Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.
Accounts Receivable	*Accounts Receivable* Accounts receivable are recorded at the net value of face amount less any allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and, based on a method of specific identification of any accounts receivable for which we deem the net realizable value to be less than the gross amount of accounts receivable recorded, we establish an allowance for doubtful accounts for those balances. In determining our need for an allowance for doubtful accounts, we consider historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, our actual experience may vary from our estimates. If the financial condition of our clients were to deteriorate, resulting in their inability or unwillingness to pay our fees, we may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that we collect retainers from our clients prior to performing significant services. The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of February 28, 2021, and February 29, 2020, we had $0 and $0 allowance for doubtful accounts, respectively.
Property and Equipment, net	*Property and Equipment, net* Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Depreciation of capitalized construction in progress costs, a component of property and equipment, net, begins once the underlying asset is placed into service and is recognized over the estimated useful life. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.”
Accounting for the Impairment of Long-Lived Assets	*Accounting for the Impairment of Long-Lived Assets* We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets.
Beneficial Conversion Feature	*Beneficial Conversion Feature* market value at issuance, this feature is characterized as a beneficial conversion feature (“BCF”). We record a BCF as a debt discount pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ACF”) Topic 470-20 Debt with Conversion and Other Options. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and we amortize the discount to interest expense over the life of the debt using the effective interest method.
Revenue Recognition	*Revenue Recognition* For annual reporting periods after December 15, 2017, the Financial Accounting Standards Board (“FASB”) made effective ASU 2014-09 “Revenue from Contracts with Customers” to supersede previous revenue recognition guidance under current U.S. GAAP. Revenue is now recognized in accordance with FASB ASC Topic 606, Revenue Recognition. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. We determined to implement the cumulative effect adjustment approach to our implementation of FASB ASC Topic 606, with no restatement of the comparative periods presented. We intend to apply this method to any incomplete contracts we determine are subject to FASB ASC Topic 606 prospectively. As is more fully discussed below, we are of the opinion that none of our contracts for services or products contain significant financing components that require revenue adjustment under FASB ASC Topic 606. In accordance with FASB ASC Topic 606, Revenue Recognition, we will recognize revenue when persuasive evidence of a significant financing component exists in our consulting and product sales contracts. We examine and evaluate when our customers become liable to pay for goods and services; how much consideration is paid as compared to the cash selling price of the goods or services; and, the length of time between our performance and the receipt of payment.
Product Sales	*Product Sales* Revenue from product sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is shipped, and collectability is reasonably assured. For any shipments with destination terms, the Company defers revenue until delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant customer financing that would materially change the amount of revenue recognized under the sales transaction, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606.
Costs of Revenues	*Costs of Revenues* Our policy is to recognize the costs of revenue in the same manner in conjunction with revenue recognition. Costs of revenues include the costs directly attributable to revenue recognition and include compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.
Stock-Based Compensation	*Stock-Based Compensation* Restricted shares are awarded to employees and entitle the grantee to receive shares of restricted common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. Stock-based compensation during the quarterly reporting period ended February 28, 2021 was $0.
Income Taxes	*Income Taxes* We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the quarterly reporting periods ending February 28, 2021 and February 29, 2020, we incurred no income taxes and had no liabilities related to federal or state income taxes.
Loss Contingencies	*Loss Contingencies* From time to time the Company is subject to various legal proceedings and claims that arise in the ordinary course of business. On at least a quarterly basis, consistent with ASC 450-20-50-1C, if the Company determines that there is a reasonable possibility that a material loss may have been incurred, or is reasonably estimable, regardless of whether the Company accrued for such a loss (or any portion of that loss), the Company will confer with its legal counsel, consistent with ASC 450. If the material loss is determinable or reasonably estimable, the Company will record it in its accounts and as a liability on the balance sheet. If the Company determines that such an estimate cannot be made, the Company's policy is to disclose a demonstration of its attempt to estimate the loss or range of losses before concluding that an estimate cannot be made, and to disclose it in the notes to the financial statements under Contingent Liabilities.
Net Income (Loss) Per Common Share	*Net Income (Loss) Per Common Share* We report net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

XML 34 R24.htm IDEA: XBRL DOCUMENT

Acquisition of Natural Plant Extract of California, Inc. (Tables)

6 Months Ended

Feb. 28, 2021

Notes to Financial Statements

Schedule of Preliminary Purchase Price Allocation

The following information summarizes the provisional purchase consideration and preliminary allocation of the fair values assigned to the assets at the purchase date:

Preliminary Purchase Price Allocation:
Cash		2,200
Accounts receivable		193,607
Notes receivable		162,247
Property and equipment		1,338,569
Right of use asset – operating lease		607,306
Goodwill		8,098,603
Total assets acquired	$	10,402,532

Accounts payable and accrued expenses		289,591
Right of use liability – operating lease		607,306
Notes payable		1,825,101
Notes payable – related party		105,539
Total Liabilities Assumed	$	2,827,537

Schedule of Unaudited Pro Forma Financial Information

	For the three months ended						For the six months ended
	February 28, 2021			February 29, 2020			February 28, 2021			February 29, 2020
	Pro Forma			Pro Forma			Pro Forma			Pro Forma
Revenue	$	126,820		$	229,597		$	979,866		$	334,144
Operating loss		(1,693,708	)		(557,425	)		(1,626,929	)		(973,276	)
Net loss attributable to common shareholders		(3,392,070	)		(1,019,316	)		(4,065,390	)		1,521,976
Net loss per common share	$	(0.06	)	$	(0.04	)	$	(0.08	)	$	(0.06	)

XML 35 R25.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements (Tables)

6 Months Ended

Feb. 28, 2021

Notes to Financial Statements

Fair Value, Assets Measured on Recurring Basis

Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of February 28, 2021 and August 31, 2020:

	February 28, 2021		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Derivative liability	$	2,054,739	$	—	$	—	$	2,054,739

		August 31, 2020				Quoted Prices in Active Markets for Identical Assets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Unobservable Inputs (Level 3)
Derivative liability		$	1,125,803			$	—			$	—			$	1,125,803

Summary of changes in fair value of Level 3 financial liabilities

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities for the six months ended February 28, 2021:

Balance, August 31, 2020	$	1,125,803
Transfers in due to issuance of convertible promissory notes		2,514,823
Transfers out due to repayments of convertible promissory notes		(1,255,220	)
Transfers out due to conversions of convertible promissory notes		(276,975	)
Change in derivative liability for the six months ended February 28, 2021		(53,692	)
Balance, February 28, 2021	$	2,054,739

XML 36 R26.htm IDEA: XBRL DOCUMENT

Organization and Description of Business (Details Narrative) - USD ($)		1 Months Ended							6 Months Ended
	Jan. 03, 2021	Jan. 27, 2021	Nov. 16, 2020	Sep. 30, 2020	Aug. 31, 2020	Aug. 21, 2020	Jul. 22, 2020	May 25, 2019	Feb. 16, 2021	Jan. 02, 2020	Jul. 01, 2019
Common stock, shares sold			3,000,000
Proceeds from sale of common stock			$ 177,000
Ethos Technology LLC [Member]
Shares issued for business acquisition			6,000,000
Stock Purchase Agreement
Common stock, shares issued					266,667				266,667
Shares issued for business acquisition						266,667
Chief Executive Officer [Member]
Accounts Payable											$ 1,000
Whisper [member]
Restricted common stock							$ 150,000
Shareholder \| Stock Purchase Agreement
Common stock purchase price					$ 2,040,000				$ 1,436,368
Debt default										$ 100,000
Hymers [Member] \| Settlement Agreement [Member]
Stock issued under agreement	1,585,791
Edward Manolos [Member]
Common stock, shares sold			1,500,000
Edward Manolos [Member] \| Ethos Technology LLC [Member]
Shares issued for business acquisition			1,500,000
Additional shares issued to related parties			1,500,000
Thang Nguyen [Member]
Common stock, shares sold			1,500,000
Thang Nguyen [Member] \| Ethos Technology LLC [Member]
Shares issued for business acquisition			1,500,000
Additional shares issued to related parties			1,500,000
Mr. Manolos
Shares issued for business acquisition		266,667
Additional shares issued to related parties		11,383,929
Lauderdale Holdings, LLC [Member]
Common stock, shares outstanding, percentage								70.70%
Lauderdale Holdings, LLC [Member] \| Mr. Robert Hymers [Member]
Common stock, shares sold								43,333,333
Proceeds from sale of common stock								$ 108,333
Lauderdale Holdings, LLC [Member] \| Edward Manolos [Member]
Common stock, shares sold								43,333,333
Proceeds from sale of common stock								$ 108,333
Lauderdale Holdings, LLC [Member] \| Dan Nguyen [Member]
Common stock, shares sold								43,333,333
Proceeds from sale of common stock								$ 108,333
Lauderdale Holdings, LLC [Member] \| Unaffiliated Parties [Member]
Common stock, shares sold								130,000,000
Proceeds from sale of common stock								$ 325,000
Marijuana Company of America, Inc [Member]
Shares issued for exchange of shares				7,222,222
Number of common stock exchanged				650,000,000

XML 37 R27.htm IDEA: XBRL DOCUMENT

Going Concern Uncertainties (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2021	Feb. 29, 2020	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated Deficit	$ (8,520,943)		$ (8,520,943)		$ (6,056,949)
Net loss	$ (2,110,770)	$ (762,196)	(2,463,994)	$ (1,147,633)
Cash used in operating activities			$ (774,444)	$ (519,668)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

XML 38 R28.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended
	Feb. 28, 2021	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2020
Accounting Policies [Abstract]
Valuation allowance	$ 0	$ 0		$ 0
Deposits	0	0
Allowance for doubtful accounts	0	0		$ 0
Income taxes		$ 0	$ 0
Stock-based compensation	$ 0

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

XML 39 R29.htm IDEA: XBRL DOCUMENT

Net Loss Per Share (Details Narrative)	6 Months Ended
Net Loss Per Share (Details Narrative)	Feb. 28, 2021 shares
Earnings Per Share [Abstract]
Conversion of Stock, Shares Converted	13,385,151

XML 40 R30.htm IDEA: XBRL DOCUMENT

Notes Receivable-Related Party (Details Narrative) - USD ($)	Jul. 09, 2019	Feb. 28, 2021	Aug. 31, 2020	Aug. 23, 2019	May 25, 2019
Note Payable		$ 1,703,579	$ 0
Dan Nguyen
Note Payable					$ 1,666,667
Interest Rate					5.00%
Edward Manolos
Note Payable					$ 1,666,667
Interest Rate					5.00%
Split Tee
Notes Receivable	$ 20,000	$ 0		$ 20,000
Interest rate	10.00%
Consulting fee	$ 5,000

XML 41 R31.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details Narrative)	1 Months Ended
Intangible Assets (Details Narrative)	Jun. 15, 2020 shares
Modification agreement \| Lelantos
Common stock obligations	400,000

XML 42 R32.htm IDEA: XBRL DOCUMENT

Acquisition of Natural Plant Extract of California, Inc. (Details) - USD ($)	Feb. 28, 2021	Feb. 16, 2021	Aug. 31, 2020
Goodwill	$ 8,098,603		$ 0
NPE
Cash		$ 2,200
Accounts receivable		193,607
Notes receivable		162,247
Property and equipment		1,338,569
Right of use asset - operating lease		607,306
Goodwill		8,098,603
Total assets acquired		10,402,532
Accounts payable and accrued expenses		289,591
Right of use liability - operating lease		607,306
Notes payable		1,825,101
Notes payable - related party		105,539
Total Liabilities Assumed		$ 2,827,537

XML 43 R33.htm IDEA: XBRL DOCUMENT

Acquisition of Natural Plant Extract of California, Inc. (Details 1) - Pro Forma [Member] - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2021	Feb. 29, 2020	Feb. 28, 2021	Feb. 29, 2020
Revenue	$ 126,820	$ 229,597	$ 979,866	$ 334,144
Operating loss	(1,693,708)	(557,425)	(1,626,929)	(973,276)
Net loss attributable to common shareholders	$ (3,392,070)	$ (1,019,316)	$ (4,065,390)	$ 1,521,976
Net loss per common share	$ (0.06)	$ (0.04)	$ (0.08)	$ (0.06)

XML 44 R34.htm IDEA: XBRL DOCUMENT

Acquisition of Natural Plant Extract of California, Inc. (Details Narrative) - USD ($)	1 Months Ended			3 Months Ended		6 Months Ended
	Feb. 16, 2021	Jan. 27, 2021	Aug. 21, 2020	Feb. 28, 2021	Feb. 29, 2020	Feb. 28, 2021	Feb. 29, 2020
Revenue				$ 25,816	$ 0	$ 30,226	$ 10,003
Net loss				(2,110,770)	$ (762,196)	(2,463,994)	$ (1,147,633)
Mr. Manolos
Shares issued for business acquisition		266,667
Additional shares issued to related parties		11,383,929
Additional fair value		$ 1,821,429
NPE
Ownership percentage	56.50%
Fair value adjustment	$ 3,684,347
Gain loss on investment	359,391
Non-controlling interest	$ 3,849,293
Revenue				18,864		18,864
Net loss				$ 17,797		$ 17,797
Stock Purchase Agreement
Shares issued for business acquisition			266,667
Stock Purchase Agreement \| NPE
Shares issued for business acquisition	266,667
Debt discount			$ 270,886
Initial investment			$ 1,714,903
Additional shares issued to related parties	1,436,368
Additional fair value	$ 400,747
Ownership percentage			4.99%

XML 45 R35.htm IDEA: XBRL DOCUMENT

Note Payable to Shareholders (Details Narrative) - USD ($)	Feb. 28, 2021	Aug. 31, 2020	May 25, 2019
Note Payable	$ 1,703,579	$ 0
Edward Manolos
Note Payable			$ 1,666,667
Interest Rate			5.00%
Dan Nguyen [Member]
Note Payable			$ 1,666,667
Interest Rate			5.00%

XML 46 R36.htm IDEA: XBRL DOCUMENT

Related Party (Details Narrative) - USD ($)			1 Months Ended				3 Months Ended	6 Months Ended	11 Months Ended	12 Months Ended
Related Party (Details Narrative) - USD ($)	Jul. 09, 2019	May 08, 2018	Jan. 27, 2021	Nov. 16, 2020	May 22, 2020	Apr. 30, 2020	Aug. 31, 2018	Feb. 28, 2021	Aug. 31, 2018	Aug. 31, 2018	Aug. 31, 2020	Feb. 29, 2020	Aug. 23, 2019	May 25, 2019
Common stock, shares sold				3,000,000
Proceeds from sale of common stock				$ 177,000
Sale of stock price per share				$ 0.001
Notes Payable, Related Party								$ 616,844			$ 499,788
Conversion of Stock, Shares Converted								13,385,151
Beneficial conversion feature										$ 27,954
Note Payable								$ 1,703,579			0
Accrued interest payable								139,401			33,301
Two Convertible Promissory Notes
Interest Rate												10.00%
Principal amount												$ 133,101
Split Tee
Consulting fee	$ 5,000
Notes Receivable	$ 20,000							$ 0					$ 20,000
Ethos Technology LLC [Member]
Shares issued for business acquisition				6,000,000
Mr. Manolos
Shares issued for business acquisition			266,667
Additional shares issued to related parties			11,383,929
Shares price			$ 0.1792
Edward Manolos [Member]
Common stock, shares sold				1,500,000
Note Payable														$ 1,666,667
Interest Rate														5.00%
Edward Manolos [Member] \| Ethos Technology LLC [Member]
Shares issued for business acquisition				1,500,000
Additional shares issued to related parties				1,500,000
Thang Nguyen [Member]
Common stock, shares sold				1,500,000
Thang Nguyen [Member] \| Ethos Technology LLC [Member]
Shares issued for business acquisition				1,500,000
Additional shares issued to related parties				1,500,000
Legal custodian
Gain on Debt Cancellation									$ 168,048
Notes Payable, Related Party							$ 10,000		10,000	10,000
Legal custodian 1
Notes Payable, Related Party							$ 35,554		$ 35,554	$ 35,554
Conversion Price							$ 0.0001		$ 0.0001	$ 0.0001
Conversion of Stock, Amount Converted		$ 13,000
Legal custodian 2
Advances							$ 600
Interest rate							10.00%
Dan Nguyen
Note Payable														$ 1,666,667
Interest Rate														5.00%
Tabatabaei \| Two Convertible Promissory Notes
Conversion of Stock, Amount Converted					$ 81,942
Conversion of Stock, Shares Converted					694,902
Tabatabaei \| Two Convertible Promissory Notes \| Principal
Conversion of Stock, Amount Converted					$ 79,333
Chief Financial Officer [Member]
Conversion Price						$ 0.02
Interest rate						10.00%
Beneficial conversion feature						$ 30,000
Carrying value											15,884
Debt discount											37,884
Accrued interest payable											3,138
Notes Receivable						$ 30,000
Former Chief Financial Officer [Member]
Carrying value											15,061
Debt discount											14,939
Accrued interest payable											$ 1,011

XML 47 R37.htm IDEA: XBRL DOCUMENT

Note Payable (Details Narrative) - USD ($)			1 Months Ended
Note Payable (Details Narrative) - USD ($)	Feb. 12, 2020	Jul. 09, 2019	Feb. 20, 2020	May 25, 2019	Feb. 28, 2021	Aug. 31, 2020	Aug. 23, 2019
Accrued interest payable					$ 139,401	$ 33,301
Split Tee
Note payable		$ 20,000					$ 20,000
Interest rate		10.00%
Consulting fee		$ 5,000
Lelantos
Business acquisition, shares issued			400,000
Issuance promissory note			$ 500,000
Edward Manolos
Note payable				$ 1,666,667
Interest rate				5.00%
Compensation Promissory Note \| Consulting Agreement \| Consultant
Interest rate	8.00%
Principal amount	$ 100,000
Maturity date	Aug. 04, 2020
Carrying value					100,000	100,000
Accrued interest payable					8,372	4,405
Three Sellers Acquisition Promissory Notes
Interest rate	8.00%
Principal amount	$ 500,000
Maturity date	May 31, 2020
Carrying value					450,000	450,000
Gain for debt forgiveness	$ 50,747
Accrued interest payable					$ 37,676	$ 19,824

XML 48 R38.htm IDEA: XBRL DOCUMENT

Convertible Note Payable (Details Narrative) - USD ($)							1 Months Ended								3 Months Ended	6 Months Ended		12 Months Ended
Convertible Note Payable (Details Narrative) - USD ($)	Mar. 08, 2021	Jan. 12, 2021	Jan. 05, 2021	Dec. 09, 2020	Oct. 09, 2020	Sep. 02, 2020	Mar. 16, 2021	Jan. 26, 2021	Aug. 31, 2020	Aug. 21, 2020	Jul. 21, 2020	May 22, 2020	Apr. 30, 2020	Mar. 19, 2020	Feb. 29, 2020	Feb. 28, 2021	Feb. 29, 2020	Aug. 31, 2018	Feb. 16, 2021
Proceeds from Convertible debt																$ 1,086,000	$ 388,101
Accrued interest payable									$ 33,301							$ 139,401
Conversion of Stock, Shares Converted																13,385,151
Beneficial Conversion Feature																		$ 27,954
Repayment of convertible debt																$ 578,000	0
Subsequent Event [Member]
Principal amount	$ 215,000						$ 215,000
Interest rate	10.00%						10.00%
NPE
Beneficial ownership percentage																			56.50%
Chief Executive Officer [Member]
Principal amount															$ 79,333		79,333
Robert L. Hymers III [Member]
Principal amount															53,768		53,768
Former Chief Financial Officer [Member]
Conversion price													$ 0.02
Chief Financial Officer [Member]
Interest rate													10.00%
Interest expense													$ 30,000
Maturity date													Dec. 31, 2020
Beneficial Conversion Feature													$ 30,000
Principal \| Chief Financial Officer [Member]
Conversion of Stock, Shares Converted					1,500,000
Robert L. Hymers III [Member]
Conversion of Stock, Shares Converted				878,190
Robert L. Hymers III [Member] \| Principal
Conversion of Stock, Amount Converted				$ 53,768
Robert L. Hymers III [Member] \| Interest
Conversion of Stock, Amount Converted				$ 4,626
Common stock subscription agreements \| Lender
Proceeds from Convertible debt									$ 329,613
Interest rate									10.00%
Interest expense									$ 50,000
Convertible debt																$ 50,000
Beneficial ownership percentage																4.99%
Conversion of Stock, Shares Converted									3,409,221
Maturity date									Aug. 07, 2021
Securities Purchase Agreement [Member] \| Accredited Investor
Principal amount			$ 110,000
Proceeds from Convertible debt			$ 97,500
Interest rate			10.00%
Interest expense			$ 110,000
Conversion price			$ 0.05
Securities Purchase Agreement [Member] \| Accredited Investor 1
Principal amount		$ 115,500
Proceeds from Convertible debt		$ 100,000
Interest rate		10.00%
Interest expense		$ 115,500
Carrying value																$ 14,873
Debt discount																42,877
Accrued interest payable																$ 902
Conversion of Stock, Shares Converted																583,354
Conversion price		$ 0.10
Securities Purchase Agreement [Member] \| Accredited Investor 1 \| Principal
Conversion of Stock, Amount Converted																$ 57,750
Securities Purchase Agreement [Member] \| Accredited Investor 1 \| Interest
Conversion of Stock, Amount Converted																585
Securities Purchase Agreement [Member] \| Accredited Investor 2
Principal amount								$ 243,875
Proceeds from Convertible debt								$ 215,500
Interest rate								10.00%
Interest expense								$ 243,875
Carrying value																22,049
Debt discount																221,826
Accrued interest payable																2,205
Stock Purchase Agreement \| NPE
Debt discount										$ 270,886
Beneficial ownership percentage										4.99%
Initial investment										$ 1,714,903
Debt default										$ 100,000
Stock Purchase Agreement \| NPE
Interest rate										10.00%
Stock Issued During Period, Shares, Acquisitions										266,667
Convertible Promissory Note
Principal amount														$ 150,000
Original issue discount														$ 15,000
Warrants exercisable														468,750
Interest rate														10.00%
Interest expense														$ 75,000
Warrant grant term														3 years
Warrant granted price														$ 0.48
Beneficial ownership percentage														4.99%
Convertible Promissory Note
Principal amount											$ 78,750
Original issue discount											3,750
Deferred finance costs											3,750
Proceeds from Convertible debt											$ 71,250
Interest rate											6.00%
Interest expense											$ 78,750
Beneficial ownership percentage											4.99%
Maturity date											Jul. 21, 2021
Two Convertible Promissory Notes
Principal amount									$ 129,250
Original issue discount									11,750
Proceeds from Convertible debt									$ 117,500
Interest rate									10.00%
Interest expense									$ 129,250
Beneficial ownership percentage									4.99%
Maturity date									May 31, 2021
Three Convertible Promissory Notes
Principal amount																279,500
Deferred finance costs																12,500
Proceeds from Convertible debt																$ 267,000
Interest rate																8.00%
Interest expense																$ 279,500
Carrying value																60,379
Debt discount																106,121
Accrued interest payable																$ 4,830
Beneficial ownership percentage																4.99%
Repayment of convertible debt																$ 113,000
Repayment of accrued interest																4,557
Convertible Promissory Note
Principal amount						$ 107,000
Original issue discount						5,000
Deferred finance costs						2,000
Proceeds from Convertible debt						100,000
Interest expense						$ 107,000
Beneficial ownership percentage						4.99%
Maturity date						Sep. 30, 2021
Repayment of convertible debt																107,000
Repayment of accrued interest																$ 5,101
Two Convertible Promissory Notes
Principal amount															$ 133,101		$ 133,101
Interest rate															10.00%
Interest expense															$ 133,101
Two Convertible Promissory Notes \| Tabatabaei
Conversion of Stock, Amount Converted												$ 81,942
Conversion of Stock, Shares Converted												694,902
Gain on conversion												$ 10,468
Two Convertible Promissory Notes \| Tabatabaei \| Principal
Conversion of Stock, Amount Converted												79,333
Two Convertible Promissory Notes \| Tabatabaei \| Interest
Conversion of Stock, Amount Converted												$ 2,608

XML 49 R39.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements (Details) - USD ($)	Feb. 28, 2021	Aug. 31, 2020
Derivative liability	$ 2,054,739	$ 1,125,803
Fair Value, Inputs, Level 1 [Member]
Derivative liability	0	0
Fair Value, Inputs, Level 2 [Member]
Derivative liability	0	0
Fair Value, Inputs, Level 3 [Member]
Derivative liability	$ 2,054,739	$ 1,125,803

XML 50 R40.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements (Details 1)	6 Months Ended
	Feb. 28, 2021 USD ($)
Notes to Financial Statements
Balance at beginning	$ 1,125,803
Transfers in due to issuance of convertible promissory notes	2,514,823
Transfers out due to repayments of convertible promissory notes	(1,255,220)
Transfers out due to conversions of convertible promissory notes	(276,975)
Change in derivative liability	(53,692)
Balance at end	$ 2,054,739

XML 51 R41.htm IDEA: XBRL DOCUMENT

Derivative Liability and Fair Value Measurements (Details Narrative)	6 Months Ended
	Feb. 28, 2021 USD ($)
Fair value of embedded derivatives	$ 2,054,739
Dividend yield	0.00%
Expected volatility	328.00%
Minimum [Member]
Risk-free interest rate	0.05%
Expected life (in years)	6 months
Maximum [Member]
Risk-free interest rate	0.08%
Expected life (in years)	1 year
Convertible Notes Payable [Member]
Fair value of embedded derivatives	$ 2,154,823
Dividend yield	0.00%
Expected life (in years)	1 year
Convertible Notes Payable [Member] \| Minimum [Member]
Expected volatility	332.00%
Risk-free interest rate	0.09%
Convertible Notes Payable [Member] \| Maximum [Member]
Expected volatility	378.00%
Risk-free interest rate	0.13%

XML 52 R42.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative)	6 Months Ended
Commitments and Contingencies (Details Narrative)	Feb. 28, 2021 USD ($)
Lease expiration date	Aug. 14, 2020
Natural Plant Extract
Lease expiration date	May 31, 2028
Base rent	$ 11,000
Lease expenses	$ 8,750

XML 53 R43.htm IDEA: XBRL DOCUMENT

Common Stock (Details Narrative) - shares	6 Months Ended
Common Stock (Details Narrative) - shares	Feb. 28, 2021	Apr. 19, 2021	Aug. 31, 2020
Reverse stock split, description	Company affected a reverse split as of September 30, 2019, which had the effect of reducing the number of outstanding shares from 187,864,600 to 12,524,307.
Common stock, shares issued	66,205,687		27,082,419
Common stock, shares outstanding	66,205,687		27,082,419
Subsequent Event [Member]
Common stock, shares issued		72,133,317
Common stock, shares outstanding		72,133,317

XML 54 R44.htm IDEA: XBRL DOCUMENT

Preferred Stock (Details Narrative) - USD ($)	1 Months Ended			6 Months Ended
Preferred Stock (Details Narrative) - USD ($)	Mar. 31, 2021	May 28, 2020	Dec. 16, 2019	Feb. 28, 2021	Aug. 31, 2020
Preferred stock, shares authorized				10,000,000	10,000,000
Preferred stock, par or stated value per share				$ 0.0001	$ 0.0001
Preferred stock, shares issued				6,000,000	6,000,000
Preferred stock, shares outstanding				6,000,000	6,000,000
Series B Preferred Stock [Member]
Proceeds from Issuance of Preferred Stock	$ 225,000
Series B Preferred Stock [Member] \| Investor [Member]
Number of shares issued				153,500
Purchase Price				$ 153,500
Series B Preferred Stock [Member] \| Investor One [Member]
Number of shares issued				78,500
Purchase Price				$ 78,500
Series A Preferred Stock [Member]
Preferred stock, shares authorized			8,000,000
Preferred stock, voting right			Holders of Series A Preferred Stock shall be entitled to 50 votes for every Share of Series A Preferred Stock
Shares returned during the period		2,000,000
Preferred stock, shares issued				6,000,000
Preferred stock, shares outstanding				6,000,000

XML 55 R45.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Narrative) - USD ($)		1 Months Ended			6 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Mar. 08, 2021	Mar. 31, 2021	Mar. 25, 2021	Mar. 16, 2021	Feb. 28, 2021	Feb. 29, 2020
Proceeds from Convertible debt					$ 1,086,000	$ 388,101
Subsequent Event [Member]
Principal amount	$ 215,000			$ 215,000
Interest rate	10.00%			10.00%
Subsequent Event [Member] \| Common Stock
Number of shares issued			1,314,188
Purchase Price			$ 78,851
Share price			$ 0.06
Subsequent Event [Member] \| Series B Preferred Stock [Member]
Proceeds from Convertible debt		$ 232,000
Interest rate		10.00%
Number of shares issued		232,000

EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 219 334 1 false 75 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://cannabisglobalinc.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://cannabisglobalinc.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://cannabisglobalinc.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://cannabisglobalinc.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) Sheet http://cannabisglobalinc.com/role/ConsolidatedStatementOfStockholdersDeficit CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) Sheet http://cannabisglobalinc.com/role/ConsolidatedStatementOfCashFlows CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Description of Business Sheet http://cannabisglobalinc.com/role/OrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Uncertainties Sheet http://cannabisglobalinc.com/role/GoingConcernUncertainties Going Concern Uncertainties Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://cannabisglobalinc.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Net Loss Per Share Sheet http://cannabisglobalinc.com/role/NetLossPerShare Net Loss Per Share Notes 10 false false R11.htm 00000011 - Disclosure - Notes Receivable ??? Related Party Notes http://cannabisglobalinc.com/role/NotesReceivableRelatedParty Notes Receivable ??? Related Party Notes 11 false false R12.htm 00000012 - Disclosure - Intangible Assets Sheet http://cannabisglobalinc.com/role/IntangibleAssets Intangible Assets Notes 12 false false R13.htm 00000013 - Disclosure - Acquisition of Natural Plant Extract of California, Inc. Sheet http://cannabisglobalinc.com/role/AcquisitionOfNaturalPlantExtractOfCaliforniaInc. Acquisition of Natural Plant Extract of California, Inc. Notes 13 false false R14.htm 00000014 - Disclosure - Note Payable to Shareholders Sheet http://cannabisglobalinc.com/role/NotePayableToShareholders Note Payable to Shareholders Notes 14 false false R15.htm 00000015 - Disclosure - Related Party Sheet http://cannabisglobalinc.com/role/RelatedParty Related Party Notes 15 false false R16.htm 00000016 - Disclosure - Note Payable Sheet http://cannabisglobalinc.com/role/NotePayable Note Payable Notes 16 false false R17.htm 00000017 - Disclosure - Convertible Note Payable Sheet http://cannabisglobalinc.com/role/ConvertibleNotePayable Convertible Note Payable Notes 17 false false R18.htm 00000018 - Disclosure - Derivative Liability and Fair Value Measurements Sheet http://cannabisglobalinc.com/role/DerivativeLiabilityAndFairValueMeasurements Derivative Liability and Fair Value Measurements Notes 18 false false R19.htm 00000019 - Disclosure - Commitments and Contingencies Sheet http://cannabisglobalinc.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 19 false false R20.htm 00000020 - Disclosure - Common Stock Sheet http://cannabisglobalinc.com/role/CommonStock Common Stock Notes 20 false false R21.htm 00000021 - Disclosure - Preferred Stock Sheet http://cannabisglobalinc.com/role/PreferredStock Preferred Stock Notes 21 false false R22.htm 00000022 - Disclosure - Subsequent Events Sheet http://cannabisglobalinc.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://cannabisglobalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://cannabisglobalinc.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Acquisition of Natural Plant Extract of California, Inc. (Tables) Sheet http://cannabisglobalinc.com/role/AcquisitionOfNaturalPlantExtractOfCaliforniaInc.Tables Acquisition of Natural Plant Extract of California, Inc. (Tables) Tables http://cannabisglobalinc.com/role/AcquisitionOfNaturalPlantExtractOfCaliforniaInc. 24 false false R25.htm 00000025 - Disclosure - Derivative Liability and Fair Value Measurements (Tables) Sheet http://cannabisglobalinc.com/role/DerivativeLiabilityAndFairValueMeasurementsTables Derivative Liability and Fair Value Measurements (Tables) Tables http://cannabisglobalinc.com/role/DerivativeLiabilityAndFairValueMeasurements 25 false false R26.htm 00000026 - Disclosure - Organization and Description of Business (Details Narrative) Sheet http://cannabisglobalinc.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative Organization and Description of Business (Details Narrative) Details http://cannabisglobalinc.com/role/OrganizationAndDescriptionOfBusiness 26 false false R27.htm 00000027 - Disclosure - Going Concern Uncertainties (Details Narrative) Sheet http://cannabisglobalinc.com/role/GoingConcernUncertaintiesDetailsNarrative Going Concern Uncertainties (Details Narrative) Details http://cannabisglobalinc.com/role/GoingConcernUncertainties 27 false false R28.htm 00000028 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://cannabisglobalinc.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://cannabisglobalinc.com/role/SummaryOfSignificantAccountingPoliciesPolicies 28 false false R29.htm 00000029 - Disclosure - Net Loss Per Share (Details Narrative) Sheet http://cannabisglobalinc.com/role/NetLossPerShareDetailsNarrative Net Loss Per Share (Details Narrative) Details http://cannabisglobalinc.com/role/NetLossPerShare 29 false false R30.htm 00000030 - Disclosure - Notes Receivable-Related Party (Details Narrative) Notes http://cannabisglobalinc.com/role/NotesReceivable-relatedPartyDetailsNarrative Notes Receivable-Related Party (Details Narrative) Details 30 false false R31.htm 00000031 - Disclosure - Intangible Assets (Details Narrative) Sheet http://cannabisglobalinc.com/role/IntangibleAssetsDetailsNarrative Intangible Assets (Details Narrative) Details http://cannabisglobalinc.com/role/IntangibleAssets 31 false false R32.htm 00000032 - Disclosure - Acquisition of Natural Plant Extract of California, Inc. (Details) Sheet http://cannabisglobalinc.com/role/AcquisitionOfNaturalPlantExtractOfCaliforniaInc.Details Acquisition of Natural Plant Extract of California, Inc. (Details) Details http://cannabisglobalinc.com/role/AcquisitionOfNaturalPlantExtractOfCaliforniaInc.Tables 32 false false R33.htm 00000033 - Disclosure - Acquisition of Natural Plant Extract of California, Inc. (Details 1) Sheet http://cannabisglobalinc.com/role/AcquisitionOfNaturalPlantExtractOfCaliforniaInc.Details1 Acquisition of Natural Plant Extract of California, Inc. (Details 1) Details http://cannabisglobalinc.com/role/AcquisitionOfNaturalPlantExtractOfCaliforniaInc.Tables 33 false false R34.htm 00000034 - Disclosure - Acquisition of Natural Plant Extract of California, Inc. (Details Narrative) Sheet http://cannabisglobalinc.com/role/AcquisitionOfNaturalPlantExtractOfCaliforniaInc.DetailsNarrative Acquisition of Natural Plant Extract of California, Inc. (Details Narrative) Details http://cannabisglobalinc.com/role/AcquisitionOfNaturalPlantExtractOfCaliforniaInc.Tables 34 false false R35.htm 00000035 - Disclosure - Note Payable to Shareholders (Details Narrative) Sheet http://cannabisglobalinc.com/role/NotePayableToShareholdersDetailsNarrative Note Payable to Shareholders (Details Narrative) Details http://cannabisglobalinc.com/role/NotePayableToShareholders 35 false false R36.htm 00000036 - Disclosure - Related Party (Details Narrative) Sheet http://cannabisglobalinc.com/role/RelatedPartyDetailsNarrative Related Party (Details Narrative) Details http://cannabisglobalinc.com/role/RelatedParty 36 false false R37.htm 00000037 - Disclosure - Note Payable (Details Narrative) Sheet http://cannabisglobalinc.com/role/NotePayableDetailsNarrative Note Payable (Details Narrative) Details http://cannabisglobalinc.com/role/NotePayableToShareholders 37 false false R38.htm 00000038 - Disclosure - Convertible Note Payable (Details Narrative) Sheet http://cannabisglobalinc.com/role/ConvertibleNotePayableDetailsNarrative Convertible Note Payable (Details Narrative) Details http://cannabisglobalinc.com/role/ConvertibleNotePayable 38 false false R39.htm 00000039 - Disclosure - Derivative Liability and Fair Value Measurements (Details) Sheet http://cannabisglobalinc.com/role/DerivativeLiabilityAndFairValueMeasurementsDetails Derivative Liability and Fair Value Measurements (Details) Details http://cannabisglobalinc.com/role/DerivativeLiabilityAndFairValueMeasurementsTables 39 false false R40.htm 00000040 - Disclosure - Derivative Liability and Fair Value Measurements (Details 1) Sheet http://cannabisglobalinc.com/role/DerivativeLiabilityAndFairValueMeasurementsDetails1 Derivative Liability and Fair Value Measurements (Details 1) Details http://cannabisglobalinc.com/role/DerivativeLiabilityAndFairValueMeasurementsTables 40 false false R41.htm 00000041 - Disclosure - Derivative Liability and Fair Value Measurements (Details Narrative) Sheet http://cannabisglobalinc.com/role/DerivativeLiabilityAndFairValueMeasurementsDetailsNarrative Derivative Liability and Fair Value Measurements (Details Narrative) Details http://cannabisglobalinc.com/role/DerivativeLiabilityAndFairValueMeasurementsTables 41 false false R42.htm 00000042 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://cannabisglobalinc.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://cannabisglobalinc.com/role/CommitmentsAndContingencies 42 false false R43.htm 00000043 - Disclosure - Common Stock (Details Narrative) Sheet http://cannabisglobalinc.com/role/CommonStockDetailsNarrative Common Stock (Details Narrative) Details http://cannabisglobalinc.com/role/CommonStock 43 false false R44.htm 00000044 - Disclosure - Preferred Stock (Details Narrative) Sheet http://cannabisglobalinc.com/role/PreferredStockDetailsNarrative Preferred Stock (Details Narrative) Details http://cannabisglobalinc.com/role/PreferredStock 44 false false R45.htm 00000045 - Disclosure - Subsequent Events (Details Narrative) Sheet http://cannabisglobalinc.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://cannabisglobalinc.com/role/SubsequentEvents 45 false false All Reports Book All Reports cbgl-20210228.xml cbgl-20210228.xsd cbgl-20210228_cal.xml cbgl-20210228_def.xml cbgl-20210228_lab.xml cbgl-20210228_pre.xml http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 true true ZIP 61 0001079973-21-000292-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001079973-21-000292-xbrl.zip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end